data_2k2a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.283 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.4 mt -54.63 -21.4 10.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.567 0.622 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.8 -15.21 63.44 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 14.8 pt-20 -50.4 -46.1 56.0 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.412 0.445 . . . . 0.0 111.53 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -74.97 -42.92 56.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.813 0.34 . . . . 0.0 110.909 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -59.59 -47.5 85.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.008 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 44.0 ptt85 -62.08 -25.41 67.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.703 -175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 79.7 mt -74.18 -20.34 60.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.058 0.456 . . . . 0.0 110.728 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 102' ' ' LYS . 34.3 m-85 -101.91 6.54 41.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.703 -175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.525 ' OD2' ' HA ' ' A' ' 98' ' ' ARG . 23.1 m-20 -80.75 33.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.478 ' HG3' ' H ' ' A' ' 103' ' ' GLU . 18.2 pttp -74.24 -47.98 31.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' H ' ' HG3' ' A' ' 102' ' ' LYS . 30.7 mt-10 -117.58 105.68 12.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.602 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 162.34 30.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -141.28 111.02 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.294 0.547 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.42 -22.61 8.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.532 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -126.4 79.53 1.86 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.475 ' HB ' HG11 ' A' ' 112' ' ' VAL . 30.8 pt -77.21 141.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.604 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 112' ' ' VAL . 18.0 m -63.52 141.34 58.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.621 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.604 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 18.2 p -53.46 -23.79 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.066 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.27 -51.49 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.051 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 109' ' ' SER . 9.8 p -69.62 -34.18 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.434 -172.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.509 ' SD ' HG23 ' A' ' 144' ' ' VAL . 25.6 ttt -65.66 -25.58 67.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.785 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.468 ' HG2' HG13 ' A' ' 133' ' ' ILE . 82.1 mtm180 -60.68 -44.59 96.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 109.845 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.64 -34.37 73.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.154 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.0 mt -60.39 -47.51 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.667 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.07 68.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.932 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -81.32 -17.46 49.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.11 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.42 -61.49 1.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.568 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.582 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 14.4 t70 -85.69 158.31 20.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.767 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -116.38 -24.73 7.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -96.24 -40.16 9.31 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.582 ' HG ' ' OD2' ' A' ' 121' ' ' ASP . 4.4 pp -76.48 150.31 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.567 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 t -94.65 178.91 5.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.258 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.425 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 15.4 m -63.52 -36.89 85.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.91 -39.28 91.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 110.313 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.63 -53.09 60.9 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 4.7 pp -67.3 -34.6 77.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.162 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.084 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.28 72.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.2 mtm -73.18 -35.44 66.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.07 0.462 . . . . 0.0 110.314 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.604 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 39.7 mm -73.99 -31.01 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.66 0.743 . . . . 0.0 110.132 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.2 -27.04 65.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.18 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.52 3.98 23.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 133' ' ' ILE . 6.3 tt -106.08 -23.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.721 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.584 ' OD1' ' HA2' ' A' ' 142' ' ' GLY . 9.8 t0 -41.63 123.54 2.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.684 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -89.14 12.76 14.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.716 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 30.0 t70 76.3 -1.93 2.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.981 0.512 . . . . 0.0 112.239 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.82 63.65 4.41 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.344 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.4 m 66.59 25.28 10.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.019 0.437 . . . . 0.0 109.945 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.584 ' HA2' ' OD1' ' A' ' 137' ' ' ASP . . . 80.7 69.46 1.4 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.559 -176.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -134.05 162.22 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.509 HG23 ' SD ' ' A' ' 113' ' ' MET . 48.7 t -120.2 136.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.45 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -82.87 176.53 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.76 -57.99 8.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.621 0.248 . . . . 0.0 111.475 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.27 -29.66 68.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -63.34 -41.57 98.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.985 0.421 . . . . 0.0 109.872 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.51 -49.86 71.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 87.5 mmm -55.73 -50.87 69.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.778 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.96 -43.12 97.03 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.239 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.44 -40.09 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.918 0.39 . . . . 0.0 111.114 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.427 -175.895 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.454 HD23 ' SD ' ' A' ' 153' ' ' MET . 55.1 mt -102.13 -1.58 31.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.175 0.512 . . . . 0.0 110.377 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.41 -35.37 30.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.041 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.97 -45.56 67.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 30.4 t80 -71.32 -43.59 66.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.25 -32.52 62.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.4 mt -73.15 -40.67 64.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.179 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.84 15.74 28.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.423 0.63 . . . . 0.0 110.189 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 103' ' ' GLU . 6.6 t70 -62.26 103.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.835 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 107' ' ' TYR . 14.5 mptt -80.67 -3.82 52.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.289 169.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 2.6 mm-40 -58.5 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -165.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.41 55.0 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 156.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 64.75 48.68 2.42 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -159.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.19 -38.84 1.91 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.512 -167.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 40.5 m-85 60.54 -171.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -171.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.18 142.67 41.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.994 -0.441 . . . . 0.0 110.303 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.547 ' HB2' HG22 ' A' ' 112' ' ' VAL . 15.6 m -70.11 142.16 52.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.051 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 17.1 p -58.94 -31.9 69.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.974 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.32 -45.94 89.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.263 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 109' ' ' SER . 58.8 t -62.88 -43.72 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.319 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.7 tpt -54.37 -36.72 64.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.889 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' THR . 78.8 mtm180 -61.49 -47.32 86.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.1 -43.78 86.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.73 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 112' ' ' VAL . 76.9 mt -57.49 -40.27 73.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.35 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.94 -29.54 35.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.657 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 129' ' ' LEU . . . -78.49 -22.11 47.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.28 -26.19 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.89 -55.98 5.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.646 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.414 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 25.7 t70 -107.16 142.38 36.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.982 0.42 . . . . 0.0 110.482 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -99.79 -9.05 23.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.779 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 p -104.24 -16.78 15.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.466 HD12 ' HE1' ' A' ' 132' ' ' MET . 97.5 mt -79.36 117.63 20.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.802 0.334 . . . . 0.0 110.29 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 2.8 t -81.47 155.36 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.361 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -59.65 -32.4 70.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.577 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.71 -50.18 74.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.448 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -34.77 72.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.091 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 133' ' ' ILE . 7.8 mt -69.14 -26.63 64.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.839 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.86 -43.68 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.66 70.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.466 ' HE1' HD12 ' A' ' 124' ' ' LEU . 65.5 mtt -70.55 -52.78 19.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.921 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 129' ' ' LEU . 42.2 mm -58.53 -33.37 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.79 -27.94 32.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -110.78 10.44 22.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.994 0.425 . . . . 0.0 110.941 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 79.7 mt -128.03 -37.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.506 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 7.1 t70 -50.46 126.85 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.046 0.451 . . . . 0.0 111.883 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -92.57 15.6 13.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.177 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 11.1 t70 81.37 -18.86 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 168.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.0 78.58 1.89 Allowed Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.717 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 p 51.6 30.22 6.34 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 110.229 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.506 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 76.68 70.71 1.25 Allowed Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.337 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 t -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 112.043 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.11 119.25 60.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.755 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.87 153.87 42.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -65.68 -12.84 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -79.74 -38.94 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.213 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.73 -29.5 45.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 97' ' ' PHE . 67.0 t80 -73.6 67.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.68 0.752 . . . . 0.0 109.548 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.423 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.1 tmt? -164.78 -70.33 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.205 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.97 -27.21 73.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.992 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.28 -36.53 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 111.433 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.454 ' SD ' HD23 ' A' ' 93' ' ' LEU . 23.9 ptm . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.634 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.37 -43.76 89.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.4 ttp85 -69.37 -39.63 77.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.83 -43.44 79.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.687 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.84 -42.47 93.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.656 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 38.6 mtm180 -63.78 -36.52 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.804 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.12 -14.32 33.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.56 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.43 -26.46 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.478 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -91.89 86.45 5.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.27 -32.93 72.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.939 -174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.583 ' HB2' HD22 ' A' ' 105' ' ' ASN . 41.3 mm-40 -85.47 -36.96 20.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.419 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.97 54.48 1.89 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.228 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.583 HD22 ' HB2' ' A' ' 103' ' ' GLU . 30.4 m-80 -93.1 -35.38 13.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 110.023 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.56 5.12 57.93 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.413 ' HD1' ' HB3' ' A' ' 145' ' ' ASP . 9.9 m-85 -136.29 145.11 45.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 144' ' ' VAL . 28.6 pt -123.32 140.73 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 111.231 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.9 t -67.16 144.98 55.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.605 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.2 p -58.96 -27.18 65.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.417 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' ARG . 18.4 t0 -70.43 -35.27 73.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 110.043 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 116' ' ' ILE . 73.6 t -66.86 -41.27 87.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.503 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.2 tpt -56.22 -34.75 66.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.839 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 111' ' ' ASP . 15.2 mtp180 -56.04 -53.88 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.693 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.57 -36.03 80.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 112' ' ' VAL . 73.8 mt -57.62 -44.14 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.96 -41.67 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HA ' HD12 ' A' ' 124' ' ' LEU . . . -68.66 -29.19 67.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.63 -5.75 59.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.003 0.43 . . . . 0.0 110.755 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 tt -88.49 -50.51 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -130.6 147.34 52.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -95.79 -22.75 17.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -82.1 -20.31 38.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 118' ' ' ALA . 3.9 pp -76.93 152.19 35.41 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.968 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -107.27 176.94 5.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.703 0.287 . . . . 0.0 110.979 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.66 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 12.1 p -69.44 -25.44 64.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.929 0.395 . . . . 0.0 110.603 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.85 -39.66 89.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 132' ' ' MET . 27.0 m-20 -61.29 -38.91 88.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 12.9 mt -56.93 -44.4 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.374 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.88 -47.9 73.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.699 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.6 98.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.726 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 128' ' ' ASP . 24.2 mmt -58.2 -55.62 32.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 111.183 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.07 -35.7 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.321 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.98 -26.67 49.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.713 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -118.2 10.17 12.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 111.42 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.63 -69.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.524 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 138' ' ' ALA . 4.5 m-20 47.11 -145.63 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 137' ' ' ASP . . . -164.74 -89.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.578 0.227 . . . . 0.0 111.476 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.2 -59.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.589 0.233 . . . . 0.0 111.593 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.46 70.9 1.4 Allowed Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.938 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 61.26 36.19 17.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 109.941 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.1 45.26 5.99 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.378 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 p -91.44 87.72 6.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.174 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.403 ' HB ' HG13 ' A' ' 108' ' ' ILE . 42.5 t -78.68 110.91 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.413 ' HB3' ' HD1' ' A' ' 107' ' ' TYR . 7.0 p-10 -85.43 176.27 8.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.894 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -61.05 -38.93 87.92 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -66.88 -49.13 66.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.6 -51.11 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.731 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.96 -42.5 76.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.359 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.75 -53.97 18.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.698 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.28 -25.83 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.649 0.261 . . . . 0.0 111.54 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 C--N 1.33 -0.242 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.978 -175.586 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.72 -21.39 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.789 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -59.82 -27.61 66.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.885 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.18 -48.23 79.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.954 0.407 . . . . 0.0 110.288 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.73 84.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.49 -43.88 88.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.491 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 98' ' ' ARG . 5.7 mmp_? -54.5 -36.42 64.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.618 0.367 . . . . 0.0 111.504 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.09 -49.47 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.49 -23.82 32.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.98 -39.16 91.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.619 0.723 . . . . 0.0 109.404 171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -71.06 -25.93 62.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.708 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -79.85 -19.4 48.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.506 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.37 -109.44 0.5 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.555 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.52 -172.1 2.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.69 76.49 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.169 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.34 112.37 17.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.4 141.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 111.225 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 m -67.89 137.31 55.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.671 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -60.21 -23.07 63.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.431 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -59.06 -45.96 89.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 109.837 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 116' ' ' ILE . 41.3 t -64.79 -38.6 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.854 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.1 ttt -59.96 -37.45 79.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 21.2 mtm180 -63.53 -46.1 87.56 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 175.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.2 -39.06 78.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 112' ' ' VAL . 68.1 mt -67.67 -57.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.479 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -73.04 -22.61 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -171.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 114' ' ' ARG . . . -66.18 -29.04 69.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.08 0.467 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.85 -23.03 42.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.44 -52.75 35.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.033 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.407 ' CG ' ' HG ' ' A' ' 124' ' ' LEU . 23.0 t70 -92.52 159.24 15.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 0.0 110.159 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.2 -25.74 52.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.938 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.3 t -149.23 26.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.558 ' HB3' HD23 ' A' ' 129' ' ' LEU . 40.5 mt -76.36 114.56 15.19 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.947 174.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 6.9 m -81.75 157.62 24.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 m -53.29 -45.78 69.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.23 -44.21 83.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.32 -35.64 77.95 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.137 0.494 . . . . 0.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 124' ' ' LEU . 7.4 mt -76.06 -44.75 37.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.275 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.5 -33.67 76.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.669 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.14 72.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.55 -32.9 25.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.172 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 129' ' ' LEU . 25.7 mm -59.92 -37.6 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.897 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.13 -32.49 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.59 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -80.05 -27.54 39.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.064 0.459 . . . . 0.0 110.574 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.0 mt -85.83 -40.23 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.109 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 118.23 9.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.313 0.578 . . . . 0.0 111.687 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.26 19.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.318 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.12 -99.7 0.44 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.426 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -108.35 71.71 0.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.169 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 m 64.66 13.53 8.39 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.24 71.44 0.36 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.921 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.34 122.58 37.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.811 0.338 . . . . 0.0 111.095 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.4 t -110.4 135.58 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.874 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 148' ' ' GLU . 3.9 p-10 -95.56 -173.06 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 150' ' ' MET . 32.9 p90 -68.43 -47.32 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -173.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.96 -22.02 31.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.461 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 145' ' ' ASP . 7.0 tp10 -63.6 -41.73 98.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.01 -39.67 93.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.029 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 25.2 mmt -63.09 -52.57 62.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.767 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.06 -40.66 66.92 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.131 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 77.1 t -67.86 -49.4 69.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 110.859 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 88.7 mmm . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.33 0.586 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.64 -9.35 58.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.952 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.1 mmt85 -58.29 -47.29 84.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.873 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 21.3 tt0 -69.61 -41.49 75.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.67 79.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.03 -43.67 91.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.563 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -69.73 -21.1 63.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.3 mt -66.0 -33.4 75.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.102 0.477 . . . . 0.0 110.496 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.436 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 96.7 m-85 -101.62 -36.25 8.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.279 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -99.76 92.98 5.57 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 109.62 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HE3' ' O ' ' A' ' 99' ' ' LEU . 34.4 mmtp -77.27 -48.64 16.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.031 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.18 40.34 0.48 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.26 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.55 10.6 68.98 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.176 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.17 21.22 4.86 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.238 0.615 . . . . 0.0 110.797 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.36 36.1 15.51 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.551 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 145' ' ' ASP . 53.5 m-85 -142.72 107.19 4.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 0.0 110.599 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.485 HD12 ' HE2' ' A' ' 113' ' ' MET . 30.8 pt -97.34 140.86 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.132 0.491 . . . . 0.0 110.423 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.482 ' HB2' HG22 ' A' ' 112' ' ' VAL . 17.7 m -69.98 142.3 52.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.574 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 21.2 p -60.1 -27.77 67.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.727 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -40.82 80.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.289 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 116' ' ' ILE . 57.5 t -70.23 -37.94 73.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.485 ' HE2' HD12 ' A' ' 108' ' ' ILE . 52.7 tpp -59.2 -34.16 71.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.528 ' HG2' HG13 ' A' ' 133' ' ' ILE . 67.9 mtt180 -57.3 -36.98 71.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.355 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.29 -37.33 38.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.814 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 112' ' ' VAL . 52.4 mt -58.83 -53.69 44.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.715 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.2 -36.89 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.65 67.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.287 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -84.94 -42.11 15.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.217 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.28 -51.81 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.242 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.84 139.15 38.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.256 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.45 -2.32 23.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.419 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.3 p -105.76 -24.18 12.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.431 HD13 HD22 ' A' ' 129' ' ' LEU . 3.0 pp -76.28 154.96 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.876 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.5 p -124.76 -178.49 4.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.363 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 p -54.66 -43.72 72.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.398 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -58.81 -54.59 45.39 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.409 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.431 HD22 HD13 ' A' ' 124' ' ' LEU . 97.3 mt -61.55 -49.3 77.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.794 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.8 -49.77 75.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.73 85.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.942 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.7 mtm -82.19 -41.38 20.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 136' ' ' ILE . 44.2 mm -70.79 -33.83 54.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.312 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.79 -16.21 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.226 0.536 . . . . 0.0 110.504 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -101.32 -15.81 17.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.524 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 133' ' ' ILE . 5.8 tt -89.47 -23.55 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.441 ' HA ' HG22 ' A' ' 110' ' ' THR . 36.7 m-20 -43.97 106.6 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.551 0.532 . . . . 0.0 110.495 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.0 -61.21 1.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' A' ' 143' ' ' THR . 5.6 m-20 -85.9 -86.56 0.14 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.57 -107.0 2.4 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.472 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 46.75 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.3 60.64 2.64 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 139' ' ' ASP . 3.0 p -121.98 146.12 47.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.502 HG12 ' HB3' ' A' ' 148' ' ' GLU . 63.9 t -128.19 123.19 59.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.83 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 107' ' ' TYR . 1.6 p-10 -97.02 -175.53 3.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -58.91 -34.17 71.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -60.65 -58.19 9.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.067 0.46 . . . . 0.0 110.751 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HB3' HG12 ' A' ' 144' ' ' VAL . 10.6 tp10 -66.98 -32.49 73.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.328 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.61 -46.76 88.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.209 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.0 mtp -80.91 -3.99 53.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.502 . . . . 0.0 110.704 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.75 -44.86 5.64 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.632 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.536 HG12 ' HG3' ' A' ' 153' ' ' MET . 7.7 p -70.27 -34.14 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 110.587 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.536 ' HG3' HG12 ' A' ' 152' ' ' VAL . 66.5 mtt . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.282 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.79 ' HG2' ' H ' ' A' ' 93' ' ' LEU . 16.2 tt0 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.452 0.644 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.79 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 79.6 mt -89.64 10.23 23.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 16.2 mmt180 -59.92 -43.12 95.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.703 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.5 mm-40 -60.88 -35.98 78.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.175 0.297 . . . . 0.0 111.721 -176.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.09 85.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.38 -36.7 38.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 29.4 mtm180 -63.69 -21.6 66.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.78 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.6 mt -61.12 -43.75 98.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.07 0.462 . . . . 0.0 110.699 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.35 -19.68 22.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.39 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 10.1 t70 -57.96 -48.4 80.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.034 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -55.02 -39.35 69.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.173 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.35 55.13 1.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.554 0.692 . . . . 0.0 110.748 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.84 14.33 1.74 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.602 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.39 19.83 10.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.187 0.595 . . . . 0.0 111.346 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 -62.8 3.44 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.224 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.497 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 22.8 m-85 -84.06 89.17 7.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.495 ' CG1' ' HB ' ' A' ' 144' ' ' VAL . 38.6 pt -69.53 141.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 111.632 -173.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -59.01 139.77 56.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 137' ' ' ASP . 14.0 p -62.08 -16.05 49.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.72 -39.47 73.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.046 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 t -74.73 -32.76 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.52 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.5 tpp -61.4 -32.94 72.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -58.56 -40.61 83.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 110.059 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.94 -35.78 72.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.426 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.1 mt -70.04 -39.03 76.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.2 -40.16 93.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 124' ' ' LEU . . . -70.07 -19.72 63.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.657 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.94 -35.43 37.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.732 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.85 -62.89 1.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.352 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -105.87 141.7 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.52 14.95 22.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.5 p -115.98 -16.1 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.632 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 118' ' ' ALA . 3.6 pp -76.04 151.26 37.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 m -112.46 179.31 4.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.828 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.9 t -61.41 -36.74 81.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 110.215 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.35 -46.27 80.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.881 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.61 -39.38 76.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.9 -34.14 71.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.813 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.95 76.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.26 -46.45 60.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.005 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' A' ' 110' ' ' THR . 48.2 mm -81.2 68.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 122.083 0.944 . . . . 0.0 109.928 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.21 -42.67 0.14 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.509 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -112.95 23.27 13.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.11 0.957 . . . . 0.0 108.735 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.72 -42.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.947 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.746 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 6.8 p-10 -89.74 138.71 31.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.814 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.65 ' H ' ' HA3' ' A' ' 142' ' ' GLY . . . -152.55 15.6 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.656 173.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 61.82 98.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.244 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.17 -42.56 2.06 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 m -117.11 61.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 137' ' ' ASP . . . 173.16 -40.84 0.15 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.411 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 107' ' ' TYR . 2.4 p -64.84 101.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 108' ' ' ILE . 94.8 t -45.07 108.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -163.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.82 165.32 21.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.534 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -47.4 -50.36 22.72 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.084 0.554 . . . . 0.0 111.45 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.65 -15.38 32.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 144' ' ' VAL . 27.1 tt0 -70.39 -31.39 68.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -56.23 -43.81 78.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 51.9 ttm -64.67 -40.22 95.03 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.15 -31.34 72.84 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.545 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.79 -40.55 39.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.0 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.326 -177.482 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 45.6 mt -74.45 -7.91 54.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.581 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -76.81 -16.29 59.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.488 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.6 -41.53 97.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.647 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.49 -41.68 31.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.57 -36.37 80.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.508 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.42 -16.05 64.02 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 111.346 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.78 -33.75 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.409 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.436 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 51.2 m-85 -85.33 -34.79 21.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.931 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -79.56 66.37 5.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.696 0.76 . . . . 0.0 109.685 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 46.3 mtpt -68.91 -49.68 56.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.034 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.44 ' OE2' ' HB2' ' A' ' 102' ' ' LYS . 6.8 mp0 -71.82 -23.37 61.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.357 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.14 1.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.732 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.89 -37.0 7.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.791 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.63 66.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.472 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 41.9 p90 -154.7 144.21 21.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.55 144.04 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.462 0.649 . . . . 0.0 111.256 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 11.6 m -62.83 139.97 58.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.882 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.595 ' HB ' HG22 ' A' ' 133' ' ' ILE . 11.8 p -55.88 -21.84 22.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.681 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -59.72 -30.68 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.928 0.394 . . . . 0.0 110.944 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 116' ' ' ILE . 24.9 t -73.0 -27.57 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.098 0.475 . . . . 0.0 110.19 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.0 tpt -65.93 -38.08 87.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.412 ' HB2' HD13 ' A' ' 129' ' ' LEU . 2.0 ptt180 -73.75 -18.98 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.941 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -75.15 -42.15 56.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 112' ' ' VAL . 64.1 mt -60.7 -51.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.408 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.51 -32.56 68.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.737 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.35 68.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.223 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -96.99 -36.67 10.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.64 -45.75 88.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -99.23 -177.04 3.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.45 89.25 3.31 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.071 0.938 . . . . 0.0 109.586 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.1 t 49.73 77.8 0.11 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.934 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.48 137.65 35.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.998 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 t -75.68 160.29 30.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.408 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -36.17 66.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.859 0.362 . . . . 0.0 110.674 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.89 -27.87 69.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.91 -42.79 20.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.557 0.694 . . . . 0.0 110.033 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 133' ' ' ILE . 81.3 mt -65.88 -37.34 85.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.309 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -51.77 -49.53 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.553 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.28 82.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.6 -39.33 80.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 129' ' ' LEU . 30.5 mm -78.52 -34.97 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.016 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.38 -40.36 96.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.948 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.49 -15.99 55.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.704 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 136' ' ' ILE . 25.0 mt -102.79 -57.94 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.441 ' N ' HG21 ' A' ' 110' ' ' THR . 10.6 t70 63.49 155.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.01 0.819 . . . . 0.0 112.955 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 109' ' ' SER . . . -117.08 65.2 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.019 -0.426 . . . . 0.0 111.062 -176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -123.02 -41.95 2.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.08 138.6 2.51 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 p 46.84 37.42 4.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.869 0.842 . . . . 0.0 109.944 -170.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.54 -36.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.548 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.53 112.23 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 37.7 t -69.77 104.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.493 -162.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 0.9 OUTLIER -93.82 -173.52 3.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 174.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 93' ' ' LEU . 71.5 t80 -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.932 0.333 . . . . 0.0 111.303 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -65.32 -48.24 73.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.564 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 152' ' ' VAL . 8.7 tp10 -63.99 -44.62 92.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -55.91 -44.57 78.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.675 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 46.2 ttm -59.15 -49.03 79.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.33 -31.7 79.79 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.311 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 148' ' ' GLU . 96.5 t -81.27 -47.58 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.792 0.296 . . . . 0.0 111.596 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.52 ' HE1' HD23 ' A' ' 93' ' ' LEU . 53.4 ttp . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.95 -27.81 66.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.053 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -59.72 -36.16 76.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.197 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.99 -45.05 91.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.713 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.4 -45.36 16.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.078 0.466 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -62.0 -32.3 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.846 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.482 ' HA ' ' OD1' ' A' ' 101' ' ' ASP . 14.1 ptm180 -67.2 -12.86 61.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.098 0.475 . . . . 0.0 111.386 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.72 -22.47 23.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.256 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' LYS . 99.3 m-85 -101.98 -30.08 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.971 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -78.07 9.35 3.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 -177.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.676 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 48.3 pttt -38.6 -48.26 1.42 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.663 1.185 . . . . 0.0 112.906 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.676 ' HG2' ' HG3' ' A' ' 102' ' ' LYS . 21.5 mm-40 -111.24 -11.02 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 110.728 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.73 -17.84 50.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.516 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 58.91 35.22 24.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.68 -29.77 6.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.011 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 28.3 p90 -123.07 125.71 45.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.008 0.432 . . . . 0.0 110.1 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 pt -110.14 150.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.226 0.536 . . . . 0.0 111.563 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 34.4 t -58.23 137.36 57.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 6.3 p -61.3 -22.54 64.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.971 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' HA ' ' CD ' ' A' ' 114' ' ' ARG . 28.8 t70 -64.4 -35.62 81.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.465 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' ILE . 58.7 t -66.73 -35.65 75.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.078 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.9 ttp -74.46 -20.15 60.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.958 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.489 ' CD ' ' HA ' ' A' ' 111' ' ' ASP . 77.3 mtp180 -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 37.6 mt-10 -80.12 -30.43 39.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.332 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 112' ' ' VAL . 42.0 mt -59.01 -40.36 80.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.234 0.54 . . . . 0.0 109.827 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -40.14 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.711 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.9 -30.03 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 43.7 mt-10 -73.51 -32.06 64.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -89.07 -52.34 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 12.1 t70 -104.52 144.97 30.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.885 0.374 . . . . 0.0 110.8 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 -12.67 13.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.775 -174.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -103.75 -3.24 25.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.956 0.407 . . . . 0.0 111.167 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' A' ' 121' ' ' ASP . 75.4 mt -76.08 121.24 22.51 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.2 t -72.37 162.18 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.685 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 5.5 p -66.39 -22.26 66.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.629 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -71.34 -37.79 71.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.92 -36.31 80.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.794 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 8.8 mt -55.53 -38.79 69.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.218 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -81.73 -46.72 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -61.01 -49.78 76.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.001 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.5 mtp -60.76 -47.84 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.126 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 31.2 mm -63.46 -34.63 68.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.56 -31.5 71.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.0 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 44.2 mt-10 -78.72 -41.12 31.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 110.306 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.79 -67.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.832 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.47 ' HA ' ' CG2' ' A' ' 110' ' ' THR . 6.1 t70 41.91 -127.45 0.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.643 0.589 . . . . 0.0 109.832 -169.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 144' ' ' VAL . . . -171.24 -63.43 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.272 0.358 . . . . 0.0 110.822 170.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -158.3 -62.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.938 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.47 47.22 3.43 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.642 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.0 p 47.22 41.75 12.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.11 0.564 . . . . 0.0 111.169 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 109' ' ' SER . . . 133.05 35.5 0.3 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.467 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.4 p -128.27 81.0 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.227 0.514 . . . . 0.0 111.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 42.8 t -65.57 101.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.45 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -88.31 174.45 8.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.119 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -58.5 -48.1 81.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.311 0.577 . . . . 0.0 110.052 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -56.56 -23.22 38.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.426 ' HG2' ' HB1' ' A' ' 138' ' ' ALA . 15.4 tp10 -90.78 -55.59 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.835 0.35 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -63.02 -35.09 79.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.475 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 86.9 mtp -81.99 -4.2 56.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -94.12 -42.53 4.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.595 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.8 m -72.41 -19.36 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.006 0.431 . . . . 0.0 110.993 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 94.0 mmm . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.107 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.466 ' HB3' ' NE ' ' A' ' 94' ' ' ARG . 44.2 tt0 . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -41.49 -37.29 1.05 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 92' ' ' GLU . 4.3 ppt_? -65.78 -12.57 55.12 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 6.4 pt-20 -49.77 -49.89 46.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.643 0.259 . . . . 0.0 111.035 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.629 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -65.38 -28.1 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.141 -176.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -60.99 -51.23 70.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.175 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -82.04 -19.62 39.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.875 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 77.0 mt -72.48 -45.14 60.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.554 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -84.73 -47.99 9.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.654 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.581 ' HB2' HG21 ' A' ' 108' ' ' ILE . 13.0 t70 -72.04 105.82 4.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.613 0.721 . . . . 0.0 111.879 -175.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -82.24 -13.54 56.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.049 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.78 -50.92 0.67 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -169.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.77 -55.62 27.97 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.16 0.424 . . . . 0.0 114.16 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.17 60.32 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.353 0.597 . . . . 0.0 110.599 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.77 -19.33 2.56 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.2 p90 -151.94 134.43 15.35 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 101' ' ' ASP . 43.7 pt -114.94 155.4 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.7 t -69.81 138.79 52.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.175 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -54.51 -32.79 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.619 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -36.56 81.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.79 -33.03 60.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.436 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 46.1 ttm -63.72 -31.76 73.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HG2' HG13 ' A' ' 133' ' ' ILE . 72.3 mtm180 -63.13 -41.96 99.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' GLU . 31.4 mt-10 -61.3 -45.77 93.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.407 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.13 -44.38 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.272 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 113' ' ' MET . 92.3 mt -64.95 -40.53 95.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.978 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 124' ' ' LEU . . . -72.43 -20.28 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.981 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 2.5 tm-20 -82.02 -38.02 25.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.567 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 tt -76.32 -55.55 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.145 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.75 152.06 37.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.567 0.698 . . . . 0.0 110.744 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -77.77 -33.23 52.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.862 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -165.86 52.57 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 118' ' ' ALA . 1.3 pp -82.26 150.05 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.719 -0.613 . . . . 0.0 110.004 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.6 m -91.33 172.3 8.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.835 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.1 p -64.93 -39.01 92.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.849 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.71 -34.79 79.02 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.545 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.11 -50.49 72.62 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 109.726 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.11 -48.41 80.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.707 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.43 -46.87 80.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.892 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.07 63.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.0 mtm -61.58 -43.17 99.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.597 0.237 . . . . 0.0 111.255 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.45 HG13 ' HG2' ' A' ' 114' ' ' ARG . 37.1 mm -64.63 -34.96 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.537 0.208 . . . . 0.0 110.481 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.57 -32.78 73.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.33 -39.66 59.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.5 mt -86.58 -51.33 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.37 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 54.45 -114.79 0.89 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.879 -167.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.503 ' HB3' ' C ' ' A' ' 143' ' ' THR . . . -156.56 -102.68 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 143' ' ' THR . 7.8 t70 -156.93 -52.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.55 -121.21 3.54 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -80.73 52.58 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.02 0.438 . . . . 0.0 110.307 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.66 32.34 33.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.205 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.503 ' C ' ' HB3' ' A' ' 138' ' ' ALA . 12.0 p -111.98 98.03 7.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.577 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 39.6 t -73.77 112.39 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 169.61 17.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.025 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -59.07 -40.56 85.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.816 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.64 -48.83 70.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.03 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.41 ' O ' HG11 ' A' ' 152' ' ' VAL . 54.8 mm-40 -63.08 -44.06 96.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.617 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -54.1 -48.97 70.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.105 0.479 . . . . 0.0 110.819 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.7 -28.63 70.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.34 -49.27 3.76 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.098 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 148' ' ' GLU . 11.9 p -69.45 -27.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.086 0.469 . . . . 0.0 111.21 179.527 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 10.3 tp10 . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD11 ' HG3' ' A' ' 150' ' ' MET . 87.8 mt -52.24 -18.29 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.606 0.639 . . . . 0.0 111.602 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -23.51 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.1 pt-20 -56.51 -47.72 78.73 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.894 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -63.82 -34.16 77.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.2 -46.68 79.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.194 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 51.4 ptt85 -80.9 -11.26 59.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.542 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 62.3 mt -81.21 -46.49 14.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.686 0.279 . . . . 0.0 110.434 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.431 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 22.0 m-85 -69.13 -49.59 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -119.29 95.56 4.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 44.6 tttm -77.3 -27.08 52.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.539 -173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -90.96 45.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.69 -146.27 18.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.102 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -85.73 94.08 9.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.66 103.16 2.17 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.478 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.573 ' HB3' ' OG1' ' A' ' 143' ' ' THR . 79.6 m-85 -73.36 74.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.0 pt -69.45 141.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.208 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 m -60.49 133.31 55.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.701 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.541 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 20.4 p -65.05 -18.81 65.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.99 -42.92 81.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.277 0.561 . . . . 0.0 109.685 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.66 -37.86 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.225 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.411 ' HG2' HD13 ' A' ' 117' ' ' LEU . 24.0 ttt -64.12 -37.3 86.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.027 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HG2' HG13 ' A' ' 133' ' ' ILE . 96.2 mtt180 -60.83 -27.16 67.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.67 0.271 . . . . 0.0 111.158 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.73 -48.0 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.401 . . . . 0.0 109.99 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 100' ' ' TYR . 48.8 mt -53.38 -52.28 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.684 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 153' ' ' MET . 9.2 mp -54.15 -53.28 55.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.093 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.21 63.07 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.58 -17.85 61.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.421 ' C ' HD12 ' A' ' 120' ' ' LEU . 3.2 tm? -94.42 -65.64 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -167.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 123' ' ' THR . 1.9 t70 -87.82 -169.72 2.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.423 0.63 . . . . 0.0 112.65 -161.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.46 67.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.517 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.443 HG23 ' OD1' ' A' ' 121' ' ' ASP . 13.8 t -176.57 -9.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 128' ' ' ASP . 3.3 pp -130.77 161.59 31.38 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.882 -0.512 . . . . 0.0 110.306 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.5 m -109.8 174.8 5.7 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.642 -171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.775 ' HA ' HD11 ' A' ' 129' ' ' LEU . 44.2 m -60.46 -28.66 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.683 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.26 -24.38 67.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.587 0.232 . . . . 0.0 111.594 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.692 ' HB2' HD11 ' A' ' 124' ' ' LEU . 6.9 m-20 -68.34 -46.55 69.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.324 0.583 . . . . 0.0 109.44 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 126' ' ' SER . 5.1 mp -62.08 -36.89 83.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.218 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.81 -38.24 78.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.789 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.68 63.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.485 ' HE1' ' HA ' ' A' ' 129' ' ' LEU . 71.9 mtm -75.52 -55.08 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.157 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.701 ' HA ' HG21 ' A' ' 136' ' ' ILE . 15.9 mm -78.9 64.51 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.61 0.719 . . . . 0.0 109.892 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -151.34 -45.56 0.11 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.393 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -106.88 -7.92 16.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.577 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -84.9 -27.42 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.717 0.77 . . . . 0.0 110.12 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.458 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 17.9 p-10 -112.16 17.76 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.931 -170.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.57 41.32 0.62 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.461 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.06 -13.73 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.184 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.7 55.44 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.614 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 55.14 64.86 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.951 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.458 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 74.34 67.96 1.66 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.467 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 107' ' ' TYR . 1.6 t -142.32 130.05 21.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.094 0.473 . . . . 0.0 109.949 173.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.31 128.67 72.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.299 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -108.15 -165.34 1.03 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.964 0.412 . . . . 0.0 110.903 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 10.2 p90 -62.59 166.54 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.235 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER 72.52 -51.33 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.337 0.655 . . . . 0.0 111.311 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -66.73 -36.48 82.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -74.59 75.89 2.0 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.528 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.667 ' HG3' HD11 ' A' ' 93' ' ' LEU . 20.2 ttt -172.41 -52.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.915 171.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.73 83.3 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.538 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.435 ' O ' HD23 ' A' ' 117' ' ' LEU . 18.4 t -72.84 -40.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.135 0.493 . . . . 0.0 109.836 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.468 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 26.9 ttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.504 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.286 0.565 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.45 -22.76 61.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.608 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.46 49.69 1.41 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 110.583 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -166.51 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.4 mt -54.63 -21.4 10.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.567 0.622 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.8 -15.21 63.44 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 14.8 pt-20 -50.4 -46.1 56.0 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.412 0.445 . . . . 0.0 111.53 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -74.97 -42.92 56.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.813 0.34 . . . . 0.0 110.909 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -59.59 -47.5 85.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.008 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 44.0 ptt85 -62.08 -25.41 67.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.703 -175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 79.7 mt -74.18 -20.34 60.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.058 0.456 . . . . 0.0 110.728 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 102' ' ' LYS . 34.3 m-85 -101.91 6.54 41.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.703 -175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.525 ' OD2' ' HA ' ' A' ' 98' ' ' ARG . 23.1 m-20 -80.75 33.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.478 ' HG3' ' H ' ' A' ' 103' ' ' GLU . 18.2 pttp -74.24 -47.98 31.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' H ' ' HG3' ' A' ' 102' ' ' LYS . 30.7 mt-10 -117.58 105.68 12.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.602 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 162.34 30.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -141.28 111.02 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.294 0.547 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.42 -22.61 8.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.532 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -126.4 79.53 1.86 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.475 ' HB ' HG11 ' A' ' 112' ' ' VAL . 30.8 pt -77.21 141.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.604 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 112' ' ' VAL . 18.0 m -63.52 141.34 58.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.621 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.604 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 18.2 p -53.46 -23.79 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.066 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.27 -51.49 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.051 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 109' ' ' SER . 9.8 p -69.62 -34.18 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.434 -172.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.509 ' SD ' HG23 ' A' ' 144' ' ' VAL . 25.6 ttt -65.66 -25.58 67.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.785 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.468 ' HG2' HG13 ' A' ' 133' ' ' ILE . 82.1 mtm180 -60.68 -44.59 96.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 109.845 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.64 -34.37 73.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.154 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.0 mt -60.39 -47.51 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.667 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.07 68.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.932 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -81.32 -17.46 49.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.11 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.42 -61.49 1.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.568 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.582 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 14.4 t70 -85.69 158.31 20.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.767 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -116.38 -24.73 7.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -96.24 -40.16 9.31 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.582 ' HG ' ' OD2' ' A' ' 121' ' ' ASP . 4.4 pp -76.48 150.31 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.567 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 t -94.65 178.91 5.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.258 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.425 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 15.4 m -63.52 -36.89 85.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.91 -39.28 91.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 110.313 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.63 -53.09 60.9 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 4.7 pp -67.3 -34.6 77.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.162 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.084 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.28 72.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.2 mtm -73.18 -35.44 66.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.07 0.462 . . . . 0.0 110.314 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.604 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 39.7 mm -73.99 -31.01 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.66 0.743 . . . . 0.0 110.132 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.2 -27.04 65.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.18 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.52 3.98 23.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 133' ' ' ILE . 6.3 tt -106.08 -23.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.721 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.584 ' OD1' ' HA2' ' A' ' 142' ' ' GLY . 9.8 t0 -41.63 123.54 2.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.684 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -89.14 12.76 14.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.716 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 30.0 t70 76.3 -1.93 2.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.981 0.512 . . . . 0.0 112.239 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.82 63.65 4.41 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.344 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.4 m 66.59 25.28 10.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.019 0.437 . . . . 0.0 109.945 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.584 ' HA2' ' OD1' ' A' ' 137' ' ' ASP . . . 80.7 69.46 1.4 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.559 -176.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -134.05 162.22 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.509 HG23 ' SD ' ' A' ' 113' ' ' MET . 48.7 t -120.2 136.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.45 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -82.87 176.53 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.76 -57.99 8.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.621 0.248 . . . . 0.0 111.475 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.27 -29.66 68.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -63.34 -41.57 98.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.985 0.421 . . . . 0.0 109.872 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.51 -49.86 71.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 87.5 mmm -55.73 -50.87 69.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.778 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.719 ' HA2' ' HB3' ' A' ' 157' ' ' ASP . . . -58.96 -43.12 97.03 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.239 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 55.3 t -77.44 -40.09 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.918 0.39 . . . . 0.0 111.114 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.3 tpt -69.26 -21.98 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.427 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.1 p -90.44 14.92 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.087 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.31 -44.81 1.83 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.305 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.96 59.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.719 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 32.6 t70 -81.81 94.49 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.486 -0.769 . . . . 0.0 111.08 -176.782 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -87.99 -62.17 1.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.507 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -120.68 56.93 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 64.59 178.29 0.18 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.842 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.454 HD23 ' SD ' ' A' ' 153' ' ' MET . 55.1 mt -102.13 -1.58 31.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.175 0.512 . . . . 0.0 110.377 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.41 -35.37 30.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.041 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.97 -45.56 67.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 30.4 t80 -71.32 -43.59 66.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.25 -32.52 62.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.4 mt -73.15 -40.67 64.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.179 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.84 15.74 28.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.423 0.63 . . . . 0.0 110.189 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 103' ' ' GLU . 6.6 t70 -62.26 103.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.835 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 107' ' ' TYR . 14.5 mptt -80.67 -3.82 52.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.289 169.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 2.6 mm-40 -58.5 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -165.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.41 55.0 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 156.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 64.75 48.68 2.42 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -159.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.19 -38.84 1.91 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.512 -167.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 40.5 m-85 60.54 -171.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -171.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.18 142.67 41.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.994 -0.441 . . . . 0.0 110.303 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.547 ' HB2' HG22 ' A' ' 112' ' ' VAL . 15.6 m -70.11 142.16 52.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.051 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.405 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 17.1 p -58.94 -31.9 69.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.974 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.32 -45.94 89.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.263 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 109' ' ' SER . 58.8 t -62.88 -43.72 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.319 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.7 tpt -54.37 -36.72 64.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.889 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' THR . 78.8 mtm180 -61.49 -47.32 86.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.1 -43.78 86.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.73 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 112' ' ' VAL . 76.9 mt -57.49 -40.27 73.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.35 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.94 -29.54 35.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.657 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 129' ' ' LEU . . . -78.49 -22.11 47.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.28 -26.19 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.89 -55.98 5.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.646 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.414 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 25.7 t70 -107.16 142.38 36.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.982 0.42 . . . . 0.0 110.482 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -99.79 -9.05 23.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.779 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 p -104.24 -16.78 15.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.466 HD12 ' HE1' ' A' ' 132' ' ' MET . 97.5 mt -79.36 117.63 20.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.802 0.334 . . . . 0.0 110.29 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 2.8 t -81.47 155.36 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.361 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -59.65 -32.4 70.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.577 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.71 -50.18 74.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.448 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -34.77 72.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.091 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 133' ' ' ILE . 7.8 mt -69.14 -26.63 64.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.839 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.86 -43.68 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.66 70.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.466 ' HE1' HD12 ' A' ' 124' ' ' LEU . 65.5 mtt -70.55 -52.78 19.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.921 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 129' ' ' LEU . 42.2 mm -58.53 -33.37 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.79 -27.94 32.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -110.78 10.44 22.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.994 0.425 . . . . 0.0 110.941 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 79.7 mt -128.03 -37.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.506 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 7.1 t70 -50.46 126.85 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.046 0.451 . . . . 0.0 111.883 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -92.57 15.6 13.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.177 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 11.1 t70 81.37 -18.86 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 168.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.0 78.58 1.89 Allowed Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.717 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 p 51.6 30.22 6.34 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 110.229 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.506 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 76.68 70.71 1.25 Allowed Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.337 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 t -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 112.043 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.11 119.25 60.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.755 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.87 153.87 42.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -65.68 -12.84 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -79.74 -38.94 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.213 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.73 -29.5 45.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 97' ' ' PHE . 67.0 t80 -73.6 67.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.68 0.752 . . . . 0.0 109.548 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.423 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.1 tmt? -164.78 -70.33 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.205 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.97 -27.21 73.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.992 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.28 -36.53 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 111.433 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.454 ' SD ' HD23 ' A' ' 93' ' ' LEU . 23.9 ptm -97.64 -16.36 20.02 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.634 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 p -105.74 63.41 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.133 0.492 . . . . 0.0 110.468 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.35 -94.38 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.72 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -87.27 -6.69 77.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.136 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.39 175.86 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.94 -177.568 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -79.95 156.84 27.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.271 0.558 . . . . 0.0 110.76 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 1.1 pm0 -80.47 8.16 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.214 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.25 -41.54 75.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.37 -43.76 89.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.4 ttp85 -69.37 -39.63 77.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.83 -43.44 79.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.687 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.84 -42.47 93.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.656 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 38.6 mtm180 -63.78 -36.52 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.804 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.12 -14.32 33.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.56 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.43 -26.46 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.478 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -91.89 86.45 5.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.27 -32.93 72.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.939 -174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.583 ' HB2' HD22 ' A' ' 105' ' ' ASN . 41.3 mm-40 -85.47 -36.96 20.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.419 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.97 54.48 1.89 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.228 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.583 HD22 ' HB2' ' A' ' 103' ' ' GLU . 30.4 m-80 -93.1 -35.38 13.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 110.023 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.56 5.12 57.93 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.413 ' HD1' ' HB3' ' A' ' 145' ' ' ASP . 9.9 m-85 -136.29 145.11 45.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 144' ' ' VAL . 28.6 pt -123.32 140.73 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 111.231 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.9 t -67.16 144.98 55.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.605 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.2 p -58.96 -27.18 65.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.417 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' ARG . 18.4 t0 -70.43 -35.27 73.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 110.043 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 116' ' ' ILE . 73.6 t -66.86 -41.27 87.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.503 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.2 tpt -56.22 -34.75 66.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.839 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 111' ' ' ASP . 15.2 mtp180 -56.04 -53.88 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.693 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.57 -36.03 80.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 112' ' ' VAL . 73.8 mt -57.62 -44.14 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.96 -41.67 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HA ' HD12 ' A' ' 124' ' ' LEU . . . -68.66 -29.19 67.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.63 -5.75 59.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.003 0.43 . . . . 0.0 110.755 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 tt -88.49 -50.51 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -130.6 147.34 52.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -95.79 -22.75 17.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -82.1 -20.31 38.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 118' ' ' ALA . 3.9 pp -76.93 152.19 35.41 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.968 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -107.27 176.94 5.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.703 0.287 . . . . 0.0 110.979 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.66 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 12.1 p -69.44 -25.44 64.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.929 0.395 . . . . 0.0 110.603 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.85 -39.66 89.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 132' ' ' MET . 27.0 m-20 -61.29 -38.91 88.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 12.9 mt -56.93 -44.4 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.374 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.88 -47.9 73.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.699 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.6 98.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.726 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 128' ' ' ASP . 24.2 mmt -58.2 -55.62 32.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 111.183 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.07 -35.7 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.321 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.98 -26.67 49.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.713 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -118.2 10.17 12.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 111.42 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.63 -69.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.524 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 138' ' ' ALA . 4.5 m-20 47.11 -145.63 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 137' ' ' ASP . . . -164.74 -89.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.578 0.227 . . . . 0.0 111.476 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.2 -59.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.589 0.233 . . . . 0.0 111.593 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.46 70.9 1.4 Allowed Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.938 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 61.26 36.19 17.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 109.941 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.1 45.26 5.99 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.378 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 p -91.44 87.72 6.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.174 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.403 ' HB ' HG13 ' A' ' 108' ' ' ILE . 42.5 t -78.68 110.91 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.413 ' HB3' ' HD1' ' A' ' 107' ' ' TYR . 7.0 p-10 -85.43 176.27 8.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.894 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -61.05 -38.93 87.92 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -66.88 -49.13 66.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.6 -51.11 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.731 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.96 -42.5 76.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.359 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.75 -53.97 18.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.698 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.28 -25.83 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.649 0.261 . . . . 0.0 111.54 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.9 ttm -100.99 -43.96 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.978 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.2 p -73.47 -12.98 60.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -100.55 74.11 0.42 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.3 -4.13 1.1 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.702 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.7 154.9 39.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.599 -0.353 . . . . 0.0 110.09 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.956 -175.135 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.29 112.01 20.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 111.185 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.86 74.15 1.48 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -34.35 102.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.297 -1.319 . . . . 0.0 113.368 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.72 -21.39 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.789 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -59.82 -27.61 66.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.885 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.18 -48.23 79.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.954 0.407 . . . . 0.0 110.288 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.73 84.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.49 -43.88 88.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.491 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 98' ' ' ARG . 5.7 mmp_? -54.5 -36.42 64.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.618 0.367 . . . . 0.0 111.504 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.09 -49.47 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.49 -23.82 32.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.98 -39.16 91.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.619 0.723 . . . . 0.0 109.404 171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -71.06 -25.93 62.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.708 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -79.85 -19.4 48.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.506 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.37 -109.44 0.5 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.555 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.52 -172.1 2.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.69 76.49 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.169 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.34 112.37 17.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.4 141.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 111.225 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 m -67.89 137.31 55.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.671 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -60.21 -23.07 63.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.431 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -59.06 -45.96 89.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 109.837 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 116' ' ' ILE . 41.3 t -64.79 -38.6 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.854 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.1 ttt -59.96 -37.45 79.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 118' ' ' ALA . 21.2 mtm180 -63.53 -46.1 87.56 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 175.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.2 -39.06 78.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 112' ' ' VAL . 68.1 mt -67.67 -57.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.479 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -73.04 -22.61 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -171.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 114' ' ' ARG . . . -66.18 -29.04 69.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.08 0.467 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.85 -23.03 42.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.44 -52.75 35.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.033 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.407 ' CG ' ' HG ' ' A' ' 124' ' ' LEU . 23.0 t70 -92.52 159.24 15.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 0.0 110.159 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.2 -25.74 52.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.938 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.3 t -149.23 26.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.558 ' HB3' HD23 ' A' ' 129' ' ' LEU . 40.5 mt -76.36 114.56 15.19 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.947 174.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 6.9 m -81.75 157.62 24.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 m -53.29 -45.78 69.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.23 -44.21 83.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.32 -35.64 77.95 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.137 0.494 . . . . 0.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 124' ' ' LEU . 7.4 mt -76.06 -44.75 37.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.275 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.5 -33.67 76.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.669 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.14 72.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.55 -32.9 25.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.172 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 129' ' ' LEU . 25.7 mm -59.92 -37.6 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.897 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.13 -32.49 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.59 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -80.05 -27.54 39.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.064 0.459 . . . . 0.0 110.574 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.0 mt -85.83 -40.23 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.109 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 118.23 9.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.313 0.578 . . . . 0.0 111.687 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.26 19.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.318 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.12 -99.7 0.44 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.426 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -108.35 71.71 0.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.169 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 m 64.66 13.53 8.39 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.24 71.44 0.36 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.921 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.34 122.58 37.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.811 0.338 . . . . 0.0 111.095 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.4 t -110.4 135.58 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.874 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 148' ' ' GLU . 3.9 p-10 -95.56 -173.06 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 150' ' ' MET . 32.9 p90 -68.43 -47.32 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -173.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.96 -22.02 31.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.461 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 145' ' ' ASP . 7.0 tp10 -63.6 -41.73 98.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.01 -39.67 93.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.029 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 25.2 mmt -63.09 -52.57 62.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.767 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.06 -40.66 66.92 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.131 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 77.1 t -67.86 -49.4 69.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 110.859 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 88.7 mmm -71.27 -34.09 70.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.8 p -93.83 10.0 34.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.293 . . . . 0.0 111.231 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.15 126.88 7.8 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.566 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.87 -7.83 36.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.971 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.82 128.35 33.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.335 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -98.32 72.05 2.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.217 0.532 . . . . 0.0 110.965 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.88 -34.92 24.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.13 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -81.51 111.53 17.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.234 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.64 -9.35 58.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.952 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.1 mmt85 -58.29 -47.29 84.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.873 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 21.3 tt0 -69.61 -41.49 75.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.67 79.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.03 -43.67 91.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.563 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -69.73 -21.1 63.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.3 mt -66.0 -33.4 75.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.102 0.477 . . . . 0.0 110.496 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.436 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 96.7 m-85 -101.62 -36.25 8.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.279 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -99.76 92.98 5.57 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 109.62 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HE3' ' O ' ' A' ' 99' ' ' LEU . 34.4 mmtp -77.27 -48.64 16.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.031 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.18 40.34 0.48 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.26 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.55 10.6 68.98 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.176 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.17 21.22 4.86 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.238 0.615 . . . . 0.0 110.797 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.36 36.1 15.51 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.551 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 145' ' ' ASP . 53.5 m-85 -142.72 107.19 4.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 0.0 110.599 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.485 HD12 ' HE2' ' A' ' 113' ' ' MET . 30.8 pt -97.34 140.86 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.132 0.491 . . . . 0.0 110.423 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.482 ' HB2' HG22 ' A' ' 112' ' ' VAL . 17.7 m -69.98 142.3 52.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.574 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 21.2 p -60.1 -27.77 67.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.727 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -40.82 80.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.289 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 116' ' ' ILE . 57.5 t -70.23 -37.94 73.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.485 ' HE2' HD12 ' A' ' 108' ' ' ILE . 52.7 tpp -59.2 -34.16 71.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.528 ' HG2' HG13 ' A' ' 133' ' ' ILE . 67.9 mtt180 -57.3 -36.98 71.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.355 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.29 -37.33 38.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.814 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 112' ' ' VAL . 52.4 mt -58.83 -53.69 44.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.715 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.2 -36.89 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.65 67.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.287 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -84.94 -42.11 15.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.217 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.28 -51.81 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.242 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.84 139.15 38.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.256 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.45 -2.32 23.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.419 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.3 p -105.76 -24.18 12.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.431 HD13 HD22 ' A' ' 129' ' ' LEU . 3.0 pp -76.28 154.96 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.876 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.5 p -124.76 -178.49 4.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.363 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 p -54.66 -43.72 72.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.398 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -58.81 -54.59 45.39 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.409 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.431 HD22 HD13 ' A' ' 124' ' ' LEU . 97.3 mt -61.55 -49.3 77.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.794 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.8 -49.77 75.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.73 85.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.942 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.7 mtm -82.19 -41.38 20.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 136' ' ' ILE . 44.2 mm -70.79 -33.83 54.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.312 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.79 -16.21 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.226 0.536 . . . . 0.0 110.504 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -101.32 -15.81 17.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.524 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 133' ' ' ILE . 5.8 tt -89.47 -23.55 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.441 ' HA ' HG22 ' A' ' 110' ' ' THR . 36.7 m-20 -43.97 106.6 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.551 0.532 . . . . 0.0 110.495 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.0 -61.21 1.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.494 ' HB2' ' OG1' ' A' ' 143' ' ' THR . 5.6 m-20 -85.9 -86.56 0.14 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.57 -107.0 2.4 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.472 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 46.75 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.3 60.64 2.64 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 139' ' ' ASP . 3.0 p -121.98 146.12 47.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.502 HG12 ' HB3' ' A' ' 148' ' ' GLU . 63.9 t -128.19 123.19 59.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.83 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.421 ' HB3' ' CE1' ' A' ' 107' ' ' TYR . 1.6 p-10 -97.02 -175.53 3.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -58.91 -34.17 71.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -60.65 -58.19 9.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.067 0.46 . . . . 0.0 110.751 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HB3' HG12 ' A' ' 144' ' ' VAL . 10.6 tp10 -66.98 -32.49 73.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.328 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.61 -46.76 88.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.209 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.0 mtp -80.91 -3.99 53.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.502 . . . . 0.0 110.704 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.75 -44.86 5.64 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.632 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.536 HG12 ' HG3' ' A' ' 153' ' ' MET . 7.7 p -70.27 -34.14 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 110.587 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.536 ' HG3' HG12 ' A' ' 152' ' ' VAL . 66.5 mtt -102.67 178.67 4.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.282 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 31.1 p 48.2 58.85 4.72 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.287 0.635 . . . . 0.0 111.934 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -114.82 73.06 0.24 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.471 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.25 70.34 0.41 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -116.0 137.61 51.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.532 178.195 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.49 0.186 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.4 tp60 -73.38 108.38 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.233 0.539 . . . . 0.0 111.031 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -68.37 0.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.79 ' HG2' ' H ' ' A' ' 93' ' ' LEU . 16.2 tt0 63.93 -175.98 0.16 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.161 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.79 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 79.6 mt -89.64 10.23 23.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 16.2 mmt180 -59.92 -43.12 95.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.703 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.5 mm-40 -60.88 -35.98 78.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.175 0.297 . . . . 0.0 111.721 -176.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.09 85.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.38 -36.7 38.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 29.4 mtm180 -63.69 -21.6 66.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.78 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.6 mt -61.12 -43.75 98.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.07 0.462 . . . . 0.0 110.699 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.35 -19.68 22.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.39 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 10.1 t70 -57.96 -48.4 80.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.034 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -55.02 -39.35 69.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.173 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.35 55.13 1.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.554 0.692 . . . . 0.0 110.748 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.84 14.33 1.74 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.602 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.39 19.83 10.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.187 0.595 . . . . 0.0 111.346 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 -62.8 3.44 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.224 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.497 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 22.8 m-85 -84.06 89.17 7.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.495 ' CG1' ' HB ' ' A' ' 144' ' ' VAL . 38.6 pt -69.53 141.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 111.632 -173.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -59.01 139.77 56.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 137' ' ' ASP . 14.0 p -62.08 -16.05 49.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.72 -39.47 73.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.046 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 t -74.73 -32.76 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.52 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.5 tpp -61.4 -32.94 72.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -58.56 -40.61 83.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 110.059 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.94 -35.78 72.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.426 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.1 mt -70.04 -39.03 76.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.2 -40.16 93.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 124' ' ' LEU . . . -70.07 -19.72 63.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.657 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.94 -35.43 37.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.732 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.85 -62.89 1.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.352 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -105.87 141.7 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.52 14.95 22.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.5 p -115.98 -16.1 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.632 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 118' ' ' ALA . 3.6 pp -76.04 151.26 37.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 m -112.46 179.31 4.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.828 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.9 t -61.41 -36.74 81.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 110.215 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.35 -46.27 80.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.881 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.61 -39.38 76.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.9 -34.14 71.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.813 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.95 76.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.26 -46.45 60.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.005 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' A' ' 110' ' ' THR . 48.2 mm -81.2 68.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 122.083 0.944 . . . . 0.0 109.928 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.21 -42.67 0.14 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.509 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -112.95 23.27 13.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.11 0.957 . . . . 0.0 108.735 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.72 -42.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.947 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.746 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 6.8 p-10 -89.74 138.71 31.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.814 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.65 ' H ' ' HA3' ' A' ' 142' ' ' GLY . . . -152.55 15.6 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.656 173.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 61.82 98.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.244 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.17 -42.56 2.06 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 m -117.11 61.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 137' ' ' ASP . . . 173.16 -40.84 0.15 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.411 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 107' ' ' TYR . 2.4 p -64.84 101.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 108' ' ' ILE . 94.8 t -45.07 108.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -163.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.82 165.32 21.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.534 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -47.4 -50.36 22.72 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.084 0.554 . . . . 0.0 111.45 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.65 -15.38 32.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 144' ' ' VAL . 27.1 tt0 -70.39 -31.39 68.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -56.23 -43.81 78.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 51.9 ttm -64.67 -40.22 95.03 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.15 -31.34 72.84 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.545 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.79 -40.55 39.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.0 mmt -70.85 -44.65 65.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.326 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.2 p -101.93 36.35 2.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.137 0.494 . . . . 0.0 110.897 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.19 76.67 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.85 56.91 0.75 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.35 128.38 36.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 111.487 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.974 175.497 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.716 0.294 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -142.3 116.79 9.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.973 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.42 -26.61 67.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.957 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 49.08 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.896 0.748 . . . . 0.0 112.913 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 45.6 mt -74.45 -7.91 54.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.581 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -76.81 -16.29 59.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.488 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.6 -41.53 97.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.647 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.49 -41.68 31.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.57 -36.37 80.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.508 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.42 -16.05 64.02 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 111.346 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.78 -33.75 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.409 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.436 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 51.2 m-85 -85.33 -34.79 21.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.931 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -79.56 66.37 5.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.696 0.76 . . . . 0.0 109.685 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 46.3 mtpt -68.91 -49.68 56.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.034 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.44 ' OE2' ' HB2' ' A' ' 102' ' ' LYS . 6.8 mp0 -71.82 -23.37 61.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.357 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.14 1.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.732 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.89 -37.0 7.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.791 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.63 66.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.472 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 41.9 p90 -154.7 144.21 21.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.55 144.04 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.462 0.649 . . . . 0.0 111.256 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 11.6 m -62.83 139.97 58.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.882 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.595 ' HB ' HG22 ' A' ' 133' ' ' ILE . 11.8 p -55.88 -21.84 22.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.681 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -59.72 -30.68 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.928 0.394 . . . . 0.0 110.944 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 116' ' ' ILE . 24.9 t -73.0 -27.57 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.098 0.475 . . . . 0.0 110.19 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.0 tpt -65.93 -38.08 87.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.412 ' HB2' HD13 ' A' ' 129' ' ' LEU . 2.0 ptt180 -73.75 -18.98 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.941 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -75.15 -42.15 56.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 112' ' ' VAL . 64.1 mt -60.7 -51.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.408 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.51 -32.56 68.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.737 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.35 68.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.223 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -96.99 -36.67 10.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.64 -45.75 88.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -99.23 -177.04 3.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.45 89.25 3.31 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.071 0.938 . . . . 0.0 109.586 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.1 t 49.73 77.8 0.11 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.934 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.48 137.65 35.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.998 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 t -75.68 160.29 30.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.408 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -36.17 66.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.859 0.362 . . . . 0.0 110.674 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.89 -27.87 69.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.91 -42.79 20.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.557 0.694 . . . . 0.0 110.033 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 133' ' ' ILE . 81.3 mt -65.88 -37.34 85.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.309 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -51.77 -49.53 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.553 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.28 82.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.6 -39.33 80.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 129' ' ' LEU . 30.5 mm -78.52 -34.97 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.016 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.38 -40.36 96.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.948 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.49 -15.99 55.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.704 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 136' ' ' ILE . 25.0 mt -102.79 -57.94 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.441 ' N ' HG21 ' A' ' 110' ' ' THR . 10.6 t70 63.49 155.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.01 0.819 . . . . 0.0 112.955 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 109' ' ' SER . . . -117.08 65.2 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.019 -0.426 . . . . 0.0 111.062 -176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -123.02 -41.95 2.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.08 138.6 2.51 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 p 46.84 37.42 4.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.869 0.842 . . . . 0.0 109.944 -170.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.54 -36.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.548 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.53 112.23 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 37.7 t -69.77 104.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.493 -162.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 0.9 OUTLIER -93.82 -173.52 3.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 174.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 93' ' ' LEU . 71.5 t80 -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.932 0.333 . . . . 0.0 111.303 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -65.32 -48.24 73.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.564 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 152' ' ' VAL . 8.7 tp10 -63.99 -44.62 92.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -55.91 -44.57 78.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.675 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 46.2 ttm -59.15 -49.03 79.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.763 ' HA2' ' HA3' ' A' ' 155' ' ' GLY . . . -66.33 -31.7 79.79 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.311 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 148' ' ' GLU . 96.5 t -81.27 -47.58 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.792 0.296 . . . . 0.0 111.596 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.52 ' HE1' HD23 ' A' ' 93' ' ' LEU . 53.4 ttp -75.43 -39.1 59.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.0 t -157.0 50.91 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.015 0.912 . . . . 0.0 110.591 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.763 ' HA3' ' HA2' ' A' ' 151' ' ' GLY . . . -114.46 5.91 22.96 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.147 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -147.65 -36.77 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.71 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.55 121.6 42.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.057 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 76.5 mmm . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.3 59.42 2.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -113.49 8.58 17.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.35 111.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.969 -1.468 . . . . 0.0 112.415 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.95 -27.81 66.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.053 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -59.72 -36.16 76.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.197 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.99 -45.05 91.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.713 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.4 -45.36 16.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.078 0.466 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -62.0 -32.3 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.846 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.482 ' HA ' ' OD1' ' A' ' 101' ' ' ASP . 14.1 ptm180 -67.2 -12.86 61.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.098 0.475 . . . . 0.0 111.386 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.72 -22.47 23.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.256 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' LYS . 99.3 m-85 -101.98 -30.08 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.971 -175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -78.07 9.35 3.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 -177.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.676 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 48.3 pttt -38.6 -48.26 1.42 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.663 1.185 . . . . 0.0 112.906 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.676 ' HG2' ' HG3' ' A' ' 102' ' ' LYS . 21.5 mm-40 -111.24 -11.02 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 110.728 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.73 -17.84 50.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.516 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 58.91 35.22 24.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.68 -29.77 6.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.011 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 28.3 p90 -123.07 125.71 45.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.008 0.432 . . . . 0.0 110.1 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 pt -110.14 150.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.226 0.536 . . . . 0.0 111.563 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 34.4 t -58.23 137.36 57.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 6.3 p -61.3 -22.54 64.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.971 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' HA ' ' CD ' ' A' ' 114' ' ' ARG . 28.8 t70 -64.4 -35.62 81.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.465 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' ILE . 58.7 t -66.73 -35.65 75.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.078 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.9 ttp -74.46 -20.15 60.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.958 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.489 ' CD ' ' HA ' ' A' ' 111' ' ' ASP . 77.3 mtp180 -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 37.6 mt-10 -80.12 -30.43 39.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.332 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 112' ' ' VAL . 42.0 mt -59.01 -40.36 80.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.234 0.54 . . . . 0.0 109.827 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -40.14 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.711 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.9 -30.03 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 43.7 mt-10 -73.51 -32.06 64.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -89.07 -52.34 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 12.1 t70 -104.52 144.97 30.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.885 0.374 . . . . 0.0 110.8 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 -12.67 13.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.775 -174.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -103.75 -3.24 25.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.956 0.407 . . . . 0.0 111.167 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' A' ' 121' ' ' ASP . 75.4 mt -76.08 121.24 22.51 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.2 t -72.37 162.18 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.685 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 5.5 p -66.39 -22.26 66.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.629 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -71.34 -37.79 71.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.92 -36.31 80.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.794 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 8.8 mt -55.53 -38.79 69.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.218 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -81.73 -46.72 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -61.01 -49.78 76.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.001 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.5 mtp -60.76 -47.84 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.126 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 31.2 mm -63.46 -34.63 68.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.56 -31.5 71.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.0 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 44.2 mt-10 -78.72 -41.12 31.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 110.306 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.79 -67.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.832 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.47 ' HA ' ' CG2' ' A' ' 110' ' ' THR . 6.1 t70 41.91 -127.45 0.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.643 0.589 . . . . 0.0 109.832 -169.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 144' ' ' VAL . . . -171.24 -63.43 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.272 0.358 . . . . 0.0 110.822 170.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -158.3 -62.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.938 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.47 47.22 3.43 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.642 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.0 p 47.22 41.75 12.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.11 0.564 . . . . 0.0 111.169 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 109' ' ' SER . . . 133.05 35.5 0.3 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.467 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.4 p -128.27 81.0 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.227 0.514 . . . . 0.0 111.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 42.8 t -65.57 101.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.45 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -88.31 174.45 8.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.119 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -58.5 -48.1 81.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.311 0.577 . . . . 0.0 110.052 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -56.56 -23.22 38.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.426 ' HG2' ' HB1' ' A' ' 138' ' ' ALA . 15.4 tp10 -90.78 -55.59 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.835 0.35 . . . . 0.0 110.445 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -63.02 -35.09 79.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.475 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 86.9 mtp -81.99 -4.2 56.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -94.12 -42.53 4.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.595 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.8 m -72.41 -19.36 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.006 0.431 . . . . 0.0 110.993 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 94.0 mmm -112.0 165.54 12.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.107 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 p 65.66 -60.2 0.28 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.373 1.469 . . . . 0.0 112.226 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.11 79.37 0.07 OUTLIER Glycine 0 CA--C 1.518 0.247 0 O-C-N 123.471 0.482 . . . . 0.0 113.933 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.17 -30.39 4.56 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.698 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -101.11 134.9 43.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.833 0.349 . . . . 0.0 110.293 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.579 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 91.5 mtp . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -89.1 -23.19 22.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -97.18 40.4 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.527 0.68 . . . . 0.0 110.97 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.466 ' HB3' ' NE ' ' A' ' 94' ' ' ARG . 44.2 tt0 -72.84 155.95 39.39 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -41.49 -37.29 1.05 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 92' ' ' GLU . 4.3 ppt_? -65.78 -12.57 55.12 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 6.4 pt-20 -49.77 -49.89 46.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.643 0.259 . . . . 0.0 111.035 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.629 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -65.38 -28.1 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.141 -176.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -60.99 -51.23 70.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.175 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -82.04 -19.62 39.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.875 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 77.0 mt -72.48 -45.14 60.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.554 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -84.73 -47.99 9.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.654 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.581 ' HB2' HG21 ' A' ' 108' ' ' ILE . 13.0 t70 -72.04 105.82 4.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.613 0.721 . . . . 0.0 111.879 -175.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -82.24 -13.54 56.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.049 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.78 -50.92 0.67 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -169.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.77 -55.62 27.97 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.16 0.424 . . . . 0.0 114.16 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.17 60.32 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.353 0.597 . . . . 0.0 110.599 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.77 -19.33 2.56 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.2 p90 -151.94 134.43 15.35 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 101' ' ' ASP . 43.7 pt -114.94 155.4 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.7 t -69.81 138.79 52.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.175 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -54.51 -32.79 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.619 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -36.56 81.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.79 -33.03 60.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.436 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 46.1 ttm -63.72 -31.76 73.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HG2' HG13 ' A' ' 133' ' ' ILE . 72.3 mtm180 -63.13 -41.96 99.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' GLU . 31.4 mt-10 -61.3 -45.77 93.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.407 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.13 -44.38 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.272 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 113' ' ' MET . 92.3 mt -64.95 -40.53 95.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.978 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 124' ' ' LEU . . . -72.43 -20.28 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.981 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 2.5 tm-20 -82.02 -38.02 25.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.567 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 tt -76.32 -55.55 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.145 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.75 152.06 37.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.567 0.698 . . . . 0.0 110.744 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -77.77 -33.23 52.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.862 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -165.86 52.57 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 118' ' ' ALA . 1.3 pp -82.26 150.05 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.719 -0.613 . . . . 0.0 110.004 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.6 m -91.33 172.3 8.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.835 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.1 p -64.93 -39.01 92.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.849 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.71 -34.79 79.02 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.545 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.11 -50.49 72.62 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 109.726 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.11 -48.41 80.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.707 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.43 -46.87 80.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.892 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.07 63.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.0 mtm -61.58 -43.17 99.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.597 0.237 . . . . 0.0 111.255 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.45 HG13 ' HG2' ' A' ' 114' ' ' ARG . 37.1 mm -64.63 -34.96 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.537 0.208 . . . . 0.0 110.481 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.57 -32.78 73.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.33 -39.66 59.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.5 mt -86.58 -51.33 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.37 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 54.45 -114.79 0.89 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.879 -167.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.503 ' HB3' ' C ' ' A' ' 143' ' ' THR . . . -156.56 -102.68 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 143' ' ' THR . 7.8 t70 -156.93 -52.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.55 -121.21 3.54 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -80.73 52.58 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.02 0.438 . . . . 0.0 110.307 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.66 32.34 33.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.205 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.503 ' C ' ' HB3' ' A' ' 138' ' ' ALA . 12.0 p -111.98 98.03 7.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.577 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 39.6 t -73.77 112.39 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 169.61 17.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.025 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -59.07 -40.56 85.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.816 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.64 -48.83 70.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.03 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.41 ' O ' HG11 ' A' ' 152' ' ' VAL . 54.8 mm-40 -63.08 -44.06 96.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.617 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -54.1 -48.97 70.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.105 0.479 . . . . 0.0 110.819 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.7 -28.63 70.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.34 -49.27 3.76 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.098 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 148' ' ' GLU . 11.9 p -69.45 -27.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 80.9 mtp -104.48 69.41 0.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.086 0.469 . . . . 0.0 111.21 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.6 p -138.82 -51.07 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.913 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.97 -121.12 11.4 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.717 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.37 14.24 6.92 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.944 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -76.2 132.01 39.68 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.156 -177.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -98.55 124.7 43.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.473 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 9.8 mm-40 -108.42 17.85 21.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.67 0.748 . . . . 0.0 109.917 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 10.3 tp10 -77.23 -177.73 4.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.929 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD11 ' HG3' ' A' ' 150' ' ' MET . 87.8 mt -52.24 -18.29 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.606 0.639 . . . . 0.0 111.602 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -23.51 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.1 pt-20 -56.51 -47.72 78.73 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.894 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.493 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -63.82 -34.16 77.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.2 -46.68 79.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.194 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 51.4 ptt85 -80.9 -11.26 59.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.542 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 62.3 mt -81.21 -46.49 14.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.686 0.279 . . . . 0.0 110.434 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.431 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 22.0 m-85 -69.13 -49.59 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -119.29 95.56 4.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 44.6 tttm -77.3 -27.08 52.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.539 -173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -90.96 45.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.69 -146.27 18.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.102 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -85.73 94.08 9.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.66 103.16 2.17 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.478 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.573 ' HB3' ' OG1' ' A' ' 143' ' ' THR . 79.6 m-85 -73.36 74.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.0 pt -69.45 141.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.208 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 m -60.49 133.31 55.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.701 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.541 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 20.4 p -65.05 -18.81 65.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.99 -42.92 81.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.277 0.561 . . . . 0.0 109.685 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.66 -37.86 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.225 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.411 ' HG2' HD13 ' A' ' 117' ' ' LEU . 24.0 ttt -64.12 -37.3 86.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.027 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HG2' HG13 ' A' ' 133' ' ' ILE . 96.2 mtt180 -60.83 -27.16 67.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.67 0.271 . . . . 0.0 111.158 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.73 -48.0 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.401 . . . . 0.0 109.99 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 100' ' ' TYR . 48.8 mt -53.38 -52.28 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.684 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.901 ' HB3' ' HA3' ' A' ' 156' ' ' GLY . 9.2 mp -54.15 -53.28 55.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.093 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . . . -61.59 -20.21 63.07 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.58 -17.85 61.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.421 ' C ' HD12 ' A' ' 120' ' ' LEU . 3.2 tm? -94.42 -65.64 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -167.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.586 ' HB3' ' HB2' ' A' ' 157' ' ' ASP . 1.9 t70 -87.82 -169.72 2.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.423 0.63 . . . . 0.0 112.65 -161.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.46 67.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.517 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.443 HG23 ' OD1' ' A' ' 121' ' ' ASP . 13.8 t -176.57 -9.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.808 ' HG ' ' HB3' ' A' ' 157' ' ' ASP . 3.3 pp -130.77 161.59 31.38 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.882 -0.512 . . . . 0.0 110.306 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.5 m -109.8 174.8 5.7 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.642 -171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.775 ' HA ' HD11 ' A' ' 129' ' ' LEU . 44.2 m -60.46 -28.66 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.683 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.26 -24.38 67.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.587 0.232 . . . . 0.0 111.594 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.692 ' HB2' HD11 ' A' ' 124' ' ' LEU . 6.9 m-20 -68.34 -46.55 69.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.324 0.583 . . . . 0.0 109.44 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 126' ' ' SER . 5.1 mp -62.08 -36.89 83.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.218 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.81 -38.24 78.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.789 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.68 63.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.485 ' HE1' ' HA ' ' A' ' 129' ' ' LEU . 71.9 mtm -75.52 -55.08 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.157 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.701 ' HA ' HG21 ' A' ' 136' ' ' ILE . 15.9 mm -78.9 64.51 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.61 0.719 . . . . 0.0 109.892 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -151.34 -45.56 0.11 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.393 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -106.88 -7.92 16.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.577 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -84.9 -27.42 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.717 0.77 . . . . 0.0 110.12 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.458 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 17.9 p-10 -112.16 17.76 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.931 -170.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.57 41.32 0.62 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.461 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.06 -13.73 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.184 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.7 55.44 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.614 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 55.14 64.86 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.951 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.458 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 74.34 67.96 1.66 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.467 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 107' ' ' TYR . 1.6 t -142.32 130.05 21.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.094 0.473 . . . . 0.0 109.949 173.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.31 128.67 72.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.299 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -108.15 -165.34 1.03 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.964 0.412 . . . . 0.0 110.903 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 10.2 p90 -62.59 166.54 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.235 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER 72.52 -51.33 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.337 0.655 . . . . 0.0 111.311 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -66.73 -36.48 82.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -74.59 75.89 2.0 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.528 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.667 ' HG3' HD11 ' A' ' 93' ' ' LEU . 20.2 ttt -172.41 -52.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.915 171.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.73 83.3 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.538 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.435 ' O ' HD23 ' A' ' 117' ' ' LEU . 18.4 t -72.84 -40.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.135 0.493 . . . . 0.0 109.836 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.513 ' C ' ' H ' ' A' ' 155' ' ' GLY . 26.9 ttt -63.5 152.16 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.504 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 153' ' ' MET . 14.3 p 70.23 -19.64 0.21 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.129 0.972 . . . . 0.0 111.441 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 153' ' ' MET . . . -87.93 9.68 73.44 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.901 ' HA3' ' HB3' ' A' ' 117' ' ' LEU . . . -119.73 154.85 16.31 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.808 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 12.7 t0 -172.51 151.12 2.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.141 -170.622 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.283 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.4 mt -54.63 -21.4 10.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.567 0.622 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.8 -15.21 63.44 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 14.8 pt-20 -50.4 -46.1 56.0 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.412 0.445 . . . . 0.0 111.53 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -74.97 -42.92 56.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.813 0.34 . . . . 0.0 110.909 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -59.59 -47.5 85.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.008 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 44.0 ptt85 -62.08 -25.41 67.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.703 -175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 79.7 mt -74.18 -20.34 60.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.058 0.456 . . . . 0.0 110.728 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -101.91 6.54 41.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.703 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 98' ' ' ARG . 23.1 m-20 -80.75 33.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 103' ' ' GLU . 18.2 pttp -74.24 -47.98 31.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 102' ' ' LYS . 30.7 mt-10 -117.58 105.68 12.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.602 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 162.34 30.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -141.28 111.02 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.294 0.547 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.42 -22.61 8.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.532 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -126.4 79.53 1.86 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -77.21 141.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.604 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.621 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.0 m -63.52 141.34 58.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.621 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.608 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 18.2 p -53.46 -23.79 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.066 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.27 -51.49 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.051 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 109' ' ' SER . 9.8 p -69.62 -34.18 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.434 -172.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 144' ' ' VAL . 25.6 ttt -65.66 -25.58 67.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.785 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG2' HG13 ' A' ' 133' ' ' ILE . 82.1 mtm180 -60.68 -44.59 96.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 109.845 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.64 -34.37 73.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.154 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 113' ' ' MET . 59.0 mt -60.39 -47.51 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.667 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.07 68.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.932 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -81.32 -17.46 49.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.11 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.42 -61.49 1.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.568 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.573 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 14.4 t70 -85.69 158.31 20.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.767 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -116.38 -24.73 7.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -96.24 -40.16 9.31 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.573 ' HG ' ' OD2' ' A' ' 121' ' ' ASP . 4.4 pp -76.48 150.31 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.567 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 t -94.65 178.91 5.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.258 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.439 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 15.4 m -63.52 -36.89 85.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.91 -39.28 91.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 110.313 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.63 -53.09 60.9 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 130' ' ' ASP . 4.7 pp -67.3 -34.6 77.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.162 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 129' ' ' LEU . 15.6 t70 -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.084 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.28 72.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.415 ' HB2' ' HE3' ' A' ' 132' ' ' MET . 72.2 mtm -73.18 -35.44 66.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.07 0.462 . . . . 0.0 110.314 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 136' ' ' ILE . 39.7 mm -73.99 -31.01 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.66 0.743 . . . . 0.0 110.132 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.2 -27.04 65.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.18 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.52 3.98 23.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 133' ' ' ILE . 6.3 tt -106.08 -23.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.721 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.569 ' OD1' ' HA2' ' A' ' 142' ' ' GLY . 9.8 t0 -41.63 123.54 2.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.684 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -89.14 12.76 14.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.716 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 30.0 t70 76.3 -1.93 2.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.981 0.512 . . . . 0.0 112.239 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.82 63.65 4.41 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.344 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.4 m 66.59 25.28 10.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.019 0.437 . . . . 0.0 109.945 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.569 ' HA2' ' OD1' ' A' ' 137' ' ' ASP . . . 80.7 69.46 1.4 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.559 -176.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -134.05 162.22 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 113' ' ' MET . 48.7 t -120.2 136.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.45 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -82.87 176.53 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.76 -57.99 8.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.621 0.248 . . . . 0.0 111.475 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.27 -29.66 68.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -63.34 -41.57 98.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.985 0.421 . . . . 0.0 109.872 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.51 -49.86 71.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 87.5 mmm -55.73 -50.87 69.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.778 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.96 -43.12 97.03 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.239 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 136' ' ' ILE . 55.3 t -77.44 -40.09 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.918 0.39 . . . . 0.0 111.114 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.427 -175.895 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' SD ' ' A' ' 153' ' ' MET . 55.1 mt -102.13 -1.58 31.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.175 0.512 . . . . 0.0 110.377 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.41 -35.37 30.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.041 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.97 -45.56 67.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 30.4 t80 -71.32 -43.59 66.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.25 -32.52 62.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.4 mt -73.15 -40.67 64.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.179 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.84 15.74 28.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.423 0.63 . . . . 0.0 110.189 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 103' ' ' GLU . 6.6 t70 -62.26 103.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.835 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' TYR . 14.5 mptt -80.67 -3.82 52.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.289 169.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 2.6 mm-40 -58.5 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -165.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' LYS . . . -121.41 55.0 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 156.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 64.75 48.68 2.42 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -159.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.19 -38.84 1.91 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.512 -167.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 40.5 m-85 60.54 -171.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -171.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.18 142.67 41.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.994 -0.441 . . . . 0.0 110.303 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.574 ' HB2' HG23 ' A' ' 112' ' ' VAL . 15.6 m -70.11 142.16 52.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.051 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.478 HG21 ' HA ' ' A' ' 137' ' ' ASP . 17.1 p -58.94 -31.9 69.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.974 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.32 -45.94 89.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.263 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 109' ' ' SER . 58.8 t -62.88 -43.72 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.319 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.7 tpt -54.37 -36.72 64.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.889 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' THR . 78.8 mtm180 -61.49 -47.32 86.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.1 -43.78 86.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.73 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 112' ' ' VAL . 76.9 mt -57.49 -40.27 73.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.35 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -80.94 -29.54 35.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.657 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -78.49 -22.11 47.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.28 -26.19 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.89 -55.98 5.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.646 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 25.7 t70 -107.16 142.38 36.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.982 0.42 . . . . 0.0 110.482 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -99.79 -9.05 23.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.779 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 p -104.24 -16.78 15.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 129' ' ' LEU . 97.5 mt -79.36 117.63 20.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.802 0.334 . . . . 0.0 110.29 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 2.8 t -81.47 155.36 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.361 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -59.65 -32.4 70.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.577 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.6 mp0 -58.71 -50.18 74.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.448 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -34.77 72.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.091 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 117' ' ' LEU . 7.8 mt -69.14 -26.63 64.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.839 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.86 -43.68 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.66 70.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.55 -52.78 19.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.921 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 129' ' ' LEU . 42.2 mm -58.53 -33.37 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.79 -27.94 32.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -110.78 10.44 22.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.994 0.425 . . . . 0.0 110.941 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 79.7 mt -128.03 -37.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 7.1 t70 -50.46 126.85 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.046 0.451 . . . . 0.0 111.883 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 143' ' ' THR . . . -92.57 15.6 13.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.177 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 11.1 t70 81.37 -18.86 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 168.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.0 78.58 1.89 Allowed Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.717 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 p 51.6 30.22 6.34 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 110.229 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.517 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 76.68 70.71 1.25 Allowed Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.337 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.495 HG23 ' HB3' ' A' ' 138' ' ' ALA . 9.2 t -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 112.043 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.11 119.25 60.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.755 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.87 153.87 42.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -65.68 -12.84 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -79.74 -38.94 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.213 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.73 -29.5 45.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 97' ' ' PHE . 67.0 t80 -73.6 67.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.68 0.752 . . . . 0.0 109.548 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.423 ' HG2' HD12 ' A' ' 93' ' ' LEU . 1.1 tmt? -164.78 -70.33 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.205 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.97 -27.21 73.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.992 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.28 -36.53 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 111.433 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.461 ' SD ' HD22 ' A' ' 93' ' ' LEU . 23.9 ptm . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.634 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.37 -43.76 89.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.4 ttp85 -69.37 -39.63 77.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.83 -43.44 79.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.687 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.84 -42.47 93.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.656 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 38.6 mtm180 -63.78 -36.52 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.804 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.12 -14.32 33.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.56 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.43 -26.46 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.478 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -91.89 86.45 5.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -61.27 -32.93 72.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.939 -174.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 41.3 mm-40 -85.47 -36.96 20.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.419 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.97 54.48 1.89 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.228 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 103' ' ' GLU . 16.4 m120 -93.1 -35.38 13.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 110.023 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.56 5.12 57.93 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 145' ' ' ASP . 9.9 m-85 -136.29 145.11 45.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 144' ' ' VAL . 28.6 pt -123.32 140.73 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 111.231 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.667 ' HB3' HG23 ' A' ' 112' ' ' VAL . 34.9 t -67.16 144.98 55.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.605 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.608 HG21 ' HA ' ' A' ' 137' ' ' ASP . 8.2 p -58.96 -27.18 65.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.417 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' ARG . 18.4 t0 -70.43 -35.27 73.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 110.043 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 109' ' ' SER . 73.6 t -66.86 -41.27 87.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.503 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.2 tpt -56.22 -34.75 66.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.839 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 111' ' ' ASP . 15.2 mtp180 -56.04 -53.88 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.693 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.57 -36.03 80.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 112' ' ' VAL . 73.8 mt -57.62 -44.14 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.96 -41.67 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -68.66 -29.19 67.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.63 -5.75 59.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.003 0.43 . . . . 0.0 110.755 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 tt -88.49 -50.51 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -130.6 147.34 52.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -95.79 -22.75 17.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -82.1 -20.31 38.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.555 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.9 pp -76.93 152.19 35.41 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.968 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -107.27 176.94 5.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.703 0.287 . . . . 0.0 110.979 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.651 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 12.1 p -69.44 -25.44 64.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.929 0.395 . . . . 0.0 110.603 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.85 -39.66 89.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 132' ' ' MET . 27.0 m-20 -61.29 -38.91 88.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 12.9 mt -56.93 -44.4 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.374 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.88 -47.9 73.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.699 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.6 98.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.726 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 128' ' ' ASP . 24.2 mmt -58.2 -55.62 32.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 111.183 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.07 -35.7 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.321 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.98 -26.67 49.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.713 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -118.2 10.17 12.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 111.42 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.63 -69.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.524 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HA ' HG21 ' A' ' 110' ' ' THR . 4.5 m-20 47.11 -145.63 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.489 ' H ' ' HB3' ' A' ' 137' ' ' ASP . . . -164.74 -89.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.578 0.227 . . . . 0.0 111.476 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.2 -59.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.589 0.233 . . . . 0.0 111.593 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 143' ' ' THR . . . -93.46 70.9 1.4 Allowed Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.938 -172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 61.26 36.19 17.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 109.941 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.1 45.26 5.99 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.378 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' GLY . 6.8 p -91.44 87.72 6.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.174 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 108' ' ' ILE . 42.5 t -78.68 110.91 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.421 ' HB3' ' HD1' ' A' ' 107' ' ' TYR . 7.0 p-10 -85.43 176.27 8.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.894 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -61.05 -38.93 87.92 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -66.88 -49.13 66.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.6 -51.11 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.731 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.96 -42.5 76.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.359 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.75 -53.97 18.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.698 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.28 -25.83 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.649 0.261 . . . . 0.0 111.54 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 C--N 1.33 -0.242 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.978 -175.586 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.72 -21.39 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.789 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -59.82 -27.61 66.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.885 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.18 -48.23 79.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.954 0.407 . . . . 0.0 110.288 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.73 84.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.49 -43.88 88.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.491 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 98' ' ' ARG . 5.7 mmp_? -54.5 -36.42 64.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.618 0.367 . . . . 0.0 111.504 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.09 -49.47 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.49 -23.82 32.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.98 -39.16 91.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.619 0.723 . . . . 0.0 109.404 171.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -71.06 -25.93 62.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.708 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -79.85 -19.4 48.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.506 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.37 -109.44 0.5 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.555 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.52 -172.1 2.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.69 76.49 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.169 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.34 112.37 17.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.4 141.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 111.225 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 m -67.89 137.31 55.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.671 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -60.21 -23.07 63.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.431 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -59.06 -45.96 89.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 109.837 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 116' ' ' ILE . 41.3 t -64.79 -38.6 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.854 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.1 ttt -59.96 -37.45 79.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -63.53 -46.1 87.56 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.2 -39.06 78.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 112' ' ' VAL . 68.1 mt -67.67 -57.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.479 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.987 HD11 HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -73.04 -22.61 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -171.252 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -66.18 -29.04 69.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.08 0.467 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.85 -23.03 42.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.44 -52.75 35.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.033 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.406 ' CG ' ' HG ' ' A' ' 124' ' ' LEU . 23.0 t70 -92.52 159.24 15.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 0.0 110.159 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.2 -25.74 52.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.938 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.3 t -149.23 26.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.943 ' HB3' HD21 ' A' ' 129' ' ' LEU . 40.5 mt -76.36 114.56 15.19 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.947 174.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 6.9 m -81.75 157.62 24.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 m -53.29 -45.78 69.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.23 -44.21 83.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.32 -35.64 77.95 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.137 0.494 . . . . 0.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.987 HD22 HD11 ' A' ' 117' ' ' LEU . 7.4 mt -76.06 -44.75 37.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.275 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.5 -33.67 76.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.669 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.14 72.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.55 -32.9 25.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.172 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 129' ' ' LEU . 25.7 mm -59.92 -37.6 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.897 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.13 -32.49 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.59 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -80.05 -27.54 39.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.064 0.459 . . . . 0.0 110.574 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.0 mt -85.83 -40.23 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.109 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 118.23 9.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.313 0.578 . . . . 0.0 111.687 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.26 19.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.318 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.12 -99.7 0.44 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.426 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -108.35 71.71 0.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.169 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 m 64.66 13.53 8.39 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.24 71.44 0.36 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.921 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.34 122.58 37.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.811 0.338 . . . . 0.0 111.095 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.4 t -110.4 135.58 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.874 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 148' ' ' GLU . 3.9 p-10 -95.56 -173.06 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 150' ' ' MET . 32.9 p90 -68.43 -47.32 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -173.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.96 -22.02 31.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.461 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 145' ' ' ASP . 7.0 tp10 -63.6 -41.73 98.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.01 -39.67 93.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.029 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 25.2 mmt -63.09 -52.57 62.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.767 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.06 -40.66 66.92 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.131 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 148' ' ' GLU . 77.1 t -67.86 -49.4 69.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 110.859 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 88.7 mmm . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.804 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.33 0.586 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.64 -9.35 58.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.952 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.1 mmt85 -58.29 -47.29 84.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.873 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 21.3 tt0 -69.61 -41.49 75.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.67 79.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.03 -43.67 91.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.563 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -69.73 -21.1 63.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.3 mt -66.0 -33.4 75.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.102 0.477 . . . . 0.0 110.496 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 96.7 m-85 -101.62 -36.25 8.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.279 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -99.76 92.98 5.57 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 109.62 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 99' ' ' LEU . 34.4 mmtp -77.27 -48.64 16.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.031 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.18 40.34 0.48 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.26 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.55 10.6 68.98 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.176 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.17 21.22 4.86 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.238 0.615 . . . . 0.0 110.797 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.36 36.1 15.51 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.551 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 145' ' ' ASP . 53.5 m-85 -142.72 107.19 4.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 0.0 110.599 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -97.34 140.86 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.132 0.491 . . . . 0.0 110.423 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 112' ' ' VAL . 17.7 m -69.98 142.3 52.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.574 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 21.2 p -60.1 -27.77 67.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.727 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -40.82 80.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.289 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 109' ' ' SER . 57.5 t -70.23 -37.94 73.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.2 -34.16 71.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 133' ' ' ILE . 67.9 mtt180 -57.3 -36.98 71.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.355 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.29 -37.33 38.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.814 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 112' ' ' VAL . 52.4 mt -58.83 -53.69 44.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.715 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.2 -36.89 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.65 67.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.287 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -84.94 -42.11 15.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.217 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.28 -51.81 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.242 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.84 139.15 38.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.256 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.45 -2.32 23.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.419 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.3 p -105.76 -24.18 12.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 pp -76.28 154.96 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.876 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.5 p -124.76 -178.49 4.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.363 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 p -54.66 -43.72 72.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.398 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -58.81 -54.59 45.39 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.409 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.55 -49.3 77.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.794 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.8 -49.77 75.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.73 85.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.942 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.7 mtm -82.19 -41.38 20.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 136' ' ' ILE . 44.2 mm -70.79 -33.83 54.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.312 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.79 -16.21 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.226 0.536 . . . . 0.0 110.504 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -101.32 -15.81 17.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.524 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 133' ' ' ILE . 5.8 tt -89.47 -23.55 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.47 ' HA ' HG21 ' A' ' 110' ' ' THR . 36.7 m-20 -43.97 106.6 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.551 0.532 . . . . 0.0 110.495 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.0 -61.21 1.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 143' ' ' THR . 5.6 m-20 -85.9 -86.56 0.14 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.57 -107.0 2.4 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.472 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 46.75 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.3 60.64 2.64 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 139' ' ' ASP . 3.0 p -121.98 146.12 47.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 148' ' ' GLU . 63.9 t -128.19 123.19 59.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.83 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 107' ' ' TYR . 1.6 p-10 -97.02 -175.53 3.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -58.91 -34.17 71.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -60.65 -58.19 9.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.067 0.46 . . . . 0.0 110.751 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 144' ' ' VAL . 10.6 tp10 -66.98 -32.49 73.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.328 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.61 -46.76 88.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.209 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.0 mtp -80.91 -3.99 53.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.502 . . . . 0.0 110.704 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.75 -44.86 5.64 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.632 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 153' ' ' MET . 7.7 p -70.27 -34.14 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 110.587 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.555 ' HG3' HG13 ' A' ' 152' ' ' VAL . 66.5 mtt . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.282 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 93' ' ' LEU . 16.2 tt0 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.452 0.644 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.749 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 79.6 mt -89.64 10.23 23.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.541 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 16.2 mmt180 -59.92 -43.12 95.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.703 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.5 mm-40 -60.88 -35.98 78.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.175 0.297 . . . . 0.0 111.721 -176.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.09 85.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.38 -36.7 38.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 29.4 mtm180 -63.69 -21.6 66.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.78 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.6 mt -61.12 -43.75 98.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.07 0.462 . . . . 0.0 110.699 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.35 -19.68 22.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.39 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 10.1 t70 -57.96 -48.4 80.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.034 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -55.02 -39.35 69.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.173 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.35 55.13 1.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.554 0.692 . . . . 0.0 110.748 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.84 14.33 1.74 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.602 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.39 19.83 10.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.187 0.595 . . . . 0.0 111.346 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 -62.8 3.44 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.224 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 22.8 m-85 -84.06 89.17 7.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 144' ' ' VAL . 38.6 pt -69.53 141.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 111.632 -173.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -59.01 139.77 56.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 137' ' ' ASP . 14.0 p -62.08 -16.05 49.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.72 -39.47 73.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.046 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 t -74.73 -32.76 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.52 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.5 tpp -61.4 -32.94 72.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.423 ' HG2' HG13 ' A' ' 133' ' ' ILE . 81.0 mtp180 -58.56 -40.61 83.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 110.059 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.94 -35.78 72.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.426 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.1 mt -70.04 -39.03 76.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.2 -40.16 93.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -70.07 -19.72 63.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.657 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.94 -35.43 37.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.732 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.85 -62.89 1.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.352 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -105.87 141.7 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.52 14.95 22.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.5 p -115.98 -16.1 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.632 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.6 pp -76.04 151.26 37.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 m -112.46 179.31 4.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.828 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.9 t -61.41 -36.74 81.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 110.215 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.35 -46.27 80.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.881 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.61 -39.38 76.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.9 -34.14 71.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.813 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.95 76.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.26 -46.45 60.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.005 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 110' ' ' THR . 48.2 mm -81.2 68.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 122.083 0.944 . . . . 0.0 109.928 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.21 -42.67 0.14 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.509 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -112.95 23.27 13.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.11 0.957 . . . . 0.0 108.735 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.72 -42.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.947 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.763 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 6.8 p-10 -89.74 138.71 31.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.814 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.596 ' H ' ' HA3' ' A' ' 142' ' ' GLY . . . -152.55 15.6 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.656 173.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 61.82 98.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.244 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.17 -42.56 2.06 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 m -117.11 61.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.763 ' HA3' ' HA ' ' A' ' 137' ' ' ASP . . . 173.16 -40.84 0.15 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.411 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 107' ' ' TYR . 2.4 p -64.84 101.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.498 ' HB ' ' CG1' ' A' ' 108' ' ' ILE . 94.8 t -45.07 108.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -163.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.82 165.32 21.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.534 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -47.4 -50.36 22.72 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.084 0.554 . . . . 0.0 111.45 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.65 -15.38 32.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 144' ' ' VAL . 27.1 tt0 -70.39 -31.39 68.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -56.23 -43.81 78.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 51.9 ttm -64.67 -40.22 95.03 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.15 -31.34 72.84 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.545 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.79 -40.55 39.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.0 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.326 -177.482 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 45.6 mt -74.45 -7.91 54.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.581 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -76.81 -16.29 59.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.488 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.6 -41.53 97.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.647 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.49 -41.68 31.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.57 -36.37 80.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.508 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.42 -16.05 64.02 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 111.346 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.78 -33.75 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.409 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.44 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 51.2 m-85 -85.33 -34.79 21.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.931 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -79.56 66.37 5.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.696 0.76 . . . . 0.0 109.685 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 46.3 mtpt -68.91 -49.68 56.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.034 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.452 ' OE2' ' HB2' ' A' ' 102' ' ' LYS . 6.8 mp0 -71.82 -23.37 61.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.357 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.14 1.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.732 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.89 -37.0 7.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.791 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.63 66.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.472 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 41.9 p90 -154.7 144.21 21.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.55 144.04 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.462 0.649 . . . . 0.0 111.256 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 m -62.83 139.97 58.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.882 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.856 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 11.8 p -55.88 -21.84 22.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.681 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -59.72 -30.68 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.928 0.394 . . . . 0.0 110.944 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 116' ' ' ILE . 24.9 t -73.0 -27.57 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.098 0.475 . . . . 0.0 110.19 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.0 tpt -65.93 -38.08 87.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.418 ' HB2' HD13 ' A' ' 129' ' ' LEU . 2.0 ptt180 -73.75 -18.98 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.941 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -75.15 -42.15 56.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 112' ' ' VAL . 64.1 mt -60.7 -51.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.408 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.51 -32.56 68.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.737 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.35 68.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.223 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -96.99 -36.67 10.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.64 -45.75 88.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -99.23 -177.04 3.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.45 89.25 3.31 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.071 0.938 . . . . 0.0 109.586 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.1 t 49.73 77.8 0.11 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.934 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.48 137.65 35.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.998 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 t -75.68 160.29 30.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.408 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -36.17 66.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.859 0.362 . . . . 0.0 110.674 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.89 -27.87 69.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.91 -42.79 20.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.557 0.694 . . . . 0.0 110.033 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 133' ' ' ILE . 81.3 mt -65.88 -37.34 85.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.309 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -51.77 -49.53 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.553 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.28 82.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.6 -39.33 80.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.603 HG23 ' HB ' ' A' ' 110' ' ' THR . 30.5 mm -78.52 -34.97 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.016 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.38 -40.36 96.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.948 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.49 -15.99 55.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.704 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 144' ' ' VAL . 25.0 mt -102.79 -57.94 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.463 ' N ' HG21 ' A' ' 110' ' ' THR . 10.6 t70 63.49 155.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.01 0.819 . . . . 0.0 112.955 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.856 ' HB2' ' H ' ' A' ' 110' ' ' THR . . . -117.08 65.2 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.019 -0.426 . . . . 0.0 111.062 -176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -123.02 -41.95 2.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.08 138.6 2.51 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 p 46.84 37.42 4.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.869 0.842 . . . . 0.0 109.944 -170.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.54 -36.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.548 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.53 112.23 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 136' ' ' ILE . 37.7 t -69.77 104.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.493 -162.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 0.9 OUTLIER -93.82 -173.52 3.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 174.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 93' ' ' LEU . 71.5 t80 -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.932 0.333 . . . . 0.0 111.303 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -65.32 -48.24 73.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.564 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 8.7 tp10 -63.99 -44.62 92.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -55.91 -44.57 78.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.675 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 46.2 ttm -59.15 -49.03 79.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.33 -31.7 79.79 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.311 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' GLU . 96.5 t -81.27 -47.58 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.792 0.296 . . . . 0.0 111.596 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.491 ' HE3' HD22 ' A' ' 93' ' ' LEU . 53.4 ttp . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.95 -27.81 66.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.053 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -59.72 -36.16 76.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.197 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.99 -45.05 91.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.713 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.4 -45.36 16.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.078 0.466 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -62.0 -32.3 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.846 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.482 ' HA ' ' OD1' ' A' ' 101' ' ' ASP . 14.1 ptm180 -67.2 -12.86 61.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.098 0.475 . . . . 0.0 111.386 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.72 -22.47 23.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.256 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -101.98 -30.08 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.971 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -78.07 9.35 3.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 -177.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.658 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 48.3 pttt -38.6 -48.26 1.42 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.663 1.185 . . . . 0.0 112.906 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 102' ' ' LYS . 21.5 mm-40 -111.24 -11.02 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 110.728 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.73 -17.84 50.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.516 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 58.91 35.22 24.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.68 -29.77 6.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.011 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 28.3 p90 -123.07 125.71 45.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.008 0.432 . . . . 0.0 110.1 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 pt -110.14 150.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.226 0.536 . . . . 0.0 111.563 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 34.4 t -58.23 137.36 57.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 137' ' ' ASP . 6.3 p -61.3 -22.54 64.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.971 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HA ' ' CD ' ' A' ' 114' ' ' ARG . 28.8 t70 -64.4 -35.62 81.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.465 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' ILE . 58.7 t -66.73 -35.65 75.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.078 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.9 ttp -74.46 -20.15 60.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.958 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.488 ' CD ' ' HA ' ' A' ' 111' ' ' ASP . 77.3 mtp180 -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 37.6 mt-10 -80.12 -30.43 39.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.332 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 112' ' ' VAL . 42.0 mt -59.01 -40.36 80.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.234 0.54 . . . . 0.0 109.827 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -40.14 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.711 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.9 -30.03 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 43.7 mt-10 -73.51 -32.06 64.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -89.07 -52.34 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 12.1 t70 -104.52 144.97 30.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.885 0.374 . . . . 0.0 110.8 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 -12.67 13.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.775 -174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -103.75 -3.24 25.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.956 0.407 . . . . 0.0 111.167 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.427 ' HG ' ' OD1' ' A' ' 121' ' ' ASP . 75.4 mt -76.08 121.24 22.51 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.2 t -72.37 162.18 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.685 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 5.5 p -66.39 -22.26 66.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.629 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -71.34 -37.79 71.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.92 -36.31 80.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.794 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 8.8 mt -55.53 -38.79 69.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.218 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -81.73 -46.72 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -61.01 -49.78 76.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.001 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.5 mtp -60.76 -47.84 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.126 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 31.2 mm -63.46 -34.63 68.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.56 -31.5 71.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.0 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 44.2 mt-10 -78.72 -41.12 31.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 110.306 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.79 -67.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.832 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.686 ' HA ' HG21 ' A' ' 110' ' ' THR . 6.1 t70 41.91 -127.45 0.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.643 0.589 . . . . 0.0 109.832 -169.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . . . -171.24 -63.43 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.272 0.358 . . . . 0.0 110.822 170.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -158.3 -62.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.938 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.47 47.22 3.43 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.642 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.0 p 47.22 41.75 12.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.11 0.564 . . . . 0.0 111.169 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 109' ' ' SER . . . 133.05 35.5 0.3 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.467 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.4 p -128.27 81.0 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.227 0.514 . . . . 0.0 111.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 42.8 t -65.57 101.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.45 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -88.31 174.45 8.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.119 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -58.5 -48.1 81.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.311 0.577 . . . . 0.0 110.052 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -56.56 -23.22 38.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -90.78 -55.59 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.835 0.35 . . . . 0.0 110.445 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -63.02 -35.09 79.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.475 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 86.9 mtp -81.99 -4.2 56.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -94.12 -42.53 4.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.595 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.8 m -72.41 -19.36 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.006 0.431 . . . . 0.0 110.993 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 94.0 mmm . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.107 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 94' ' ' ARG . 44.2 tt0 . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -41.49 -37.29 1.05 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 92' ' ' GLU . 4.3 ppt_? -65.78 -12.57 55.12 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.642 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 6.4 pt-20 -49.77 -49.89 46.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.643 0.259 . . . . 0.0 111.035 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.628 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -65.38 -28.1 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.141 -176.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 101' ' ' ASP . 27.9 t80 -60.99 -51.23 70.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -82.04 -19.62 39.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.875 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 77.0 mt -72.48 -45.14 60.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.554 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -84.73 -47.99 9.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.654 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 108' ' ' ILE . 13.0 t70 -72.04 105.82 4.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.613 0.721 . . . . 0.0 111.879 -175.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -82.24 -13.54 56.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.049 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.78 -50.92 0.67 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -169.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.77 -55.62 27.97 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.16 0.424 . . . . 0.0 114.16 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 59.17 60.32 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.353 0.597 . . . . 0.0 110.599 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.77 -19.33 2.56 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.2 p90 -151.94 134.43 15.35 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.607 HG22 ' HB2' ' A' ' 101' ' ' ASP . 43.7 pt -114.94 155.4 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.739 ' HB3' HG23 ' A' ' 112' ' ' VAL . 47.7 t -69.81 138.79 52.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.175 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 138' ' ' ALA . 2.4 p -54.51 -32.79 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.619 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -36.56 81.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' SER . 54.6 t -64.79 -33.03 60.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.697 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 46.1 ttm -63.72 -31.76 73.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.466 ' HG2' HG13 ' A' ' 133' ' ' ILE . 72.3 mtm180 -63.13 -41.96 99.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' GLU . 31.4 mt-10 -61.3 -45.77 93.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.407 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.13 -44.38 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.272 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 113' ' ' MET . 92.3 mt -64.95 -40.53 95.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.978 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -72.43 -20.28 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.981 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 2.5 tm-20 -82.02 -38.02 25.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.567 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 tt -76.32 -55.55 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.145 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.75 152.06 37.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.567 0.698 . . . . 0.0 110.744 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -77.77 -33.23 52.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.862 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -165.86 52.57 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.537 HD11 ' HA ' ' A' ' 118' ' ' ALA . 1.3 pp -82.26 150.05 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.719 -0.613 . . . . 0.0 110.004 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.6 m -91.33 172.3 8.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.835 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.1 p -64.93 -39.01 92.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.849 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.71 -34.79 79.02 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.545 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.11 -50.49 72.62 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 109.726 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.11 -48.41 80.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.707 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.43 -46.87 80.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.892 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.07 63.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.0 mtm -61.58 -43.17 99.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.597 0.237 . . . . 0.0 111.255 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.466 HG13 ' HG2' ' A' ' 114' ' ' ARG . 37.1 mm -64.63 -34.96 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.537 0.208 . . . . 0.0 110.481 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.57 -32.78 73.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.33 -39.66 59.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 152' ' ' VAL . 55.5 mt -86.58 -51.33 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.37 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 54.45 -114.79 0.89 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.879 -167.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 143' ' ' THR . . . -156.56 -102.68 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 143' ' ' THR . 7.8 t70 -156.93 -52.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.55 -121.21 3.54 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -80.73 52.58 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.02 0.438 . . . . 0.0 110.307 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.66 32.34 33.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.205 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.536 ' C ' ' HB1' ' A' ' 138' ' ' ALA . 12.0 p -111.98 98.03 7.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.577 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 39.6 t -73.77 112.39 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 169.61 17.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.025 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -59.07 -40.56 85.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.816 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.64 -48.83 70.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.03 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 152' ' ' VAL . 54.8 mm-40 -63.08 -44.06 96.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.617 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -54.1 -48.97 70.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.105 0.479 . . . . 0.0 110.819 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.7 -28.63 70.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.34 -49.27 3.76 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.098 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 136' ' ' ILE . 11.9 p -69.45 -27.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.086 0.469 . . . . 0.0 111.21 179.527 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 10.3 tp10 . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' HG3' ' A' ' 150' ' ' MET . 87.8 mt -52.24 -18.29 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.606 0.639 . . . . 0.0 111.602 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -23.51 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.1 pt-20 -56.51 -47.72 78.73 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.894 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -63.82 -34.16 77.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.2 -46.68 79.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.194 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.4 ptt85 -80.9 -11.26 59.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.542 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 62.3 mt -81.21 -46.49 14.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.686 0.279 . . . . 0.0 110.434 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.441 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 22.0 m-85 -69.13 -49.59 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 12.4 t70 -119.29 95.56 4.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -77.3 -27.08 52.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.539 -173.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -90.96 45.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.69 -146.27 18.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.102 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -85.73 94.08 9.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 101' ' ' ASP . . . -80.66 103.16 2.17 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.478 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.57 ' HB3' ' OG1' ' A' ' 143' ' ' THR . 79.6 m-85 -73.36 74.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.0 pt -69.45 141.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.208 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 m -60.49 133.31 55.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.701 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.664 HG21 ' CB ' ' A' ' 137' ' ' ASP . 20.4 p -65.05 -18.81 65.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.99 -42.92 81.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.277 0.561 . . . . 0.0 109.685 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.66 -37.86 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.225 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.0 ttt -64.12 -37.3 86.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.027 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.458 ' HG2' HG13 ' A' ' 133' ' ' ILE . 96.2 mtt180 -60.83 -27.16 67.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.67 0.271 . . . . 0.0 111.158 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.73 -48.0 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.401 . . . . 0.0 109.99 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 ' CZ ' ' A' ' 100' ' ' TYR . 48.8 mt -53.38 -52.28 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.684 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.879 HD21 HG12 ' A' ' 152' ' ' VAL . 9.2 mp -54.15 -53.28 55.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.093 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.21 63.07 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.58 -17.85 61.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD13 ' C ' ' A' ' 120' ' ' LEU . 3.2 tm? -94.42 -65.64 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -167.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 123' ' ' THR . 1.9 t70 -87.82 -169.72 2.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.423 0.63 . . . . 0.0 112.65 -161.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.46 67.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.517 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 121' ' ' ASP . 13.8 t -176.57 -9.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 128' ' ' ASP . 3.3 pp -130.77 161.59 31.38 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.882 -0.512 . . . . 0.0 110.306 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.5 m -109.8 174.8 5.7 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.642 -171.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' HD13 ' A' ' 129' ' ' LEU . 44.2 m -60.46 -28.66 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.683 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.26 -24.38 67.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.587 0.232 . . . . 0.0 111.594 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.9 m-20 -68.34 -46.55 69.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.324 0.583 . . . . 0.0 109.44 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' A' ' 126' ' ' SER . 5.1 mp -62.08 -36.89 83.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.218 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.81 -38.24 78.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.789 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.68 63.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.9 mtm -75.52 -55.08 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.157 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 15.9 mm -78.9 64.51 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.61 0.719 . . . . 0.0 109.892 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -151.34 -45.56 0.11 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.393 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -106.88 -7.92 16.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.577 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.544 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 -27.42 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.717 0.77 . . . . 0.0 110.12 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.664 ' CB ' HG21 ' A' ' 110' ' ' THR . 17.9 p-10 -112.16 17.76 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.931 -170.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.57 41.32 0.62 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.461 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.06 -13.73 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.184 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.7 55.44 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.614 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 55.14 64.86 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.951 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 74.34 67.96 1.66 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.467 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 107' ' ' TYR . 1.6 t -142.32 130.05 21.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.094 0.473 . . . . 0.0 109.949 173.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.31 128.67 72.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.299 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -108.15 -165.34 1.03 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.964 0.412 . . . . 0.0 110.903 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 10.2 p90 -62.59 166.54 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.235 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER 72.52 -51.33 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.337 0.655 . . . . 0.0 111.311 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -66.73 -36.48 82.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -74.59 75.89 2.0 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.528 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.656 ' HG3' HD12 ' A' ' 93' ' ' LEU . 20.2 ttt -172.41 -52.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.915 171.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.73 83.3 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.538 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.879 HG12 HD21 ' A' ' 117' ' ' LEU . 18.4 t -72.84 -40.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.135 0.493 . . . . 0.0 109.836 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.468 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 26.9 ttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.504 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.286 0.565 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.45 -22.76 61.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.608 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.46 49.69 1.41 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 110.583 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -166.51 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.4 mt -54.63 -21.4 10.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.567 0.622 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.8 -15.21 63.44 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 14.8 pt-20 -50.4 -46.1 56.0 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.412 0.445 . . . . 0.0 111.53 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -74.97 -42.92 56.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.813 0.34 . . . . 0.0 110.909 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -59.59 -47.5 85.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.008 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 44.0 ptt85 -62.08 -25.41 67.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.703 -175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 79.7 mt -74.18 -20.34 60.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.058 0.456 . . . . 0.0 110.728 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -101.91 6.54 41.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.703 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 98' ' ' ARG . 23.1 m-20 -80.75 33.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 103' ' ' GLU . 18.2 pttp -74.24 -47.98 31.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 102' ' ' LYS . 30.7 mt-10 -117.58 105.68 12.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.602 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 162.34 30.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -141.28 111.02 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.294 0.547 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.42 -22.61 8.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.532 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -126.4 79.53 1.86 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -77.21 141.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.604 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.621 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.0 m -63.52 141.34 58.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.621 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.608 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 18.2 p -53.46 -23.79 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.066 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.27 -51.49 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.051 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 109' ' ' SER . 9.8 p -69.62 -34.18 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.434 -172.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 144' ' ' VAL . 25.6 ttt -65.66 -25.58 67.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.785 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG2' HG13 ' A' ' 133' ' ' ILE . 82.1 mtm180 -60.68 -44.59 96.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 109.845 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.64 -34.37 73.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.154 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 113' ' ' MET . 59.0 mt -60.39 -47.51 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.667 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.07 68.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.932 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -81.32 -17.46 49.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.11 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.42 -61.49 1.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.568 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.573 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 14.4 t70 -85.69 158.31 20.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.767 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -116.38 -24.73 7.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -96.24 -40.16 9.31 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.573 ' HG ' ' OD2' ' A' ' 121' ' ' ASP . 4.4 pp -76.48 150.31 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.567 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 t -94.65 178.91 5.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.258 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.439 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 15.4 m -63.52 -36.89 85.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.91 -39.28 91.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 110.313 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.63 -53.09 60.9 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 130' ' ' ASP . 4.7 pp -67.3 -34.6 77.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.162 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 129' ' ' LEU . 15.6 t70 -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.084 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.28 72.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.415 ' HB2' ' HE3' ' A' ' 132' ' ' MET . 72.2 mtm -73.18 -35.44 66.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.07 0.462 . . . . 0.0 110.314 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 136' ' ' ILE . 39.7 mm -73.99 -31.01 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.66 0.743 . . . . 0.0 110.132 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.2 -27.04 65.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.18 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.52 3.98 23.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 133' ' ' ILE . 6.3 tt -106.08 -23.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.721 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.569 ' OD1' ' HA2' ' A' ' 142' ' ' GLY . 9.8 t0 -41.63 123.54 2.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.684 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -89.14 12.76 14.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.716 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 30.0 t70 76.3 -1.93 2.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.981 0.512 . . . . 0.0 112.239 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.82 63.65 4.41 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.344 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.4 m 66.59 25.28 10.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.019 0.437 . . . . 0.0 109.945 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.569 ' HA2' ' OD1' ' A' ' 137' ' ' ASP . . . 80.7 69.46 1.4 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.559 -176.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -134.05 162.22 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 113' ' ' MET . 48.7 t -120.2 136.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.45 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -82.87 176.53 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.76 -57.99 8.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.621 0.248 . . . . 0.0 111.475 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.27 -29.66 68.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -63.34 -41.57 98.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.985 0.421 . . . . 0.0 109.872 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.51 -49.86 71.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 87.5 mmm -55.73 -50.87 69.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.778 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.719 ' HA2' ' HB3' ' A' ' 157' ' ' ASP . . . -58.96 -43.12 97.03 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.239 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 136' ' ' ILE . 55.3 t -77.44 -40.09 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.918 0.39 . . . . 0.0 111.114 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.3 tpt -69.26 -21.98 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.427 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.1 p -90.44 14.92 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.087 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.31 -44.81 1.83 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.305 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.96 59.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.719 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 32.6 t70 -81.81 94.49 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 6.8 pt-20 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.486 -0.769 . . . . 0.0 111.08 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -87.99 -62.17 1.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.507 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -120.68 56.93 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 64.59 178.29 0.18 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.842 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' SD ' ' A' ' 153' ' ' MET . 55.1 mt -102.13 -1.58 31.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.175 0.512 . . . . 0.0 110.377 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.41 -35.37 30.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.041 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.97 -45.56 67.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 30.4 t80 -71.32 -43.59 66.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.25 -32.52 62.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.4 mt -73.15 -40.67 64.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.179 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.84 15.74 28.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.423 0.63 . . . . 0.0 110.189 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 103' ' ' GLU . 6.6 t70 -62.26 103.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.835 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' TYR . 14.5 mptt -80.67 -3.82 52.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.289 169.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 2.6 mm-40 -58.5 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -165.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' LYS . . . -121.41 55.0 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 156.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 64.75 48.68 2.42 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -159.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.19 -38.84 1.91 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.512 -167.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 40.5 m-85 60.54 -171.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -171.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.18 142.67 41.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.994 -0.441 . . . . 0.0 110.303 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.574 ' HB2' HG23 ' A' ' 112' ' ' VAL . 15.6 m -70.11 142.16 52.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.051 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.478 HG21 ' HA ' ' A' ' 137' ' ' ASP . 17.1 p -58.94 -31.9 69.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.974 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.32 -45.94 89.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.263 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 109' ' ' SER . 58.8 t -62.88 -43.72 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.319 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.7 tpt -54.37 -36.72 64.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.889 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' THR . 78.8 mtm180 -61.49 -47.32 86.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.1 -43.78 86.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.73 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 112' ' ' VAL . 76.9 mt -57.49 -40.27 73.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.35 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -80.94 -29.54 35.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.657 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -78.49 -22.11 47.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.28 -26.19 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.89 -55.98 5.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.646 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 25.7 t70 -107.16 142.38 36.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.982 0.42 . . . . 0.0 110.482 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -99.79 -9.05 23.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.779 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 p -104.24 -16.78 15.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 129' ' ' LEU . 97.5 mt -79.36 117.63 20.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.802 0.334 . . . . 0.0 110.29 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 2.8 t -81.47 155.36 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.361 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -59.65 -32.4 70.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.577 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.6 mp0 -58.71 -50.18 74.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.448 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -34.77 72.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.091 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 117' ' ' LEU . 7.8 mt -69.14 -26.63 64.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.839 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.86 -43.68 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.66 70.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.55 -52.78 19.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.921 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 129' ' ' LEU . 42.2 mm -58.53 -33.37 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.79 -27.94 32.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -110.78 10.44 22.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.994 0.425 . . . . 0.0 110.941 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 79.7 mt -128.03 -37.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 7.1 t70 -50.46 126.85 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.046 0.451 . . . . 0.0 111.883 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 143' ' ' THR . . . -92.57 15.6 13.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.177 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 11.1 t70 81.37 -18.86 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 168.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.0 78.58 1.89 Allowed Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.717 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 p 51.6 30.22 6.34 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 110.229 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.517 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 76.68 70.71 1.25 Allowed Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.337 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.495 HG23 ' HB3' ' A' ' 138' ' ' ALA . 9.2 t -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 112.043 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.11 119.25 60.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.755 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.87 153.87 42.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -65.68 -12.84 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -79.74 -38.94 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.213 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.73 -29.5 45.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 97' ' ' PHE . 67.0 t80 -73.6 67.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.68 0.752 . . . . 0.0 109.548 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.423 ' HG2' HD12 ' A' ' 93' ' ' LEU . 1.1 tmt? -164.78 -70.33 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.205 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.97 -27.21 73.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.992 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.28 -36.53 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 111.433 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.461 ' SD ' HD22 ' A' ' 93' ' ' LEU . 23.9 ptm -97.64 -16.36 20.02 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.634 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 p -105.74 63.41 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.133 0.492 . . . . 0.0 110.468 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.35 -94.38 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.72 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -87.27 -6.69 77.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.136 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.39 175.86 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.94 -177.568 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -79.95 156.84 27.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.271 0.558 . . . . 0.0 110.76 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 1.1 pm0 -80.47 8.16 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.214 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.25 -41.54 75.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.37 -43.76 89.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.4 ttp85 -69.37 -39.63 77.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.83 -43.44 79.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.687 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.84 -42.47 93.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.656 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 38.6 mtm180 -63.78 -36.52 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.804 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.12 -14.32 33.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.56 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.43 -26.46 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.478 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -91.89 86.45 5.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -61.27 -32.93 72.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.939 -174.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 41.3 mm-40 -85.47 -36.96 20.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.419 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.97 54.48 1.89 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.228 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 103' ' ' GLU . 16.4 m120 -93.1 -35.38 13.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 110.023 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.56 5.12 57.93 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 145' ' ' ASP . 9.9 m-85 -136.29 145.11 45.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 144' ' ' VAL . 28.6 pt -123.32 140.73 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 111.231 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.667 ' HB3' HG23 ' A' ' 112' ' ' VAL . 34.9 t -67.16 144.98 55.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.605 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.608 HG21 ' HA ' ' A' ' 137' ' ' ASP . 8.2 p -58.96 -27.18 65.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.417 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' ARG . 18.4 t0 -70.43 -35.27 73.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 110.043 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 109' ' ' SER . 73.6 t -66.86 -41.27 87.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.503 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.2 tpt -56.22 -34.75 66.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.839 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 111' ' ' ASP . 15.2 mtp180 -56.04 -53.88 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.693 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.57 -36.03 80.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 112' ' ' VAL . 73.8 mt -57.62 -44.14 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.96 -41.67 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -68.66 -29.19 67.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.63 -5.75 59.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.003 0.43 . . . . 0.0 110.755 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 tt -88.49 -50.51 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -130.6 147.34 52.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -95.79 -22.75 17.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -82.1 -20.31 38.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.555 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.9 pp -76.93 152.19 35.41 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.968 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -107.27 176.94 5.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.703 0.287 . . . . 0.0 110.979 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.651 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 12.1 p -69.44 -25.44 64.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.929 0.395 . . . . 0.0 110.603 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.85 -39.66 89.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 132' ' ' MET . 27.0 m-20 -61.29 -38.91 88.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 12.9 mt -56.93 -44.4 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.374 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.88 -47.9 73.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.699 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.6 98.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.726 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 128' ' ' ASP . 24.2 mmt -58.2 -55.62 32.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 111.183 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.07 -35.7 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.321 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.98 -26.67 49.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.713 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -118.2 10.17 12.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 111.42 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.63 -69.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.524 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HA ' HG21 ' A' ' 110' ' ' THR . 4.5 m-20 47.11 -145.63 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.489 ' H ' ' HB3' ' A' ' 137' ' ' ASP . . . -164.74 -89.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.578 0.227 . . . . 0.0 111.476 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.2 -59.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.589 0.233 . . . . 0.0 111.593 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 143' ' ' THR . . . -93.46 70.9 1.4 Allowed Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.938 -172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 61.26 36.19 17.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 109.941 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.1 45.26 5.99 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.378 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' GLY . 6.8 p -91.44 87.72 6.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.174 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 108' ' ' ILE . 42.5 t -78.68 110.91 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.421 ' HB3' ' HD1' ' A' ' 107' ' ' TYR . 7.0 p-10 -85.43 176.27 8.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.894 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -61.05 -38.93 87.92 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -66.88 -49.13 66.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.6 -51.11 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.731 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.96 -42.5 76.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.359 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.75 -53.97 18.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.698 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.28 -25.83 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.649 0.261 . . . . 0.0 111.54 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.9 ttm -100.99 -43.96 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.978 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.2 p -73.47 -12.98 60.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -100.55 74.11 0.42 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.3 -4.13 1.1 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.702 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.7 154.9 39.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.599 -0.353 . . . . 0.0 110.09 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.956 -175.135 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.29 112.01 20.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 111.185 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.86 74.15 1.48 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -34.35 102.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.297 -1.319 . . . . 0.0 113.368 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.72 -21.39 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.789 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -59.82 -27.61 66.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.885 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.18 -48.23 79.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.954 0.407 . . . . 0.0 110.288 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.73 84.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.49 -43.88 88.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.491 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 98' ' ' ARG . 5.7 mmp_? -54.5 -36.42 64.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.618 0.367 . . . . 0.0 111.504 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.09 -49.47 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.49 -23.82 32.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.98 -39.16 91.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.619 0.723 . . . . 0.0 109.404 171.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -71.06 -25.93 62.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.708 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -79.85 -19.4 48.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.506 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.37 -109.44 0.5 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.555 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.52 -172.1 2.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.69 76.49 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.169 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.34 112.37 17.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.4 141.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 111.225 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 m -67.89 137.31 55.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.671 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -60.21 -23.07 63.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.431 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -59.06 -45.96 89.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 109.837 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 116' ' ' ILE . 41.3 t -64.79 -38.6 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.854 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.1 ttt -59.96 -37.45 79.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -63.53 -46.1 87.56 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.2 -39.06 78.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 112' ' ' VAL . 68.1 mt -67.67 -57.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.479 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.987 HD11 HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -73.04 -22.61 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -171.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -66.18 -29.04 69.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.08 0.467 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.85 -23.03 42.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.44 -52.75 35.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.033 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.406 ' CG ' ' HG ' ' A' ' 124' ' ' LEU . 23.0 t70 -92.52 159.24 15.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 0.0 110.159 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.2 -25.74 52.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.938 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.3 t -149.23 26.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.943 ' HB3' HD21 ' A' ' 129' ' ' LEU . 40.5 mt -76.36 114.56 15.19 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.947 174.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 6.9 m -81.75 157.62 24.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 m -53.29 -45.78 69.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.23 -44.21 83.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.32 -35.64 77.95 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.137 0.494 . . . . 0.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.987 HD22 HD11 ' A' ' 117' ' ' LEU . 7.4 mt -76.06 -44.75 37.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.275 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.5 -33.67 76.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.669 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.14 72.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.55 -32.9 25.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.172 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 129' ' ' LEU . 25.7 mm -59.92 -37.6 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.897 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.13 -32.49 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.59 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -80.05 -27.54 39.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.064 0.459 . . . . 0.0 110.574 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.0 mt -85.83 -40.23 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.109 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 118.23 9.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.313 0.578 . . . . 0.0 111.687 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.26 19.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.318 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.12 -99.7 0.44 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.426 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -108.35 71.71 0.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.169 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 m 64.66 13.53 8.39 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.24 71.44 0.36 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.921 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.34 122.58 37.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.811 0.338 . . . . 0.0 111.095 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.4 t -110.4 135.58 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.874 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 148' ' ' GLU . 3.9 p-10 -95.56 -173.06 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 150' ' ' MET . 32.9 p90 -68.43 -47.32 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -173.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.96 -22.02 31.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.461 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 145' ' ' ASP . 7.0 tp10 -63.6 -41.73 98.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.01 -39.67 93.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.029 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 25.2 mmt -63.09 -52.57 62.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.767 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.06 -40.66 66.92 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.131 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 148' ' ' GLU . 77.1 t -67.86 -49.4 69.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 110.859 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 88.7 mmm -71.27 -34.09 70.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.8 p -93.83 10.0 34.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.293 . . . . 0.0 111.231 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.15 126.88 7.8 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.566 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.87 -7.83 36.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.971 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.82 128.35 33.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.335 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -98.32 72.05 2.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.217 0.532 . . . . 0.0 110.965 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.88 -34.92 24.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.13 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -81.51 111.53 17.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.234 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.64 -9.35 58.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.952 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.1 mmt85 -58.29 -47.29 84.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.873 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 21.3 tt0 -69.61 -41.49 75.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.67 79.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.03 -43.67 91.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.563 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -69.73 -21.1 63.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.3 mt -66.0 -33.4 75.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.102 0.477 . . . . 0.0 110.496 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 96.7 m-85 -101.62 -36.25 8.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.279 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -99.76 92.98 5.57 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 109.62 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 99' ' ' LEU . 34.4 mmtp -77.27 -48.64 16.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.031 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.18 40.34 0.48 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.26 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.55 10.6 68.98 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.176 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.17 21.22 4.86 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.238 0.615 . . . . 0.0 110.797 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.36 36.1 15.51 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.551 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 145' ' ' ASP . 53.5 m-85 -142.72 107.19 4.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 0.0 110.599 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -97.34 140.86 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.132 0.491 . . . . 0.0 110.423 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 112' ' ' VAL . 17.7 m -69.98 142.3 52.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.574 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 21.2 p -60.1 -27.77 67.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.727 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -40.82 80.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.289 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 109' ' ' SER . 57.5 t -70.23 -37.94 73.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.2 -34.16 71.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 133' ' ' ILE . 67.9 mtt180 -57.3 -36.98 71.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.355 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.29 -37.33 38.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.814 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 112' ' ' VAL . 52.4 mt -58.83 -53.69 44.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.715 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.2 -36.89 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.65 67.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.287 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -84.94 -42.11 15.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.217 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.28 -51.81 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.242 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.84 139.15 38.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.256 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.45 -2.32 23.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.419 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.3 p -105.76 -24.18 12.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 pp -76.28 154.96 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.876 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.5 p -124.76 -178.49 4.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.363 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 p -54.66 -43.72 72.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.398 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -58.81 -54.59 45.39 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.409 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.55 -49.3 77.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.794 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.8 -49.77 75.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.73 85.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.942 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.7 mtm -82.19 -41.38 20.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 136' ' ' ILE . 44.2 mm -70.79 -33.83 54.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.312 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.79 -16.21 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.226 0.536 . . . . 0.0 110.504 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -101.32 -15.81 17.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.524 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 133' ' ' ILE . 5.8 tt -89.47 -23.55 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.47 ' HA ' HG21 ' A' ' 110' ' ' THR . 36.7 m-20 -43.97 106.6 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.551 0.532 . . . . 0.0 110.495 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.0 -61.21 1.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 143' ' ' THR . 5.6 m-20 -85.9 -86.56 0.14 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.57 -107.0 2.4 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.472 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 46.75 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.3 60.64 2.64 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 139' ' ' ASP . 3.0 p -121.98 146.12 47.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 148' ' ' GLU . 63.9 t -128.19 123.19 59.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.83 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 107' ' ' TYR . 1.6 p-10 -97.02 -175.53 3.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -58.91 -34.17 71.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -60.65 -58.19 9.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.067 0.46 . . . . 0.0 110.751 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 144' ' ' VAL . 10.6 tp10 -66.98 -32.49 73.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.328 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.61 -46.76 88.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.209 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.0 mtp -80.91 -3.99 53.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.502 . . . . 0.0 110.704 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.75 -44.86 5.64 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.632 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 153' ' ' MET . 7.7 p -70.27 -34.14 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 110.587 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.555 ' HG3' HG13 ' A' ' 152' ' ' VAL . 66.5 mtt -102.67 178.67 4.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.282 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 31.1 p 48.2 58.85 4.72 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.287 0.635 . . . . 0.0 111.934 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -114.82 73.06 0.24 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.471 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.25 70.34 0.41 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -116.0 137.61 51.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.532 178.195 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.49 0.186 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.4 tp60 -73.38 108.38 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.233 0.539 . . . . 0.0 111.031 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -68.37 0.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 93' ' ' LEU . 16.2 tt0 63.93 -175.98 0.16 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.161 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.749 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 79.6 mt -89.64 10.23 23.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.541 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 16.2 mmt180 -59.92 -43.12 95.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.703 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.5 mm-40 -60.88 -35.98 78.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.175 0.297 . . . . 0.0 111.721 -176.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.09 85.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.38 -36.7 38.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 29.4 mtm180 -63.69 -21.6 66.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.78 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.6 mt -61.12 -43.75 98.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.07 0.462 . . . . 0.0 110.699 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.35 -19.68 22.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.39 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 10.1 t70 -57.96 -48.4 80.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.034 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -55.02 -39.35 69.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.173 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.35 55.13 1.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.554 0.692 . . . . 0.0 110.748 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.84 14.33 1.74 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.602 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.39 19.83 10.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.187 0.595 . . . . 0.0 111.346 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 -62.8 3.44 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.224 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 22.8 m-85 -84.06 89.17 7.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 144' ' ' VAL . 38.6 pt -69.53 141.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 111.632 -173.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -59.01 139.77 56.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 137' ' ' ASP . 14.0 p -62.08 -16.05 49.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.72 -39.47 73.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.046 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 t -74.73 -32.76 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.52 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.5 tpp -61.4 -32.94 72.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.423 ' HG2' HG13 ' A' ' 133' ' ' ILE . 81.0 mtp180 -58.56 -40.61 83.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 110.059 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.94 -35.78 72.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.426 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.1 mt -70.04 -39.03 76.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.2 -40.16 93.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -70.07 -19.72 63.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.657 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.94 -35.43 37.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.732 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.85 -62.89 1.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.352 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -105.87 141.7 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.52 14.95 22.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.5 p -115.98 -16.1 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.632 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.6 pp -76.04 151.26 37.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 m -112.46 179.31 4.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.828 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.9 t -61.41 -36.74 81.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 110.215 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.35 -46.27 80.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.881 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.61 -39.38 76.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.9 -34.14 71.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.813 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.95 76.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.26 -46.45 60.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.005 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 110' ' ' THR . 48.2 mm -81.2 68.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 122.083 0.944 . . . . 0.0 109.928 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.21 -42.67 0.14 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.509 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -112.95 23.27 13.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.11 0.957 . . . . 0.0 108.735 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.72 -42.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.947 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.763 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 6.8 p-10 -89.74 138.71 31.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.814 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.596 ' H ' ' HA3' ' A' ' 142' ' ' GLY . . . -152.55 15.6 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.656 173.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 61.82 98.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.244 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.17 -42.56 2.06 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 m -117.11 61.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.763 ' HA3' ' HA ' ' A' ' 137' ' ' ASP . . . 173.16 -40.84 0.15 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.411 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 107' ' ' TYR . 2.4 p -64.84 101.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.498 ' HB ' ' CG1' ' A' ' 108' ' ' ILE . 94.8 t -45.07 108.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -163.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.82 165.32 21.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.534 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -47.4 -50.36 22.72 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.084 0.554 . . . . 0.0 111.45 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.65 -15.38 32.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 144' ' ' VAL . 27.1 tt0 -70.39 -31.39 68.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -56.23 -43.81 78.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 51.9 ttm -64.67 -40.22 95.03 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.15 -31.34 72.84 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.545 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.79 -40.55 39.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.0 mmt -70.85 -44.65 65.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.326 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.2 p -101.93 36.35 2.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.137 0.494 . . . . 0.0 110.897 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.19 76.67 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.85 56.91 0.75 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.35 128.38 36.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 111.487 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.974 175.497 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.716 0.294 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -142.3 116.79 9.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.973 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 3.0 pm0 -66.42 -26.61 67.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.957 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 49.08 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.896 0.748 . . . . 0.0 112.913 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 45.6 mt -74.45 -7.91 54.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.581 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -76.81 -16.29 59.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.488 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.6 -41.53 97.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.647 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.49 -41.68 31.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.57 -36.37 80.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.508 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.42 -16.05 64.02 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 111.346 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.78 -33.75 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.409 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.44 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 51.2 m-85 -85.33 -34.79 21.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.931 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -79.56 66.37 5.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.696 0.76 . . . . 0.0 109.685 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 46.3 mtpt -68.91 -49.68 56.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.034 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' OE2' ' HB2' ' A' ' 102' ' ' LYS . 6.8 mp0 -71.82 -23.37 61.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.357 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.14 1.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.732 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.89 -37.0 7.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.791 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.63 66.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.472 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 41.9 p90 -154.7 144.21 21.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.55 144.04 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.462 0.649 . . . . 0.0 111.256 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 m -62.83 139.97 58.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.882 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.856 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 11.8 p -55.88 -21.84 22.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.681 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -59.72 -30.68 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.928 0.394 . . . . 0.0 110.944 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 116' ' ' ILE . 24.9 t -73.0 -27.57 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.098 0.475 . . . . 0.0 110.19 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.0 tpt -65.93 -38.08 87.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.418 ' HB2' HD13 ' A' ' 129' ' ' LEU . 2.0 ptt180 -73.75 -18.98 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.941 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -75.15 -42.15 56.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 112' ' ' VAL . 64.1 mt -60.7 -51.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.408 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.51 -32.56 68.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.737 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.35 68.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.223 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -96.99 -36.67 10.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.64 -45.75 88.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -99.23 -177.04 3.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.45 89.25 3.31 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.071 0.938 . . . . 0.0 109.586 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.1 t 49.73 77.8 0.11 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.934 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.48 137.65 35.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.998 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 t -75.68 160.29 30.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.408 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -36.17 66.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.859 0.362 . . . . 0.0 110.674 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.89 -27.87 69.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.91 -42.79 20.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.557 0.694 . . . . 0.0 110.033 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 133' ' ' ILE . 81.3 mt -65.88 -37.34 85.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.309 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -51.77 -49.53 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.553 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.28 82.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.6 -39.33 80.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.603 HG23 ' HB ' ' A' ' 110' ' ' THR . 30.5 mm -78.52 -34.97 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.016 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.38 -40.36 96.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.948 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.49 -15.99 55.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.704 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 144' ' ' VAL . 25.0 mt -102.79 -57.94 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.463 ' N ' HG21 ' A' ' 110' ' ' THR . 10.6 t70 63.49 155.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.01 0.819 . . . . 0.0 112.955 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.856 ' HB2' ' H ' ' A' ' 110' ' ' THR . . . -117.08 65.2 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.019 -0.426 . . . . 0.0 111.062 -176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -123.02 -41.95 2.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.08 138.6 2.51 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 p 46.84 37.42 4.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.869 0.842 . . . . 0.0 109.944 -170.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.54 -36.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.548 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.53 112.23 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 136' ' ' ILE . 37.7 t -69.77 104.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.493 -162.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 0.9 OUTLIER -93.82 -173.52 3.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 174.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 93' ' ' LEU . 71.5 t80 -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.932 0.333 . . . . 0.0 111.303 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -65.32 -48.24 73.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.564 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 8.7 tp10 -63.99 -44.62 92.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -55.91 -44.57 78.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.675 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 46.2 ttm -59.15 -49.03 79.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.762 ' HA2' ' HA3' ' A' ' 155' ' ' GLY . . . -66.33 -31.7 79.79 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.311 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' GLU . 96.5 t -81.27 -47.58 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.792 0.296 . . . . 0.0 111.596 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.525 ' HE1' HD22 ' A' ' 93' ' ' LEU . 53.4 ttp -75.43 -39.1 59.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.0 t -157.0 50.91 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.015 0.912 . . . . 0.0 110.591 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.762 ' HA3' ' HA2' ' A' ' 151' ' ' GLY . . . -114.46 5.91 22.96 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.147 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -147.65 -36.77 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.71 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.55 121.6 42.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.057 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 76.5 mmm . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -78.3 59.42 2.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -113.49 8.58 17.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.35 111.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.969 -1.468 . . . . 0.0 112.415 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.95 -27.81 66.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.053 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -59.72 -36.16 76.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.197 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.99 -45.05 91.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.713 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.4 -45.36 16.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.078 0.466 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -62.0 -32.3 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.846 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.482 ' HA ' ' OD1' ' A' ' 101' ' ' ASP . 14.1 ptm180 -67.2 -12.86 61.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.098 0.475 . . . . 0.0 111.386 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.72 -22.47 23.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.256 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -101.98 -30.08 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.971 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -78.07 9.35 3.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 -177.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.658 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 48.3 pttt -38.6 -48.26 1.42 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.663 1.185 . . . . 0.0 112.906 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 102' ' ' LYS . 21.5 mm-40 -111.24 -11.02 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 110.728 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.73 -17.84 50.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.516 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 58.91 35.22 24.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.68 -29.77 6.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.011 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 28.3 p90 -123.07 125.71 45.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.008 0.432 . . . . 0.0 110.1 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 pt -110.14 150.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.226 0.536 . . . . 0.0 111.563 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 34.4 t -58.23 137.36 57.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 137' ' ' ASP . 6.3 p -61.3 -22.54 64.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.971 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HA ' ' CD ' ' A' ' 114' ' ' ARG . 28.8 t70 -64.4 -35.62 81.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.465 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' ILE . 58.7 t -66.73 -35.65 75.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.078 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.9 ttp -74.46 -20.15 60.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.958 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.488 ' CD ' ' HA ' ' A' ' 111' ' ' ASP . 77.3 mtp180 -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 37.6 mt-10 -80.12 -30.43 39.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.332 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 112' ' ' VAL . 42.0 mt -59.01 -40.36 80.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.234 0.54 . . . . 0.0 109.827 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -40.14 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.711 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.9 -30.03 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 43.7 mt-10 -73.51 -32.06 64.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -89.07 -52.34 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 12.1 t70 -104.52 144.97 30.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.885 0.374 . . . . 0.0 110.8 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 -12.67 13.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.775 -174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -103.75 -3.24 25.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.956 0.407 . . . . 0.0 111.167 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.427 ' HG ' ' OD1' ' A' ' 121' ' ' ASP . 75.4 mt -76.08 121.24 22.51 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.2 t -72.37 162.18 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.685 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 5.5 p -66.39 -22.26 66.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.629 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -71.34 -37.79 71.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.92 -36.31 80.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.794 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 8.8 mt -55.53 -38.79 69.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.218 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -81.73 -46.72 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -61.01 -49.78 76.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.001 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.5 mtp -60.76 -47.84 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.126 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 31.2 mm -63.46 -34.63 68.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.56 -31.5 71.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.0 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 44.2 mt-10 -78.72 -41.12 31.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 110.306 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.79 -67.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.832 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.686 ' HA ' HG21 ' A' ' 110' ' ' THR . 6.1 t70 41.91 -127.45 0.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.643 0.589 . . . . 0.0 109.832 -169.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . . . -171.24 -63.43 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.272 0.358 . . . . 0.0 110.822 170.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -158.3 -62.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.938 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.47 47.22 3.43 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.642 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.0 p 47.22 41.75 12.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.11 0.564 . . . . 0.0 111.169 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 109' ' ' SER . . . 133.05 35.5 0.3 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.467 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.4 p -128.27 81.0 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.227 0.514 . . . . 0.0 111.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 42.8 t -65.57 101.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.45 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -88.31 174.45 8.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.119 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -58.5 -48.1 81.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.311 0.577 . . . . 0.0 110.052 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -56.56 -23.22 38.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -90.78 -55.59 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.835 0.35 . . . . 0.0 110.445 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -63.02 -35.09 79.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.475 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 86.9 mtp -81.99 -4.2 56.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -94.12 -42.53 4.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.595 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.8 m -72.41 -19.36 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.006 0.431 . . . . 0.0 110.993 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 94.0 mmm -112.0 165.54 12.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.107 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 p 65.66 -60.2 0.28 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.373 1.469 . . . . 0.0 112.226 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.11 79.37 0.07 OUTLIER Glycine 0 CA--C 1.518 0.247 0 O-C-N 123.471 0.482 . . . . 0.0 113.933 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.17 -30.39 4.56 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.698 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -101.11 134.9 43.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.833 0.349 . . . . 0.0 110.293 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.579 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 91.5 mtp . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -89.1 -23.19 22.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -97.18 40.4 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.527 0.68 . . . . 0.0 110.97 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 94' ' ' ARG . 44.2 tt0 -72.84 155.95 39.39 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -41.49 -37.29 1.05 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 92' ' ' GLU . 4.3 ppt_? -65.78 -12.57 55.12 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.642 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 6.4 pt-20 -49.77 -49.89 46.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.643 0.259 . . . . 0.0 111.035 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.628 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -65.38 -28.1 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.141 -176.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 101' ' ' ASP . 27.9 t80 -60.99 -51.23 70.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -82.04 -19.62 39.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.875 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 77.0 mt -72.48 -45.14 60.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.554 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -84.73 -47.99 9.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.654 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 108' ' ' ILE . 13.0 t70 -72.04 105.82 4.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.613 0.721 . . . . 0.0 111.879 -175.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -82.24 -13.54 56.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.049 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.78 -50.92 0.67 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -169.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.77 -55.62 27.97 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.16 0.424 . . . . 0.0 114.16 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 59.17 60.32 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.353 0.597 . . . . 0.0 110.599 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.77 -19.33 2.56 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.2 p90 -151.94 134.43 15.35 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.607 HG22 ' HB2' ' A' ' 101' ' ' ASP . 43.7 pt -114.94 155.4 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.739 ' HB3' HG23 ' A' ' 112' ' ' VAL . 47.7 t -69.81 138.79 52.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.175 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 138' ' ' ALA . 2.4 p -54.51 -32.79 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.619 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -36.56 81.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' SER . 54.6 t -64.79 -33.03 60.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.697 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 46.1 ttm -63.72 -31.76 73.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.466 ' HG2' HG13 ' A' ' 133' ' ' ILE . 72.3 mtm180 -63.13 -41.96 99.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' GLU . 31.4 mt-10 -61.3 -45.77 93.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.407 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.13 -44.38 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.272 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 113' ' ' MET . 92.3 mt -64.95 -40.53 95.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.978 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -72.43 -20.28 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.981 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 2.5 tm-20 -82.02 -38.02 25.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.567 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 tt -76.32 -55.55 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.145 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.75 152.06 37.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.567 0.698 . . . . 0.0 110.744 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -77.77 -33.23 52.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.862 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -165.86 52.57 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.537 HD11 ' HA ' ' A' ' 118' ' ' ALA . 1.3 pp -82.26 150.05 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.719 -0.613 . . . . 0.0 110.004 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.6 m -91.33 172.3 8.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.835 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.1 p -64.93 -39.01 92.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.849 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.71 -34.79 79.02 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.545 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.11 -50.49 72.62 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 109.726 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.11 -48.41 80.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.707 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.43 -46.87 80.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.892 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.07 63.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.0 mtm -61.58 -43.17 99.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.597 0.237 . . . . 0.0 111.255 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.466 HG13 ' HG2' ' A' ' 114' ' ' ARG . 37.1 mm -64.63 -34.96 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.537 0.208 . . . . 0.0 110.481 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.57 -32.78 73.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.33 -39.66 59.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 152' ' ' VAL . 55.5 mt -86.58 -51.33 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.37 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 54.45 -114.79 0.89 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.879 -167.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 143' ' ' THR . . . -156.56 -102.68 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 143' ' ' THR . 7.8 t70 -156.93 -52.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.55 -121.21 3.54 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -80.73 52.58 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.02 0.438 . . . . 0.0 110.307 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.66 32.34 33.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.205 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.536 ' C ' ' HB1' ' A' ' 138' ' ' ALA . 12.0 p -111.98 98.03 7.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.577 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 39.6 t -73.77 112.39 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 169.61 17.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.025 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -59.07 -40.56 85.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.816 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.64 -48.83 70.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.03 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 152' ' ' VAL . 54.8 mm-40 -63.08 -44.06 96.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.617 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -54.1 -48.97 70.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.105 0.479 . . . . 0.0 110.819 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.7 -28.63 70.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.34 -49.27 3.76 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.098 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 136' ' ' ILE . 11.9 p -69.45 -27.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 80.9 mtp -104.48 69.41 0.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.086 0.469 . . . . 0.0 111.21 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.6 p -138.82 -51.07 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.913 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.97 -121.12 11.4 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.717 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.37 14.24 6.92 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.944 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -76.2 132.01 39.68 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.156 -177.612 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -98.55 124.7 43.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 9.8 mm-40 -108.42 17.85 21.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.67 0.748 . . . . 0.0 109.917 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 10.3 tp10 -77.23 -177.73 4.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.929 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' HG3' ' A' ' 150' ' ' MET . 87.8 mt -52.24 -18.29 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.606 0.639 . . . . 0.0 111.602 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -23.51 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.1 pt-20 -56.51 -47.72 78.73 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.894 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -63.82 -34.16 77.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.2 -46.68 79.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.194 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.4 ptt85 -80.9 -11.26 59.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.542 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 62.3 mt -81.21 -46.49 14.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.686 0.279 . . . . 0.0 110.434 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.441 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 22.0 m-85 -69.13 -49.59 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 12.4 t70 -119.29 95.56 4.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -77.3 -27.08 52.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.539 -173.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -90.96 45.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.69 -146.27 18.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.102 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -85.73 94.08 9.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 101' ' ' ASP . . . -80.66 103.16 2.17 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.478 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.57 ' HB3' ' OG1' ' A' ' 143' ' ' THR . 79.6 m-85 -73.36 74.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.0 pt -69.45 141.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.208 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 m -60.49 133.31 55.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.701 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.664 HG21 ' CB ' ' A' ' 137' ' ' ASP . 20.4 p -65.05 -18.81 65.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.99 -42.92 81.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.277 0.561 . . . . 0.0 109.685 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.66 -37.86 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.225 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.0 ttt -64.12 -37.3 86.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.027 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.458 ' HG2' HG13 ' A' ' 133' ' ' ILE . 96.2 mtt180 -60.83 -27.16 67.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.67 0.271 . . . . 0.0 111.158 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.73 -48.0 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.401 . . . . 0.0 109.99 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 ' CZ ' ' A' ' 100' ' ' TYR . 48.8 mt -53.38 -52.28 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.684 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.895 ' HB3' ' HA3' ' A' ' 156' ' ' GLY . 9.2 mp -54.15 -53.28 55.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.093 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . . . -61.59 -20.21 63.07 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.58 -17.85 61.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 154' ' ' THR . 3.2 tm? -94.42 -65.64 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -167.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 157' ' ' ASP . 1.9 t70 -87.82 -169.72 2.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.423 0.63 . . . . 0.0 112.65 -161.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.46 67.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.517 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 121' ' ' ASP . 13.8 t -176.57 -9.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.814 ' HG ' ' HB3' ' A' ' 157' ' ' ASP . 3.3 pp -130.77 161.59 31.38 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.882 -0.512 . . . . 0.0 110.306 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.5 m -109.8 174.8 5.7 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.642 -171.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' HD13 ' A' ' 129' ' ' LEU . 44.2 m -60.46 -28.66 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.683 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.26 -24.38 67.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.587 0.232 . . . . 0.0 111.594 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.9 m-20 -68.34 -46.55 69.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.324 0.583 . . . . 0.0 109.44 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.677 HD11 ' H ' ' A' ' 157' ' ' ASP . 5.1 mp -62.08 -36.89 83.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.218 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.81 -38.24 78.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.789 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.68 63.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.436 ' HE1' ' O ' ' A' ' 155' ' ' GLY . 71.9 mtm -75.52 -55.08 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.157 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 15.9 mm -78.9 64.51 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.61 0.719 . . . . 0.0 109.892 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -151.34 -45.56 0.11 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.393 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -106.88 -7.92 16.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.577 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.544 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 -27.42 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.717 0.77 . . . . 0.0 110.12 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.664 ' CB ' HG21 ' A' ' 110' ' ' THR . 17.9 p-10 -112.16 17.76 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.931 -170.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.57 41.32 0.62 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.461 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.06 -13.73 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.184 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.7 55.44 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.614 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 55.14 64.86 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.951 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 74.34 67.96 1.66 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.467 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 107' ' ' TYR . 1.6 t -142.32 130.05 21.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.094 0.473 . . . . 0.0 109.949 173.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.31 128.67 72.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.299 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -108.15 -165.34 1.03 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.964 0.412 . . . . 0.0 110.903 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 10.2 p90 -62.59 166.54 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.235 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER 72.52 -51.33 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.337 0.655 . . . . 0.0 111.311 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -66.73 -36.48 82.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -74.59 75.89 2.0 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.528 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.656 ' HG3' HD12 ' A' ' 93' ' ' LEU . 20.2 ttt -172.41 -52.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.915 171.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.73 83.3 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.538 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.879 HG12 HD21 ' A' ' 117' ' ' LEU . 18.4 t -72.84 -40.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.135 0.493 . . . . 0.0 109.836 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.468 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 26.9 ttt -63.5 152.16 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.504 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.743 HG22 ' HG ' ' A' ' 120' ' ' LEU . 14.3 p 70.23 -19.64 0.21 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.129 0.972 . . . . 0.0 111.441 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 153' ' ' MET . . . -87.93 9.68 73.44 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.895 ' HA3' ' HB3' ' A' ' 117' ' ' LEU . . . -119.73 154.85 16.31 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.814 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 12.7 t0 -172.51 151.12 2.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.141 -170.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.283 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.4 mt -54.63 -21.4 10.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.567 0.622 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.8 -15.21 63.44 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 14.8 pt-20 -50.4 -46.1 56.0 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.412 0.445 . . . . 0.0 111.53 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -74.97 -42.92 56.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.813 0.34 . . . . 0.0 110.909 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -59.59 -47.5 85.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.008 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 44.0 ptt85 -62.08 -25.41 67.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.703 -175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 79.7 mt -74.18 -20.34 60.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.058 0.456 . . . . 0.0 110.728 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -101.91 6.54 41.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.703 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 98' ' ' ARG . 23.1 m-20 -80.75 33.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 103' ' ' GLU . 18.2 pttp -74.24 -47.98 31.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 102' ' ' LYS . 30.7 mt-10 -117.58 105.68 12.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.602 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 162.34 30.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -141.28 111.02 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.294 0.547 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.42 -22.61 8.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.532 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -126.4 79.53 1.86 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -77.21 141.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.604 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.621 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.0 m -63.52 141.34 58.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.621 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.608 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 18.2 p -53.46 -23.79 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.066 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.27 -51.49 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.051 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 109' ' ' SER . 9.8 p -69.62 -34.18 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.434 -172.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 144' ' ' VAL . 25.6 ttt -65.66 -25.58 67.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.785 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG2' HG13 ' A' ' 133' ' ' ILE . 82.1 mtm180 -60.68 -44.59 96.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 109.845 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.64 -34.37 73.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.154 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 113' ' ' MET . 59.0 mt -60.39 -47.51 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.667 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.07 68.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.932 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -81.32 -17.46 49.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.11 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.42 -61.49 1.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.568 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.573 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 14.4 t70 -85.69 158.31 20.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.767 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -116.38 -24.73 7.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -96.24 -40.16 9.31 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.573 ' HG ' ' OD2' ' A' ' 121' ' ' ASP . 4.4 pp -76.48 150.31 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.567 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 t -94.65 178.91 5.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.258 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.439 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 15.4 m -63.52 -36.89 85.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.91 -39.28 91.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 110.313 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.63 -53.09 60.9 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 130' ' ' ASP . 4.7 pp -67.3 -34.6 77.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.162 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 129' ' ' LEU . 15.6 t70 -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.084 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.28 72.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.415 ' HB2' ' HE3' ' A' ' 132' ' ' MET . 72.2 mtm -73.18 -35.44 66.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.07 0.462 . . . . 0.0 110.314 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 136' ' ' ILE . 39.7 mm -73.99 -31.01 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.66 0.743 . . . . 0.0 110.132 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.2 -27.04 65.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.18 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.52 3.98 23.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 133' ' ' ILE . 6.3 tt -106.08 -23.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.721 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.569 ' OD1' ' HA2' ' A' ' 142' ' ' GLY . 9.8 t0 -41.63 123.54 2.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.684 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -89.14 12.76 14.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.716 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 30.0 t70 76.3 -1.93 2.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.981 0.512 . . . . 0.0 112.239 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.82 63.65 4.41 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.344 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.4 m 66.59 25.28 10.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.019 0.437 . . . . 0.0 109.945 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.569 ' HA2' ' OD1' ' A' ' 137' ' ' ASP . . . 80.7 69.46 1.4 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.559 -176.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -134.05 162.22 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 113' ' ' MET . 48.7 t -120.2 136.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.45 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -82.87 176.53 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.76 -57.99 8.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.621 0.248 . . . . 0.0 111.475 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.27 -29.66 68.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -63.34 -41.57 98.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.985 0.421 . . . . 0.0 109.872 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.51 -49.86 71.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 87.5 mmm -55.73 -50.87 69.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.778 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.96 -43.12 97.03 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.239 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 136' ' ' ILE . 55.3 t -77.44 -40.09 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.918 0.39 . . . . 0.0 111.114 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.427 -175.895 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' SD ' ' A' ' 153' ' ' MET . 55.1 mt -102.13 -1.58 31.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.175 0.512 . . . . 0.0 110.377 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.41 -35.37 30.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.041 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.97 -45.56 67.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 30.4 t80 -71.32 -43.59 66.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.25 -32.52 62.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.4 mt -73.15 -40.67 64.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.179 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.84 15.74 28.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.423 0.63 . . . . 0.0 110.189 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 103' ' ' GLU . 6.6 t70 -62.26 103.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.835 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' TYR . 14.5 mptt -80.67 -3.82 52.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.289 169.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 2.6 mm-40 -58.5 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -165.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' LYS . . . -121.41 55.0 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 156.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 64.75 48.68 2.42 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -159.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.19 -38.84 1.91 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.512 -167.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 40.5 m-85 60.54 -171.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -171.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.18 142.67 41.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.994 -0.441 . . . . 0.0 110.303 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.574 ' HB2' HG23 ' A' ' 112' ' ' VAL . 15.6 m -70.11 142.16 52.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.051 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.478 HG21 ' HA ' ' A' ' 137' ' ' ASP . 17.1 p -58.94 -31.9 69.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.974 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.32 -45.94 89.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.263 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 109' ' ' SER . 58.8 t -62.88 -43.72 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.319 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.7 tpt -54.37 -36.72 64.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.889 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' THR . 78.8 mtm180 -61.49 -47.32 86.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.1 -43.78 86.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.73 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 112' ' ' VAL . 76.9 mt -57.49 -40.27 73.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.35 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -80.94 -29.54 35.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.657 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -78.49 -22.11 47.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.28 -26.19 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.89 -55.98 5.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.646 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 25.7 t70 -107.16 142.38 36.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.982 0.42 . . . . 0.0 110.482 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -99.79 -9.05 23.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.779 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 p -104.24 -16.78 15.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 129' ' ' LEU . 97.5 mt -79.36 117.63 20.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.802 0.334 . . . . 0.0 110.29 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 2.8 t -81.47 155.36 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.361 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -59.65 -32.4 70.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.577 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.6 mp0 -58.71 -50.18 74.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.448 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -34.77 72.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.091 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 117' ' ' LEU . 7.8 mt -69.14 -26.63 64.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.839 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.86 -43.68 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.66 70.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.55 -52.78 19.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.921 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 129' ' ' LEU . 42.2 mm -58.53 -33.37 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.79 -27.94 32.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -110.78 10.44 22.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.994 0.425 . . . . 0.0 110.941 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 79.7 mt -128.03 -37.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 7.1 t70 -50.46 126.85 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.046 0.451 . . . . 0.0 111.883 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 143' ' ' THR . . . -92.57 15.6 13.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.177 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 11.1 t70 81.37 -18.86 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 168.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.0 78.58 1.89 Allowed Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.717 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 p 51.6 30.22 6.34 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 110.229 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.517 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 76.68 70.71 1.25 Allowed Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.337 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.495 HG23 ' HB3' ' A' ' 138' ' ' ALA . 9.2 t -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 112.043 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.11 119.25 60.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.755 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.87 153.87 42.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -65.68 -12.84 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -79.74 -38.94 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.213 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.73 -29.5 45.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 97' ' ' PHE . 67.0 t80 -73.6 67.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.68 0.752 . . . . 0.0 109.548 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.423 ' HG2' HD12 ' A' ' 93' ' ' LEU . 1.1 tmt? -164.78 -70.33 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.205 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.97 -27.21 73.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.992 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.28 -36.53 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 111.433 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.461 ' SD ' HD22 ' A' ' 93' ' ' LEU . 23.9 ptm . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.634 -175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.37 -43.76 89.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.4 ttp85 -69.37 -39.63 77.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.83 -43.44 79.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.687 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.84 -42.47 93.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.656 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 38.6 mtm180 -63.78 -36.52 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.804 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.12 -14.32 33.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.56 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.43 -26.46 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.478 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -91.89 86.45 5.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -61.27 -32.93 72.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.939 -174.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.586 ' HB2' HD21 ' A' ' 105' ' ' ASN . 41.3 mm-40 -85.47 -36.96 20.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.419 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.97 54.48 1.89 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.228 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 103' ' ' GLU . 30.4 m-80 -93.1 -35.38 13.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 110.023 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.56 5.12 57.93 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 145' ' ' ASP . 9.9 m-85 -136.29 145.11 45.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 144' ' ' VAL . 28.6 pt -123.32 140.73 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 111.231 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.667 ' HB3' HG23 ' A' ' 112' ' ' VAL . 34.9 t -67.16 144.98 55.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.605 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.608 HG21 ' HA ' ' A' ' 137' ' ' ASP . 8.2 p -58.96 -27.18 65.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.417 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' ARG . 18.4 t0 -70.43 -35.27 73.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 110.043 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 109' ' ' SER . 73.6 t -66.86 -41.27 87.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.503 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.2 tpt -56.22 -34.75 66.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.839 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 111' ' ' ASP . 15.2 mtp180 -56.04 -53.88 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.693 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.57 -36.03 80.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 112' ' ' VAL . 73.8 mt -57.62 -44.14 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.96 -41.67 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -68.66 -29.19 67.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.63 -5.75 59.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.003 0.43 . . . . 0.0 110.755 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 tt -88.49 -50.51 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -130.6 147.34 52.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -95.79 -22.75 17.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -82.1 -20.31 38.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.555 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.9 pp -76.93 152.19 35.41 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.968 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -107.27 176.94 5.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.703 0.287 . . . . 0.0 110.979 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.651 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 12.1 p -69.44 -25.44 64.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.929 0.395 . . . . 0.0 110.603 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.85 -39.66 89.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 132' ' ' MET . 27.0 m-20 -61.29 -38.91 88.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 12.9 mt -56.93 -44.4 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.374 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.88 -47.9 73.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.699 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.6 98.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.726 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 128' ' ' ASP . 24.2 mmt -58.2 -55.62 32.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 111.183 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.07 -35.7 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.321 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.98 -26.67 49.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.713 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -118.2 10.17 12.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 111.42 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.63 -69.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.524 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HA ' HG21 ' A' ' 110' ' ' THR . 4.5 m-20 47.11 -145.63 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.489 ' H ' ' HB3' ' A' ' 137' ' ' ASP . . . -164.74 -89.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.578 0.227 . . . . 0.0 111.476 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.2 -59.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.589 0.233 . . . . 0.0 111.593 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 143' ' ' THR . . . -93.46 70.9 1.4 Allowed Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.938 -172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 61.26 36.19 17.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 109.941 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.1 45.26 5.99 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.378 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' GLY . 6.8 p -91.44 87.72 6.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.174 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 108' ' ' ILE . 42.5 t -78.68 110.91 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.421 ' HB3' ' HD1' ' A' ' 107' ' ' TYR . 7.0 p-10 -85.43 176.27 8.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.894 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -61.05 -38.93 87.92 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -66.88 -49.13 66.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.6 -51.11 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.731 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.96 -42.5 76.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.359 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.75 -53.97 18.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.698 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.28 -25.83 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.649 0.261 . . . . 0.0 111.54 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 C--N 1.33 -0.242 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.978 -175.586 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.72 -21.39 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.789 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -59.82 -27.61 66.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.885 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.18 -48.23 79.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.954 0.407 . . . . 0.0 110.288 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.73 84.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.49 -43.88 88.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.491 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 98' ' ' ARG . 5.7 mmp_? -54.5 -36.42 64.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.618 0.367 . . . . 0.0 111.504 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.09 -49.47 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.49 -23.82 32.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.98 -39.16 91.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.619 0.723 . . . . 0.0 109.404 171.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -71.06 -25.93 62.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.708 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -79.85 -19.4 48.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.506 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.37 -109.44 0.5 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.555 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.52 -172.1 2.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.69 76.49 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.169 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.34 112.37 17.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.4 141.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 111.225 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 m -67.89 137.31 55.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.671 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -60.21 -23.07 63.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.431 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -59.06 -45.96 89.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 109.837 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 116' ' ' ILE . 41.3 t -64.79 -38.6 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.854 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.1 ttt -59.96 -37.45 79.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -63.53 -46.1 87.56 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.2 -39.06 78.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 112' ' ' VAL . 68.1 mt -67.67 -57.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.479 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.987 HD11 HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -73.04 -22.61 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -171.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -66.18 -29.04 69.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.08 0.467 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.85 -23.03 42.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.44 -52.75 35.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.033 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.406 ' CG ' ' HG ' ' A' ' 124' ' ' LEU . 23.0 t70 -92.52 159.24 15.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 0.0 110.159 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.2 -25.74 52.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.938 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.3 t -149.23 26.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.943 ' HB3' HD21 ' A' ' 129' ' ' LEU . 40.5 mt -76.36 114.56 15.19 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.947 174.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 6.9 m -81.75 157.62 24.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 m -53.29 -45.78 69.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.23 -44.21 83.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.32 -35.64 77.95 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.137 0.494 . . . . 0.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.987 HD22 HD11 ' A' ' 117' ' ' LEU . 7.4 mt -76.06 -44.75 37.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.275 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.5 -33.67 76.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.669 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.14 72.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.55 -32.9 25.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.172 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 129' ' ' LEU . 25.7 mm -59.92 -37.6 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.897 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.13 -32.49 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.59 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -80.05 -27.54 39.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.064 0.459 . . . . 0.0 110.574 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.0 mt -85.83 -40.23 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.109 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 118.23 9.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.313 0.578 . . . . 0.0 111.687 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.26 19.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.318 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.12 -99.7 0.44 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.426 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -108.35 71.71 0.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.169 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 m 64.66 13.53 8.39 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.24 71.44 0.36 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.921 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.34 122.58 37.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.811 0.338 . . . . 0.0 111.095 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.4 t -110.4 135.58 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.874 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 148' ' ' GLU . 3.9 p-10 -95.56 -173.06 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 150' ' ' MET . 32.9 p90 -68.43 -47.32 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -173.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.96 -22.02 31.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.461 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 145' ' ' ASP . 7.0 tp10 -63.6 -41.73 98.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.01 -39.67 93.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.029 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 25.2 mmt -63.09 -52.57 62.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.767 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.06 -40.66 66.92 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.131 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 148' ' ' GLU . 77.1 t -67.86 -49.4 69.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 110.859 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 88.7 mmm . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 121.33 0.586 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.64 -9.35 58.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.952 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.1 mmt85 -58.29 -47.29 84.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.873 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 21.3 tt0 -69.61 -41.49 75.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.67 79.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.03 -43.67 91.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.563 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -69.73 -21.1 63.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.3 mt -66.0 -33.4 75.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.102 0.477 . . . . 0.0 110.496 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 96.7 m-85 -101.62 -36.25 8.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.279 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -99.76 92.98 5.57 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 109.62 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 99' ' ' LEU . 34.4 mmtp -77.27 -48.64 16.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.031 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.18 40.34 0.48 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.26 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.55 10.6 68.98 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.176 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.17 21.22 4.86 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.238 0.615 . . . . 0.0 110.797 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.36 36.1 15.51 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.551 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 145' ' ' ASP . 53.5 m-85 -142.72 107.19 4.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 0.0 110.599 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -97.34 140.86 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.132 0.491 . . . . 0.0 110.423 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 112' ' ' VAL . 17.7 m -69.98 142.3 52.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.574 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 21.2 p -60.1 -27.77 67.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.727 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -40.82 80.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.289 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 109' ' ' SER . 57.5 t -70.23 -37.94 73.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.2 -34.16 71.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 133' ' ' ILE . 67.9 mtt180 -57.3 -36.98 71.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.355 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.29 -37.33 38.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.814 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 112' ' ' VAL . 52.4 mt -58.83 -53.69 44.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.715 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.2 -36.89 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.65 67.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.287 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -84.94 -42.11 15.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.217 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.28 -51.81 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.242 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.84 139.15 38.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.256 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.45 -2.32 23.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.419 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.3 p -105.76 -24.18 12.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 pp -76.28 154.96 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.876 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.5 p -124.76 -178.49 4.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.363 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 p -54.66 -43.72 72.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.398 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -58.81 -54.59 45.39 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.409 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.55 -49.3 77.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.794 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.8 -49.77 75.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.73 85.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.942 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.7 mtm -82.19 -41.38 20.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 136' ' ' ILE . 44.2 mm -70.79 -33.83 54.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.312 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.79 -16.21 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.226 0.536 . . . . 0.0 110.504 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -101.32 -15.81 17.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.524 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 133' ' ' ILE . 5.8 tt -89.47 -23.55 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.47 ' HA ' HG21 ' A' ' 110' ' ' THR . 36.7 m-20 -43.97 106.6 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.551 0.532 . . . . 0.0 110.495 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.0 -61.21 1.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -171.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 143' ' ' THR . 5.6 m-20 -85.9 -86.56 0.14 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.57 -107.0 2.4 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.472 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 46.75 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.3 60.64 2.64 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 139' ' ' ASP . 3.0 p -121.98 146.12 47.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 148' ' ' GLU . 63.9 t -128.19 123.19 59.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.83 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 107' ' ' TYR . 1.6 p-10 -97.02 -175.53 3.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -58.91 -34.17 71.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -60.65 -58.19 9.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.067 0.46 . . . . 0.0 110.751 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 144' ' ' VAL . 10.6 tp10 -66.98 -32.49 73.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.328 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.61 -46.76 88.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.209 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.0 mtp -80.91 -3.99 53.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.502 . . . . 0.0 110.704 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.75 -44.86 5.64 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.632 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 153' ' ' MET . 7.7 p -70.27 -34.14 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 110.587 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.555 ' HG3' HG13 ' A' ' 152' ' ' VAL . 66.5 mtt . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.282 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 93' ' ' LEU . 16.2 tt0 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.452 0.644 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.749 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 79.6 mt -89.64 10.23 23.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.541 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 16.2 mmt180 -59.92 -43.12 95.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.703 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.5 mm-40 -60.88 -35.98 78.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.175 0.297 . . . . 0.0 111.721 -176.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.09 85.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.38 -36.7 38.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 29.4 mtm180 -63.69 -21.6 66.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.78 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.6 mt -61.12 -43.75 98.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.07 0.462 . . . . 0.0 110.699 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.35 -19.68 22.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.39 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 10.1 t70 -57.96 -48.4 80.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.034 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -55.02 -39.35 69.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.173 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.35 55.13 1.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.554 0.692 . . . . 0.0 110.748 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.84 14.33 1.74 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.602 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.39 19.83 10.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.187 0.595 . . . . 0.0 111.346 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 -62.8 3.44 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.224 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 22.8 m-85 -84.06 89.17 7.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 144' ' ' VAL . 38.6 pt -69.53 141.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 111.632 -173.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -59.01 139.77 56.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 137' ' ' ASP . 14.0 p -62.08 -16.05 49.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.72 -39.47 73.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.046 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 t -74.73 -32.76 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.52 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.5 tpp -61.4 -32.94 72.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.423 ' HG2' HG13 ' A' ' 133' ' ' ILE . 81.0 mtp180 -58.56 -40.61 83.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 110.059 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.94 -35.78 72.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.426 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.1 mt -70.04 -39.03 76.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.2 -40.16 93.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -70.07 -19.72 63.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.657 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.94 -35.43 37.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.732 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.85 -62.89 1.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.352 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -105.87 141.7 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.52 14.95 22.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.5 p -115.98 -16.1 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.632 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.6 pp -76.04 151.26 37.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 m -112.46 179.31 4.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.828 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.9 t -61.41 -36.74 81.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 110.215 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.35 -46.27 80.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.881 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.61 -39.38 76.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.9 -34.14 71.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.813 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.95 76.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.26 -46.45 60.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.005 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 110' ' ' THR . 48.2 mm -81.2 68.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 122.083 0.944 . . . . 0.0 109.928 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.21 -42.67 0.14 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.509 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -112.95 23.27 13.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.11 0.957 . . . . 0.0 108.735 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.72 -42.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.947 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.763 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 6.8 p-10 -89.74 138.71 31.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.814 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.596 ' H ' ' HA3' ' A' ' 142' ' ' GLY . . . -152.55 15.6 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.656 173.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 61.82 98.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.244 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.17 -42.56 2.06 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 m -117.11 61.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.763 ' HA3' ' HA ' ' A' ' 137' ' ' ASP . . . 173.16 -40.84 0.15 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.411 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 107' ' ' TYR . 2.4 p -64.84 101.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.498 ' HB ' ' CG1' ' A' ' 108' ' ' ILE . 94.8 t -45.07 108.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -163.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.82 165.32 21.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.534 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -47.4 -50.36 22.72 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.084 0.554 . . . . 0.0 111.45 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.65 -15.38 32.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 144' ' ' VAL . 27.1 tt0 -70.39 -31.39 68.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -56.23 -43.81 78.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 51.9 ttm -64.67 -40.22 95.03 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.15 -31.34 72.84 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.545 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.79 -40.55 39.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.0 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.326 -177.482 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 45.6 mt -74.45 -7.91 54.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.581 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -76.81 -16.29 59.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.488 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.6 -41.53 97.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.647 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.49 -41.68 31.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.57 -36.37 80.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.508 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.42 -16.05 64.02 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 111.346 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.78 -33.75 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.409 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.44 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 51.2 m-85 -85.33 -34.79 21.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.931 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -79.56 66.37 5.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.696 0.76 . . . . 0.0 109.685 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 46.3 mtpt -68.91 -49.68 56.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.034 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.452 ' OE2' ' HB2' ' A' ' 102' ' ' LYS . 6.8 mp0 -71.82 -23.37 61.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.357 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.14 1.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.732 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.89 -37.0 7.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.791 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.63 66.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.472 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 41.9 p90 -154.7 144.21 21.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.55 144.04 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.462 0.649 . . . . 0.0 111.256 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 m -62.83 139.97 58.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.882 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.856 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 11.8 p -55.88 -21.84 22.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.681 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -59.72 -30.68 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.928 0.394 . . . . 0.0 110.944 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 116' ' ' ILE . 24.9 t -73.0 -27.57 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.098 0.475 . . . . 0.0 110.19 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.0 tpt -65.93 -38.08 87.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.418 ' HB2' HD13 ' A' ' 129' ' ' LEU . 2.0 ptt180 -73.75 -18.98 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.941 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -75.15 -42.15 56.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 112' ' ' VAL . 64.1 mt -60.7 -51.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.408 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.51 -32.56 68.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.737 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.35 68.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.223 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -96.99 -36.67 10.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.64 -45.75 88.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -99.23 -177.04 3.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.45 89.25 3.31 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.071 0.938 . . . . 0.0 109.586 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.1 t 49.73 77.8 0.11 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.934 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.48 137.65 35.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.998 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 t -75.68 160.29 30.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.408 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -36.17 66.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.859 0.362 . . . . 0.0 110.674 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.89 -27.87 69.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.91 -42.79 20.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.557 0.694 . . . . 0.0 110.033 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 133' ' ' ILE . 81.3 mt -65.88 -37.34 85.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.309 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -51.77 -49.53 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.553 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.28 82.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.6 -39.33 80.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.603 HG23 ' HB ' ' A' ' 110' ' ' THR . 30.5 mm -78.52 -34.97 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.016 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.38 -40.36 96.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.948 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.49 -15.99 55.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.704 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 144' ' ' VAL . 25.0 mt -102.79 -57.94 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.463 ' N ' HG21 ' A' ' 110' ' ' THR . 10.6 t70 63.49 155.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.01 0.819 . . . . 0.0 112.955 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.856 ' HB2' ' H ' ' A' ' 110' ' ' THR . . . -117.08 65.2 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.019 -0.426 . . . . 0.0 111.062 -176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -123.02 -41.95 2.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.08 138.6 2.51 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 p 46.84 37.42 4.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.869 0.842 . . . . 0.0 109.944 -170.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.54 -36.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.548 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.53 112.23 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 136' ' ' ILE . 37.7 t -69.77 104.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.493 -162.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 0.9 OUTLIER -93.82 -173.52 3.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 174.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 93' ' ' LEU . 71.5 t80 -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.932 0.333 . . . . 0.0 111.303 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -65.32 -48.24 73.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.564 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 8.7 tp10 -63.99 -44.62 92.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -55.91 -44.57 78.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.675 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 46.2 ttm -59.15 -49.03 79.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.33 -31.7 79.79 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.311 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' GLU . 96.5 t -81.27 -47.58 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.792 0.296 . . . . 0.0 111.596 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.491 ' HE3' HD22 ' A' ' 93' ' ' LEU . 53.4 ttp . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -174.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.95 -27.81 66.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.053 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -59.72 -36.16 76.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.197 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.99 -45.05 91.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.713 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.4 -45.36 16.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.078 0.466 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -62.0 -32.3 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.846 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.482 ' HA ' ' OD1' ' A' ' 101' ' ' ASP . 14.1 ptm180 -67.2 -12.86 61.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.098 0.475 . . . . 0.0 111.386 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.72 -22.47 23.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.256 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -101.98 -30.08 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.971 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -78.07 9.35 3.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 -177.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.658 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 48.3 pttt -38.6 -48.26 1.42 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.663 1.185 . . . . 0.0 112.906 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 102' ' ' LYS . 21.5 mm-40 -111.24 -11.02 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 110.728 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.73 -17.84 50.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.516 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 58.91 35.22 24.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.68 -29.77 6.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.011 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 28.3 p90 -123.07 125.71 45.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.008 0.432 . . . . 0.0 110.1 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 pt -110.14 150.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.226 0.536 . . . . 0.0 111.563 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 34.4 t -58.23 137.36 57.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 137' ' ' ASP . 6.3 p -61.3 -22.54 64.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.971 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HA ' ' CD ' ' A' ' 114' ' ' ARG . 28.8 t70 -64.4 -35.62 81.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.465 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' ILE . 58.7 t -66.73 -35.65 75.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.078 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.9 ttp -74.46 -20.15 60.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.958 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.488 ' CD ' ' HA ' ' A' ' 111' ' ' ASP . 77.3 mtp180 -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 37.6 mt-10 -80.12 -30.43 39.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.332 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 112' ' ' VAL . 42.0 mt -59.01 -40.36 80.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.234 0.54 . . . . 0.0 109.827 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -40.14 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.711 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.9 -30.03 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 43.7 mt-10 -73.51 -32.06 64.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -89.07 -52.34 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 12.1 t70 -104.52 144.97 30.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.885 0.374 . . . . 0.0 110.8 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 -12.67 13.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.775 -174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -103.75 -3.24 25.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.956 0.407 . . . . 0.0 111.167 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.427 ' HG ' ' OD1' ' A' ' 121' ' ' ASP . 75.4 mt -76.08 121.24 22.51 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.2 t -72.37 162.18 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.685 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 5.5 p -66.39 -22.26 66.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.629 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -71.34 -37.79 71.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.92 -36.31 80.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.794 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 8.8 mt -55.53 -38.79 69.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.218 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -81.73 -46.72 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -61.01 -49.78 76.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.001 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.5 mtp -60.76 -47.84 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.126 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 31.2 mm -63.46 -34.63 68.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.56 -31.5 71.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.0 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 44.2 mt-10 -78.72 -41.12 31.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 110.306 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.79 -67.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.832 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.686 ' HA ' HG21 ' A' ' 110' ' ' THR . 6.1 t70 41.91 -127.45 0.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.643 0.589 . . . . 0.0 109.832 -169.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . . . -171.24 -63.43 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.272 0.358 . . . . 0.0 110.822 170.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -158.3 -62.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.938 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.47 47.22 3.43 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.642 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.0 p 47.22 41.75 12.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.11 0.564 . . . . 0.0 111.169 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 109' ' ' SER . . . 133.05 35.5 0.3 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.467 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.4 p -128.27 81.0 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.227 0.514 . . . . 0.0 111.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 42.8 t -65.57 101.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.45 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -88.31 174.45 8.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.119 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -58.5 -48.1 81.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.311 0.577 . . . . 0.0 110.052 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -56.56 -23.22 38.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -90.78 -55.59 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.835 0.35 . . . . 0.0 110.445 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -63.02 -35.09 79.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.475 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 86.9 mtp -81.99 -4.2 56.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -94.12 -42.53 4.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.595 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.8 m -72.41 -19.36 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.006 0.431 . . . . 0.0 110.993 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 94.0 mmm . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.107 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 94' ' ' ARG . 44.2 tt0 . . . . . 0 C--O 1.224 -0.258 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -41.49 -37.29 1.05 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 92' ' ' GLU . 4.3 ppt_? -65.78 -12.57 55.12 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.642 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 6.4 pt-20 -49.77 -49.89 46.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.643 0.259 . . . . 0.0 111.035 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.628 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -65.38 -28.1 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.141 -176.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 101' ' ' ASP . 27.9 t80 -60.99 -51.23 70.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -82.04 -19.62 39.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.875 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 77.0 mt -72.48 -45.14 60.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.554 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -84.73 -47.99 9.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.654 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 108' ' ' ILE . 13.0 t70 -72.04 105.82 4.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.613 0.721 . . . . 0.0 111.879 -175.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -82.24 -13.54 56.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.049 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.78 -50.92 0.67 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -169.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.77 -55.62 27.97 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.16 0.424 . . . . 0.0 114.16 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.17 60.32 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.353 0.597 . . . . 0.0 110.599 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.77 -19.33 2.56 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.2 p90 -151.94 134.43 15.35 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.607 HG22 ' HB2' ' A' ' 101' ' ' ASP . 43.7 pt -114.94 155.4 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.739 ' HB3' HG23 ' A' ' 112' ' ' VAL . 47.7 t -69.81 138.79 52.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.175 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 138' ' ' ALA . 2.4 p -54.51 -32.79 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.619 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -36.56 81.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' SER . 54.6 t -64.79 -33.03 60.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.697 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 46.1 ttm -63.72 -31.76 73.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.466 ' HG2' HG13 ' A' ' 133' ' ' ILE . 72.3 mtm180 -63.13 -41.96 99.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' GLU . 31.4 mt-10 -61.3 -45.77 93.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.407 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.13 -44.38 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.272 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 113' ' ' MET . 92.3 mt -64.95 -40.53 95.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.978 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -72.43 -20.28 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.981 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 2.5 tm-20 -82.02 -38.02 25.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.567 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 tt -76.32 -55.55 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.145 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.75 152.06 37.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.567 0.698 . . . . 0.0 110.744 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -77.77 -33.23 52.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.862 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -165.86 52.57 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.537 HD11 ' HA ' ' A' ' 118' ' ' ALA . 1.3 pp -82.26 150.05 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.719 -0.613 . . . . 0.0 110.004 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.6 m -91.33 172.3 8.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.835 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.1 p -64.93 -39.01 92.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.849 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.71 -34.79 79.02 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.545 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.11 -50.49 72.62 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 109.726 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.11 -48.41 80.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.707 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.43 -46.87 80.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.892 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.07 63.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.0 mtm -61.58 -43.17 99.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.597 0.237 . . . . 0.0 111.255 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.466 HG13 ' HG2' ' A' ' 114' ' ' ARG . 37.1 mm -64.63 -34.96 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.537 0.208 . . . . 0.0 110.481 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.57 -32.78 73.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.33 -39.66 59.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 152' ' ' VAL . 55.5 mt -86.58 -51.33 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.37 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 54.45 -114.79 0.89 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.879 -167.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 143' ' ' THR . . . -156.56 -102.68 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 143' ' ' THR . 7.8 t70 -156.93 -52.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.55 -121.21 3.54 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -80.73 52.58 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.02 0.438 . . . . 0.0 110.307 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.66 32.34 33.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.205 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.536 ' C ' ' HB1' ' A' ' 138' ' ' ALA . 12.0 p -111.98 98.03 7.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.577 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 39.6 t -73.77 112.39 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 169.61 17.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.025 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -59.07 -40.56 85.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.816 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.64 -48.83 70.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.03 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 152' ' ' VAL . 54.8 mm-40 -63.08 -44.06 96.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.617 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -54.1 -48.97 70.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.105 0.479 . . . . 0.0 110.819 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.7 -28.63 70.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.34 -49.27 3.76 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.098 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 136' ' ' ILE . 11.9 p -69.45 -27.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.086 0.469 . . . . 0.0 111.21 179.527 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 10.3 tp10 . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' HG3' ' A' ' 150' ' ' MET . 87.8 mt -52.24 -18.29 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.606 0.639 . . . . 0.0 111.602 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -23.51 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.1 pt-20 -56.51 -47.72 78.73 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.894 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -63.82 -34.16 77.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.2 -46.68 79.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.194 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.4 ptt85 -80.9 -11.26 59.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.542 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 62.3 mt -81.21 -46.49 14.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.686 0.279 . . . . 0.0 110.434 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.441 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 22.0 m-85 -69.13 -49.59 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 12.4 t70 -119.29 95.56 4.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -77.3 -27.08 52.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.539 -173.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -90.96 45.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.69 -146.27 18.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.102 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -85.73 94.08 9.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 101' ' ' ASP . . . -80.66 103.16 2.17 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.478 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.57 ' HB3' ' OG1' ' A' ' 143' ' ' THR . 79.6 m-85 -73.36 74.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.0 pt -69.45 141.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.208 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 m -60.49 133.31 55.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.701 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.664 HG21 ' CB ' ' A' ' 137' ' ' ASP . 20.4 p -65.05 -18.81 65.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.99 -42.92 81.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.277 0.561 . . . . 0.0 109.685 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.66 -37.86 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.225 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.0 ttt -64.12 -37.3 86.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.027 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.458 ' HG2' HG13 ' A' ' 133' ' ' ILE . 96.2 mtt180 -60.83 -27.16 67.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.67 0.271 . . . . 0.0 111.158 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.73 -48.0 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.401 . . . . 0.0 109.99 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 ' CZ ' ' A' ' 100' ' ' TYR . 48.8 mt -53.38 -52.28 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.684 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.879 HD21 HG12 ' A' ' 152' ' ' VAL . 9.2 mp -54.15 -53.28 55.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.093 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.21 63.07 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.58 -17.85 61.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD13 ' C ' ' A' ' 120' ' ' LEU . 3.2 tm? -94.42 -65.64 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -167.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 123' ' ' THR . 1.9 t70 -87.82 -169.72 2.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.423 0.63 . . . . 0.0 112.65 -161.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.46 67.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.517 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 121' ' ' ASP . 13.8 t -176.57 -9.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 128' ' ' ASP . 3.3 pp -130.77 161.59 31.38 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.882 -0.512 . . . . 0.0 110.306 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.5 m -109.8 174.8 5.7 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.642 -171.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' HD13 ' A' ' 129' ' ' LEU . 44.2 m -60.46 -28.66 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.683 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.26 -24.38 67.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.587 0.232 . . . . 0.0 111.594 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.9 m-20 -68.34 -46.55 69.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.324 0.583 . . . . 0.0 109.44 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' A' ' 126' ' ' SER . 5.1 mp -62.08 -36.89 83.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.218 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.81 -38.24 78.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.789 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.68 63.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.9 mtm -75.52 -55.08 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.157 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 15.9 mm -78.9 64.51 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.61 0.719 . . . . 0.0 109.892 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -151.34 -45.56 0.11 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.393 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -106.88 -7.92 16.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.577 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.544 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 -27.42 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.717 0.77 . . . . 0.0 110.12 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.664 ' CB ' HG21 ' A' ' 110' ' ' THR . 17.9 p-10 -112.16 17.76 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.931 -170.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.57 41.32 0.62 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.461 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.06 -13.73 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.184 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.7 55.44 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.614 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 55.14 64.86 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.951 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 74.34 67.96 1.66 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.467 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 107' ' ' TYR . 1.6 t -142.32 130.05 21.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.094 0.473 . . . . 0.0 109.949 173.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.31 128.67 72.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.299 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -108.15 -165.34 1.03 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.964 0.412 . . . . 0.0 110.903 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 10.2 p90 -62.59 166.54 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.235 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER 72.52 -51.33 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.337 0.655 . . . . 0.0 111.311 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -66.73 -36.48 82.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -74.59 75.89 2.0 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.528 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.656 ' HG3' HD12 ' A' ' 93' ' ' LEU . 20.2 ttt -172.41 -52.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.915 171.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.73 83.3 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.538 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.879 HG12 HD21 ' A' ' 117' ' ' LEU . 18.4 t -72.84 -40.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.135 0.493 . . . . 0.0 109.836 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.468 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 26.9 ttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.504 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.286 0.565 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -71.45 -22.76 61.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.608 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.46 49.69 1.41 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.413 0.625 . . . . 0.0 110.583 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -166.51 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 171.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.4 mt -54.63 -21.4 10.43 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.567 0.622 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.8 -15.21 63.44 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 14.8 pt-20 -50.4 -46.1 56.0 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.412 0.445 . . . . 0.0 111.53 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -74.97 -42.92 56.63 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.813 0.34 . . . . 0.0 110.909 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -59.59 -47.5 85.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.008 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 44.0 ptt85 -62.08 -25.41 67.68 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.703 -175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 79.7 mt -74.18 -20.34 60.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.058 0.456 . . . . 0.0 110.728 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -101.91 6.54 41.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.703 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 98' ' ' ARG . 23.1 m-20 -80.75 33.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 103' ' ' GLU . 18.2 pttp -74.24 -47.98 31.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 102' ' ' LYS . 30.7 mt-10 -117.58 105.68 12.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.602 176.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.11 162.34 30.76 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -141.28 111.02 6.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.294 0.547 . . . . 0.0 110.159 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.42 -22.61 8.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.532 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -126.4 79.53 1.86 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -77.21 141.82 15.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.604 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.621 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.0 m -63.52 141.34 58.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.621 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.608 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 18.2 p -53.46 -23.79 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.066 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.27 -51.49 53.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.051 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 109' ' ' SER . 9.8 p -69.62 -34.18 60.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.434 -172.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 144' ' ' VAL . 25.6 ttt -65.66 -25.58 67.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.785 -177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.485 ' HG2' HG13 ' A' ' 133' ' ' ILE . 82.1 mtm180 -60.68 -44.59 96.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.192 0.52 . . . . 0.0 109.845 174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.64 -34.37 73.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.154 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 113' ' ' MET . 59.0 mt -60.39 -47.51 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.667 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.9 -37.9 88.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.07 68.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.932 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -81.32 -17.46 49.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.11 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.42 -61.49 1.5 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.568 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.573 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 14.4 t70 -85.69 158.31 20.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.767 -173.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -116.38 -24.73 7.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -96.24 -40.16 9.31 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.573 ' HG ' ' OD2' ' A' ' 121' ' ' ASP . 4.4 pp -76.48 150.31 36.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.567 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 t -94.65 178.91 5.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.258 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.439 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 15.4 m -63.52 -36.89 85.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.91 -39.28 91.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.773 0.321 . . . . 0.0 110.313 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.63 -53.09 60.9 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.091 0.472 . . . . 0.0 110.447 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 130' ' ' ASP . 4.7 pp -67.3 -34.6 77.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.162 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.551 ' N ' HD12 ' A' ' 129' ' ' LEU . 15.6 t70 -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.084 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.28 72.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.415 ' HB2' ' HE3' ' A' ' 132' ' ' MET . 72.2 mtm -73.18 -35.44 66.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.07 0.462 . . . . 0.0 110.314 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 136' ' ' ILE . 39.7 mm -73.99 -31.01 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.66 0.743 . . . . 0.0 110.132 175.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.2 -27.04 65.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.18 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.52 3.98 23.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 133' ' ' ILE . 6.3 tt -106.08 -23.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.721 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.569 ' OD1' ' HA2' ' A' ' 142' ' ' GLY . 9.8 t0 -41.63 123.54 2.25 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.684 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 139' ' ' ASP . . . -89.14 12.76 14.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.716 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 30.0 t70 76.3 -1.93 2.82 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.981 0.512 . . . . 0.0 112.239 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.82 63.65 4.41 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.344 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.4 m 66.59 25.28 10.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.019 0.437 . . . . 0.0 109.945 -173.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.569 ' HA2' ' OD1' ' A' ' 137' ' ' ASP . . . 80.7 69.46 1.4 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.559 -176.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -134.05 162.22 32.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 113' ' ' MET . 48.7 t -120.2 136.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.45 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -82.87 176.53 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -63.76 -57.99 8.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.621 0.248 . . . . 0.0 111.475 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.27 -29.66 68.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.593 0.235 . . . . 0.0 110.826 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -63.34 -41.57 98.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.985 0.421 . . . . 0.0 109.872 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.51 -49.86 71.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 87.5 mmm -55.73 -50.87 69.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.778 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.719 ' HA2' ' HB3' ' A' ' 157' ' ' ASP . . . -58.96 -43.12 97.03 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.239 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 136' ' ' ILE . 55.3 t -77.44 -40.09 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.918 0.39 . . . . 0.0 111.114 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.3 tpt -69.26 -21.98 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.427 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.1 p -90.44 14.92 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.393 . . . . 0.0 111.087 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.31 -44.81 1.83 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.305 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.96 59.6 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.719 ' HB3' ' HA2' ' A' ' 151' ' ' GLY . 32.6 t70 -81.81 94.49 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 158' ' ' GLU . 6.8 pt-20 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.486 -0.769 . . . . 0.0 111.08 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -87.99 -62.17 1.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.507 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -120.68 56.93 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 64.59 178.29 0.18 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.842 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' SD ' ' A' ' 153' ' ' MET . 55.1 mt -102.13 -1.58 31.19 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.175 0.512 . . . . 0.0 110.377 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.41 -35.37 30.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.041 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.97 -45.56 67.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.425 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 30.4 t80 -71.32 -43.59 66.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.382 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.25 -32.52 62.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.4 mt -73.15 -40.67 64.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.179 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.84 15.74 28.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.423 0.63 . . . . 0.0 110.189 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 103' ' ' GLU . 6.6 t70 -62.26 103.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.835 -172.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' TYR . 14.5 mptt -80.67 -3.82 52.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.289 169.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 2.6 mm-40 -58.5 78.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -165.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 102' ' ' LYS . . . -121.41 55.0 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 156.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 64.75 48.68 2.42 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -159.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.19 -38.84 1.91 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.512 -167.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 40.5 m-85 60.54 -171.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -171.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.7 pt -133.18 142.67 41.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.994 -0.441 . . . . 0.0 110.303 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.574 ' HB2' HG23 ' A' ' 112' ' ' VAL . 15.6 m -70.11 142.16 52.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.051 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.478 HG21 ' HA ' ' A' ' 137' ' ' ASP . 17.1 p -58.94 -31.9 69.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.974 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.32 -45.94 89.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.263 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 109' ' ' SER . 58.8 t -62.88 -43.72 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.319 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.7 tpt -54.37 -36.72 64.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.889 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 110' ' ' THR . 78.8 mtm180 -61.49 -47.32 86.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.409 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.1 -43.78 86.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.73 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 112' ' ' VAL . 76.9 mt -57.49 -40.27 73.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.35 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -80.94 -29.54 35.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.657 -178.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -78.49 -22.11 47.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.28 -26.19 33.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.89 -55.98 5.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.646 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' OD2' ' HG ' ' A' ' 124' ' ' LEU . 25.7 t70 -107.16 142.38 36.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.982 0.42 . . . . 0.0 110.482 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -99.79 -9.05 23.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.779 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.2 p -104.24 -16.78 15.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 129' ' ' LEU . 97.5 mt -79.36 117.63 20.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.802 0.334 . . . . 0.0 110.29 176.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 2.8 t -81.47 155.36 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.361 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -59.65 -32.4 70.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.577 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.6 mp0 -58.71 -50.18 74.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.448 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -34.77 72.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.091 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 117' ' ' LEU . 7.8 mt -69.14 -26.63 64.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.839 -175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.86 -43.68 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.32 -29.66 70.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.55 -52.78 19.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.921 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 129' ' ' LEU . 42.2 mm -58.53 -33.37 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.863 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.79 -27.94 32.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -110.78 10.44 22.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.994 0.425 . . . . 0.0 110.941 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 79.7 mt -128.03 -37.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HA2' ' A' ' 142' ' ' GLY . 7.1 t70 -50.46 126.85 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.046 0.451 . . . . 0.0 111.883 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 143' ' ' THR . . . -92.57 15.6 13.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.177 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 11.1 t70 81.37 -18.86 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 168.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.0 78.58 1.89 Allowed Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.717 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 p 51.6 30.22 6.34 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 110.229 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.517 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 76.68 70.71 1.25 Allowed Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.337 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.495 HG23 ' HB3' ' A' ' 138' ' ' ALA . 9.2 t -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 112.043 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.11 119.25 60.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.755 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.87 153.87 42.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -65.68 -12.84 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -79.74 -38.94 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.213 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.73 -29.5 45.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 97' ' ' PHE . 67.0 t80 -73.6 67.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.68 0.752 . . . . 0.0 109.548 174.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.423 ' HG2' HD12 ' A' ' 93' ' ' LEU . 1.1 tmt? -164.78 -70.33 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.205 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.97 -27.21 73.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.992 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.28 -36.53 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.846 0.355 . . . . 0.0 111.433 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.461 ' SD ' HD22 ' A' ' 93' ' ' LEU . 23.9 ptm -97.64 -16.36 20.02 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.634 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.6 p -105.74 63.41 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.133 0.492 . . . . 0.0 110.468 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.35 -94.38 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.72 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -87.27 -6.69 77.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.136 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.39 175.86 6.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.94 -177.568 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -79.95 156.84 27.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.271 0.558 . . . . 0.0 110.76 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 1.1 pm0 -80.47 8.16 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.214 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -56.25 -41.54 75.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.37 -43.76 89.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.212 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 13.4 ttp85 -69.37 -39.63 77.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -67.83 -43.44 79.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.23 90.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.687 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.84 -42.47 93.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.656 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 38.6 mtm180 -63.78 -36.52 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.804 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.12 -14.32 33.9 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.56 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -89.43 -26.46 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.478 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -91.89 86.45 5.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -61.27 -32.93 72.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.939 -174.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' HB2' HD21 ' A' ' 105' ' ' ASN . 41.3 mm-40 -85.47 -36.96 20.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.419 -175.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.97 54.48 1.89 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.228 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 103' ' ' GLU . 30.4 m-80 -93.1 -35.38 13.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.257 0.551 . . . . 0.0 110.023 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.56 5.12 57.93 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 145' ' ' ASP . 9.9 m-85 -136.29 145.11 45.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 144' ' ' VAL . 28.6 pt -123.32 140.73 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 111.231 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.667 ' HB3' HG23 ' A' ' 112' ' ' VAL . 34.9 t -67.16 144.98 55.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.605 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.608 HG21 ' HA ' ' A' ' 137' ' ' ASP . 8.2 p -58.96 -27.18 65.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.417 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 114' ' ' ARG . 18.4 t0 -70.43 -35.27 73.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 110.043 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 109' ' ' SER . 73.6 t -66.86 -41.27 87.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.503 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.2 tpt -56.22 -34.75 66.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.839 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 111' ' ' ASP . 15.2 mtp180 -56.04 -53.88 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.693 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.57 -36.03 80.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 112' ' ' VAL . 73.8 mt -57.62 -44.14 84.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.96 -41.67 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -68.66 -29.19 67.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.63 -5.75 59.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.003 0.43 . . . . 0.0 110.755 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 tt -88.49 -50.51 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -130.6 147.34 52.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -95.79 -22.75 17.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.468 -176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -82.1 -20.31 38.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.555 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.9 pp -76.93 152.19 35.41 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.968 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -107.27 176.94 5.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.703 0.287 . . . . 0.0 110.979 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.651 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 12.1 p -69.44 -25.44 64.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.929 0.395 . . . . 0.0 110.603 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.85 -39.66 89.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 132' ' ' MET . 27.0 m-20 -61.29 -38.91 88.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 12.9 mt -56.93 -44.4 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.374 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.88 -47.9 73.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.699 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.73 -43.6 98.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.726 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 128' ' ' ASP . 24.2 mmt -58.2 -55.62 32.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 111.183 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.07 -35.7 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.321 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -55.98 -26.67 49.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.713 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -118.2 10.17 12.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 111.42 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.63 -69.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.524 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HA ' HG21 ' A' ' 110' ' ' THR . 4.5 m-20 47.11 -145.63 0.25 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 -171.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.489 ' H ' ' HB3' ' A' ' 137' ' ' ASP . . . -164.74 -89.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.578 0.227 . . . . 0.0 111.476 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.2 -59.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.589 0.233 . . . . 0.0 111.593 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 143' ' ' THR . . . -93.46 70.9 1.4 Allowed Glycine 0 C--O 1.227 -0.316 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.938 -172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 61.26 36.19 17.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 109.941 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.1 45.26 5.99 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.378 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 140' ' ' GLY . 6.8 p -91.44 87.72 6.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.023 0.439 . . . . 0.0 111.174 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 108' ' ' ILE . 42.5 t -78.68 110.91 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.421 ' HB3' ' HD1' ' A' ' 107' ' ' TYR . 7.0 p-10 -85.43 176.27 8.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.894 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -61.05 -38.93 87.92 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -66.88 -49.13 66.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.6 -51.11 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.731 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.96 -42.5 76.32 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.359 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 ttp -68.75 -53.97 18.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.698 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.28 -25.83 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.649 0.261 . . . . 0.0 111.54 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.9 ttm -100.99 -43.96 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.978 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.2 p -73.47 -12.98 60.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -100.55 74.11 0.42 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.3 -4.13 1.1 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.702 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -73.7 154.9 39.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.599 -0.353 . . . . 0.0 110.09 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.956 -175.135 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.29 112.01 20.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 111.185 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.86 74.15 1.48 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -34.35 102.32 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.297 -1.319 . . . . 0.0 113.368 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.72 -21.39 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.789 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -59.82 -27.61 66.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.885 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.18 -48.23 79.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.954 0.407 . . . . 0.0 110.288 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.73 84.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.49 -43.88 88.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.491 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 98' ' ' ARG . 5.7 mmp_? -54.5 -36.42 64.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.618 0.367 . . . . 0.0 111.504 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.09 -49.47 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -83.49 -23.82 32.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.98 -39.16 91.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.619 0.723 . . . . 0.0 109.404 171.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -71.06 -25.93 62.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.708 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -79.85 -19.4 48.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.506 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.37 -109.44 0.5 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.555 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -125.52 -172.1 2.52 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.69 76.49 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.169 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.34 112.37 17.51 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.4 141.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 111.225 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.3 m -67.89 137.31 55.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.671 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 p -60.21 -23.07 63.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.431 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -59.06 -45.96 89.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 109.837 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 116' ' ' ILE . 41.3 t -64.79 -38.6 83.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.854 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.1 ttt -59.96 -37.45 79.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -63.53 -46.1 87.56 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.2 -39.06 78.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 112' ' ' VAL . 68.1 mt -67.67 -57.38 9.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.479 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.987 HD11 HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -73.04 -22.61 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -171.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -66.18 -29.04 69.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.08 0.467 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.85 -23.03 42.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -67.44 -52.75 35.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.033 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.406 ' CG ' ' HG ' ' A' ' 124' ' ' LEU . 23.0 t70 -92.52 159.24 15.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.272 0.558 . . . . 0.0 110.159 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.2 -25.74 52.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.938 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.3 t -149.23 26.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.943 ' HB3' HD21 ' A' ' 129' ' ' LEU . 40.5 mt -76.36 114.56 15.19 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.947 174.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 6.9 m -81.75 157.62 24.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.261 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 m -53.29 -45.78 69.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.23 -44.21 83.58 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.069 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.32 -35.64 77.95 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.137 0.494 . . . . 0.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.987 HD22 HD11 ' A' ' 117' ' ' LEU . 7.4 mt -76.06 -44.75 37.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.275 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.5 -33.67 76.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.669 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.99 -31.14 72.22 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.749 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.55 -32.9 25.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.172 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 129' ' ' LEU . 25.7 mm -59.92 -37.6 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.897 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.13 -32.49 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.59 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -80.05 -27.54 39.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.064 0.459 . . . . 0.0 110.574 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 61.0 mt -85.83 -40.23 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.109 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 118.23 9.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.313 0.578 . . . . 0.0 111.687 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.26 19.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.318 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.12 -99.7 0.44 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.426 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -108.35 71.71 0.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.169 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.8 m 64.66 13.53 8.39 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.24 71.44 0.36 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.921 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.34 122.58 37.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.811 0.338 . . . . 0.0 111.095 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.4 t -110.4 135.58 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.874 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 148' ' ' GLU . 3.9 p-10 -95.56 -173.06 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.508 ' O ' ' HG2' ' A' ' 150' ' ' MET . 32.9 p90 -68.43 -47.32 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -173.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.96 -22.02 31.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.461 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 145' ' ' ASP . 7.0 tp10 -63.6 -41.73 98.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 172.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.01 -39.67 93.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.029 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 25.2 mmt -63.09 -52.57 62.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.767 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.06 -40.66 66.92 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.131 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 148' ' ' GLU . 77.1 t -67.86 -49.4 69.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 110.859 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 88.7 mmm -71.27 -34.09 70.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.8 p -93.83 10.0 34.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.293 . . . . 0.0 111.231 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -112.15 126.88 7.8 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.566 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.87 -7.83 36.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.971 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.82 128.35 33.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--O 1.248 0.995 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.335 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -98.32 72.05 2.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.217 0.532 . . . . 0.0 110.965 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.88 -34.92 24.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.13 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -81.51 111.53 17.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.234 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.64 -9.35 58.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.952 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.1 mmt85 -58.29 -47.29 84.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.873 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 21.3 tt0 -69.61 -41.49 75.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.67 79.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.03 -43.67 91.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.563 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -69.73 -21.1 63.5 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.3 mt -66.0 -33.4 75.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.102 0.477 . . . . 0.0 110.496 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 96.7 m-85 -101.62 -36.25 8.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.279 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -99.76 92.98 5.57 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 109.62 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 99' ' ' LEU . 34.4 mmtp -77.27 -48.64 16.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.031 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.18 40.34 0.48 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.26 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.55 10.6 68.98 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.176 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.17 21.22 4.86 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.238 0.615 . . . . 0.0 110.797 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.36 36.1 15.51 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.551 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 145' ' ' ASP . 53.5 m-85 -142.72 107.19 4.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 0.0 110.599 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.8 pt -97.34 140.86 16.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.132 0.491 . . . . 0.0 110.423 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 112' ' ' VAL . 17.7 m -69.98 142.3 52.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.574 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.509 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 21.2 p -60.1 -27.77 67.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.727 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -40.82 80.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.289 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 109' ' ' SER . 57.5 t -70.23 -37.94 73.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.367 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 52.7 tpp -59.2 -34.16 71.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.81 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.535 ' HG2' HG13 ' A' ' 133' ' ' ILE . 67.9 mtt180 -57.3 -36.98 71.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.355 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.29 -37.33 38.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.814 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 112' ' ' VAL . 52.4 mt -58.83 -53.69 44.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.715 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.2 -36.89 85.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.72 -28.65 67.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.287 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -84.94 -42.11 15.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.217 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.28 -51.81 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.242 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.84 139.15 38.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.429 . . . . 0.0 110.256 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.45 -2.32 23.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.419 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.3 p -105.76 -24.18 12.56 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 124' ' ' LEU . 3.0 pp -76.28 154.96 34.71 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.876 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.5 p -124.76 -178.49 4.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.363 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 p -54.66 -43.72 72.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.398 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -58.81 -54.59 45.39 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.409 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.55 -49.3 77.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.794 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.8 -49.77 75.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.73 85.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.942 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 71.7 mtm -82.19 -41.38 20.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 136' ' ' ILE . 44.2 mm -70.79 -33.83 54.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.312 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.79 -16.21 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.226 0.536 . . . . 0.0 110.504 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -101.32 -15.81 17.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.524 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 133' ' ' ILE . 5.8 tt -89.47 -23.55 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.47 ' HA ' HG21 ' A' ' 110' ' ' THR . 36.7 m-20 -43.97 106.6 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.551 0.532 . . . . 0.0 110.495 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.0 -61.21 1.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -171.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 143' ' ' THR . 5.6 m-20 -85.9 -86.56 0.14 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -164.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.57 -107.0 2.4 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.472 -171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 46.75 0.63 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.3 60.64 2.64 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 139' ' ' ASP . 3.0 p -121.98 146.12 47.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 148' ' ' GLU . 63.9 t -128.19 123.19 59.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.83 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 107' ' ' TYR . 1.6 p-10 -97.02 -175.53 3.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -58.91 -34.17 71.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -60.65 -58.19 9.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.067 0.46 . . . . 0.0 110.751 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 144' ' ' VAL . 10.6 tp10 -66.98 -32.49 73.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.328 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.61 -46.76 88.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.209 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 81.0 mtp -80.91 -3.99 53.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.153 0.502 . . . . 0.0 110.704 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.75 -44.86 5.64 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.632 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 153' ' ' MET . 7.7 p -70.27 -34.14 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 110.587 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.555 ' HG3' HG13 ' A' ' 152' ' ' VAL . 66.5 mtt -102.67 178.67 4.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.282 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 31.1 p 48.2 58.85 4.72 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.287 0.635 . . . . 0.0 111.934 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -114.82 73.06 0.24 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.471 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 117.25 70.34 0.41 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -116.0 137.61 51.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.532 178.195 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.49 0.186 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 6.4 tp60 -73.38 108.38 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.233 0.539 . . . . 0.0 111.031 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.48 -68.37 0.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.749 ' HG2' ' H ' ' A' ' 93' ' ' LEU . 16.2 tt0 63.93 -175.98 0.16 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.161 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.749 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 79.6 mt -89.64 10.23 23.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.541 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 16.2 mmt180 -59.92 -43.12 95.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.703 -175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.5 mm-40 -60.88 -35.98 78.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.175 0.297 . . . . 0.0 111.721 -176.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.09 85.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -79.38 -36.7 38.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.656 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 94' ' ' ARG . 29.4 mtm180 -63.69 -21.6 66.47 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.78 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 96.6 mt -61.12 -43.75 98.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.07 0.462 . . . . 0.0 110.699 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -91.35 -19.68 22.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.39 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 98' ' ' ARG . 10.1 t70 -57.96 -48.4 80.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.034 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -55.02 -39.35 69.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.173 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.35 55.13 1.69 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.554 0.692 . . . . 0.0 110.748 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.84 14.33 1.74 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.602 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.39 19.83 10.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.187 0.595 . . . . 0.0 111.346 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 -62.8 3.44 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.224 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 22.8 m-85 -84.06 89.17 7.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.498 ' CG1' ' HB ' ' A' ' 144' ' ' VAL . 38.6 pt -69.53 141.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 111.632 -173.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -59.01 139.77 56.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.643 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 137' ' ' ASP . 14.0 p -62.08 -16.05 49.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.72 -39.47 73.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.046 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.9 t -74.73 -32.76 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.52 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.5 tpp -61.4 -32.94 72.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.423 ' HG2' HG13 ' A' ' 133' ' ' ILE . 81.0 mtp180 -58.56 -40.61 83.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 110.059 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -70.94 -35.78 72.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.426 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.1 mt -70.04 -39.03 76.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.2 -40.16 93.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -70.07 -19.72 63.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.657 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.94 -35.43 37.73 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.732 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -73.85 -62.89 1.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.352 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -105.87 141.7 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.607 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -110.52 14.95 22.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.5 p -115.98 -16.1 11.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.632 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 118' ' ' ALA . 3.6 pp -76.04 151.26 37.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 m -112.46 179.31 4.02 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.828 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.9 t -61.41 -36.74 81.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.31 . . . . 0.0 110.215 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.35 -46.27 80.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.881 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.61 -39.38 76.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.638 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.9 -34.14 71.26 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.813 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.95 76.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.26 -46.45 60.92 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.005 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 110' ' ' THR . 48.2 mm -81.2 68.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 122.083 0.944 . . . . 0.0 109.928 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.21 -42.67 0.14 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.509 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -112.95 23.27 13.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.11 0.957 . . . . 0.0 108.735 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.72 -42.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.947 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.763 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 6.8 p-10 -89.74 138.71 31.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.814 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.596 ' H ' ' HA3' ' A' ' 142' ' ' GLY . . . -152.55 15.6 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.656 173.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 61.82 98.98 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.244 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.17 -42.56 2.06 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.5 m -117.11 61.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.763 ' HA3' ' HA ' ' A' ' 137' ' ' ASP . . . 173.16 -40.84 0.15 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.411 -175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 107' ' ' TYR . 2.4 p -64.84 101.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.498 ' HB ' ' CG1' ' A' ' 108' ' ' ILE . 94.8 t -45.07 108.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -163.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.82 165.32 21.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.534 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -47.4 -50.36 22.72 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.084 0.554 . . . . 0.0 111.45 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.65 -15.38 32.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 144' ' ' VAL . 27.1 tt0 -70.39 -31.39 68.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -56.23 -43.81 78.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 51.9 ttm -64.67 -40.22 95.03 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.563 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.15 -31.34 72.84 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.545 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.79 -40.55 39.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.0 mmt -70.85 -44.65 65.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.326 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.2 p -101.93 36.35 2.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.137 0.494 . . . . 0.0 110.897 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.19 76.67 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.388 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.85 56.91 0.75 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.35 128.38 36.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 111.487 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.974 175.497 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.716 0.294 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -142.3 116.79 9.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.973 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 3.0 pm0 -66.42 -26.61 67.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.957 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 49.08 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.896 0.748 . . . . 0.0 112.913 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 45.6 mt -74.45 -7.91 54.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.581 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -76.81 -16.29 59.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.488 -174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.6 -41.53 97.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.647 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.49 -41.68 31.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.57 -36.37 80.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.508 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.42 -16.05 64.02 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.829 0.347 . . . . 0.0 111.346 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.78 -33.75 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.409 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.44 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 51.2 m-85 -85.33 -34.79 21.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.931 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -79.56 66.37 5.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.696 0.76 . . . . 0.0 109.685 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 46.3 mtpt -68.91 -49.68 56.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.034 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' OE2' ' HB2' ' A' ' 102' ' ' LYS . 6.8 mp0 -71.82 -23.37 61.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.357 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.91 62.14 1.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.732 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.89 -37.0 7.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.791 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.63 66.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.472 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 41.9 p90 -154.7 144.21 21.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.55 144.04 29.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.462 0.649 . . . . 0.0 111.256 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 m -62.83 139.97 58.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.882 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.856 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 11.8 p -55.88 -21.84 22.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.681 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -59.72 -30.68 68.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.928 0.394 . . . . 0.0 110.944 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 116' ' ' ILE . 24.9 t -73.0 -27.57 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.098 0.475 . . . . 0.0 110.19 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.0 tpt -65.93 -38.08 87.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.418 ' HB2' HD13 ' A' ' 129' ' ' LEU . 2.0 ptt180 -73.75 -18.98 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.524 -0.471 . . . . 0.0 110.941 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -75.15 -42.15 56.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 112' ' ' VAL . 64.1 mt -60.7 -51.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.408 175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.51 -32.56 68.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.737 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.35 68.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.223 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -96.99 -36.67 10.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.91 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.64 -45.75 88.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -99.23 -177.04 3.48 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.45 89.25 3.31 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.071 0.938 . . . . 0.0 109.586 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.1 t 49.73 77.8 0.11 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.934 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.48 137.65 35.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.998 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 t -75.68 160.29 30.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.408 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -36.17 66.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.859 0.362 . . . . 0.0 110.674 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.89 -27.87 69.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.91 -42.79 20.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.557 0.694 . . . . 0.0 110.033 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 133' ' ' ILE . 81.3 mt -65.88 -37.34 85.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.309 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -51.77 -49.53 62.47 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.553 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.28 82.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.214 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.0 mmt -58.6 -39.33 80.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.603 HG23 ' HB ' ' A' ' 110' ' ' THR . 30.5 mm -78.52 -34.97 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.016 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.38 -40.36 96.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.948 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.49 -15.99 55.4 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.704 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.513 HG21 HG22 ' A' ' 144' ' ' VAL . 25.0 mt -102.79 -57.94 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.463 ' N ' HG21 ' A' ' 110' ' ' THR . 10.6 t70 63.49 155.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.01 0.819 . . . . 0.0 112.955 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.856 ' HB2' ' H ' ' A' ' 110' ' ' THR . . . -117.08 65.2 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.019 -0.426 . . . . 0.0 111.062 -176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -123.02 -41.95 2.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.08 138.6 2.51 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.7 p 46.84 37.42 4.8 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.869 0.842 . . . . 0.0 109.944 -170.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.54 -36.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.548 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.53 112.23 0.52 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 136' ' ' ILE . 37.7 t -69.77 104.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.493 -162.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 0.9 OUTLIER -93.82 -173.52 3.17 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 174.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 93' ' ' LEU . 71.5 t80 -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.932 0.333 . . . . 0.0 111.303 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -65.32 -48.24 73.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.564 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 152' ' ' VAL . 8.7 tp10 -63.99 -44.62 92.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -55.91 -44.57 78.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.675 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 46.2 ttm -59.15 -49.03 79.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.762 ' HA2' ' HA3' ' A' ' 155' ' ' GLY . . . -66.33 -31.7 79.79 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.311 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 148' ' ' GLU . 96.5 t -81.27 -47.58 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.792 0.296 . . . . 0.0 111.596 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.525 ' HE1' HD22 ' A' ' 93' ' ' LEU . 53.4 ttp -75.43 -39.1 59.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.0 t -157.0 50.91 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.015 0.912 . . . . 0.0 110.591 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.762 ' HA3' ' HA2' ' A' ' 151' ' ' GLY . . . -114.46 5.91 22.96 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.147 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -147.65 -36.77 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.71 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.55 121.6 42.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.057 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 76.5 mmm . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -78.3 59.42 2.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -113.49 8.58 17.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 168.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.35 111.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.969 -1.468 . . . . 0.0 112.415 -171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.95 -27.81 66.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.053 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -59.72 -36.16 76.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.197 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.99 -45.05 91.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.978 0.418 . . . . 0.0 110.713 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.4 -45.36 16.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.078 0.466 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -62.0 -32.3 72.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.846 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.482 ' HA ' ' OD1' ' A' ' 101' ' ' ASP . 14.1 ptm180 -67.2 -12.86 61.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.098 0.475 . . . . 0.0 111.386 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.0 mt -88.72 -22.47 23.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.256 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -101.98 -30.08 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.971 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.482 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -78.07 9.35 3.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 -177.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.658 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 48.3 pttt -38.6 -48.26 1.42 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.663 1.185 . . . . 0.0 112.906 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 102' ' ' LYS . 21.5 mm-40 -111.24 -11.02 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.043 0.449 . . . . 0.0 110.728 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.73 -17.84 50.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.516 -170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 58.91 35.22 24.07 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 118.68 -29.77 6.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.011 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 28.3 p90 -123.07 125.71 45.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.008 0.432 . . . . 0.0 110.1 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 pt -110.14 150.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.226 0.536 . . . . 0.0 111.563 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 34.4 t -58.23 137.36 57.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.135 174.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 137' ' ' ASP . 6.3 p -61.3 -22.54 64.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.971 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HA ' ' CD ' ' A' ' 114' ' ' ARG . 28.8 t70 -64.4 -35.62 81.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.465 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' ILE . 58.7 t -66.73 -35.65 75.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.078 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 43.9 ttp -74.46 -20.15 60.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.958 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.488 ' CD ' ' HA ' ' A' ' 111' ' ' ASP . 77.3 mtp180 -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 37.6 mt-10 -80.12 -30.43 39.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.332 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 112' ' ' VAL . 42.0 mt -59.01 -40.36 80.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.234 0.54 . . . . 0.0 109.827 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -40.14 91.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.711 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.9 -30.03 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 43.7 mt-10 -73.51 -32.06 64.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.815 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -89.07 -52.34 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 12.1 t70 -104.52 144.97 30.96 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.885 0.374 . . . . 0.0 110.8 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 -12.67 13.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.775 -174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -103.75 -3.24 25.24 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.956 0.407 . . . . 0.0 111.167 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.427 ' HG ' ' OD1' ' A' ' 121' ' ' ASP . 75.4 mt -76.08 121.24 22.51 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.2 t -72.37 162.18 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.809 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.685 ' HA ' ' HG ' ' A' ' 129' ' ' LEU . 5.5 p -66.39 -22.26 66.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.629 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -71.34 -37.79 71.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.92 -36.31 80.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.794 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 126' ' ' SER . 8.8 mt -55.53 -38.79 69.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.218 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -81.73 -46.72 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -61.01 -49.78 76.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.001 -176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 90.5 mtp -60.76 -47.84 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.962 0.41 . . . . 0.0 111.126 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 31.2 mm -63.46 -34.63 68.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.56 -31.5 71.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.0 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 44.2 mt-10 -78.72 -41.12 31.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 110.306 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.79 -67.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.832 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.686 ' HA ' HG21 ' A' ' 110' ' ' THR . 6.1 t70 41.91 -127.45 0.61 Allowed 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.643 0.589 . . . . 0.0 109.832 -169.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . . . -171.24 -63.43 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.272 0.358 . . . . 0.0 110.822 170.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -158.3 -62.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.938 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.47 47.22 3.43 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.642 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 59.0 p 47.22 41.75 12.37 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.11 0.564 . . . . 0.0 111.169 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 109' ' ' SER . . . 133.05 35.5 0.3 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.27 -0.966 . . . . 0.0 113.467 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.4 p -128.27 81.0 2.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.227 0.514 . . . . 0.0 111.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 42.8 t -65.57 101.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.45 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -88.31 174.45 8.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.119 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -58.5 -48.1 81.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.311 0.577 . . . . 0.0 110.052 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -56.56 -23.22 38.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -90.78 -55.59 3.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.835 0.35 . . . . 0.0 110.445 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -63.02 -35.09 79.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.475 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 86.9 mtp -81.99 -4.2 56.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -94.12 -42.53 4.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.595 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.8 m -72.41 -19.36 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.006 0.431 . . . . 0.0 110.993 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 94.0 mmm -112.0 165.54 12.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.107 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 p 65.66 -60.2 0.28 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.373 1.469 . . . . 0.0 112.226 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.11 79.37 0.07 OUTLIER Glycine 0 CA--C 1.518 0.247 0 O-C-N 123.471 0.482 . . . . 0.0 113.933 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 125.17 -30.39 4.56 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.698 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -101.11 134.9 43.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.833 0.349 . . . . 0.0 110.293 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.579 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 91.5 mtp . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -89.1 -23.19 22.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -97.18 40.4 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.527 0.68 . . . . 0.0 110.97 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 94' ' ' ARG . 44.2 tt0 -72.84 155.95 39.39 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -41.49 -37.29 1.05 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 92' ' ' GLU . 4.3 ppt_? -65.78 -12.57 55.12 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.642 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 6.4 pt-20 -49.77 -49.89 46.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.643 0.259 . . . . 0.0 111.035 177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.628 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -65.38 -28.1 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.141 -176.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 101' ' ' ASP . 27.9 t80 -60.99 -51.23 70.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -82.04 -19.62 39.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.875 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 77.0 mt -72.48 -45.14 60.88 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.554 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -84.73 -47.99 9.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.654 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 108' ' ' ILE . 13.0 t70 -72.04 105.82 4.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.613 0.721 . . . . 0.0 111.879 -175.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -82.24 -13.54 56.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.049 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -136.78 -50.92 0.67 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -169.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.77 -55.62 27.97 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 114.16 0.424 . . . . 0.0 114.16 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.17 60.32 2.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.353 0.597 . . . . 0.0 110.599 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.77 -19.33 2.56 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.2 p90 -151.94 134.43 15.35 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.607 HG22 ' HB2' ' A' ' 101' ' ' ASP . 43.7 pt -114.94 155.4 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 111.148 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.739 ' HB3' HG23 ' A' ' 112' ' ' VAL . 47.7 t -69.81 138.79 52.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.175 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 138' ' ' ALA . 2.4 p -54.51 -32.79 58.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.619 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.36 -36.56 81.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' SER . 54.6 t -64.79 -33.03 60.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.697 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.435 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 46.1 ttm -63.72 -31.76 73.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.634 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.466 ' HG2' HG13 ' A' ' 133' ' ' ILE . 72.3 mtm180 -63.13 -41.96 99.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' GLU . 31.4 mt-10 -61.3 -45.77 93.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.407 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.9 mt -65.13 -44.38 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.272 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 113' ' ' MET . 92.3 mt -64.95 -40.53 95.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.978 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 124' ' ' LEU . . . -72.43 -20.28 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.981 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 2.5 tm-20 -82.02 -38.02 25.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.567 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.0 tt -76.32 -55.55 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.145 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -75.75 152.06 37.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.567 0.698 . . . . 0.0 110.744 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -77.77 -33.23 52.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.862 -171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.8 t -165.86 52.57 0.1 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.537 HD11 ' HA ' ' A' ' 118' ' ' ALA . 1.3 pp -82.26 150.05 27.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.719 -0.613 . . . . 0.0 110.004 169.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.6 m -91.33 172.3 8.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.835 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.1 p -64.93 -39.01 92.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.849 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.71 -34.79 79.02 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.545 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.11 -50.49 72.62 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 109.726 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.11 -48.41 80.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.707 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.43 -46.87 80.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.892 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.11 -51.07 63.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.424 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 72.0 mtm -61.58 -43.17 99.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.597 0.237 . . . . 0.0 111.255 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.466 HG13 ' HG2' ' A' ' 114' ' ' ARG . 37.1 mm -64.63 -34.96 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.537 0.208 . . . . 0.0 110.481 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.57 -32.78 73.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.902 0.382 . . . . 0.0 111.079 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.33 -39.66 59.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.081 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 152' ' ' VAL . 55.5 mt -86.58 -51.33 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.37 -173.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 54.45 -114.79 0.89 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.879 -167.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 143' ' ' THR . . . -156.56 -102.68 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 143' ' ' THR . 7.8 t70 -156.93 -52.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.55 -121.21 3.54 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 m -80.73 52.58 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.02 0.438 . . . . 0.0 110.307 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.66 32.34 33.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.205 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.536 ' C ' ' HB1' ' A' ' 138' ' ' ALA . 12.0 p -111.98 98.03 7.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.577 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 39.6 t -73.77 112.39 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.9 169.61 17.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.025 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -59.07 -40.56 85.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.816 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.64 -48.83 70.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.03 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 152' ' ' VAL . 54.8 mm-40 -63.08 -44.06 96.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.617 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -54.1 -48.97 70.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.105 0.479 . . . . 0.0 110.819 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.7 -28.63 70.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.34 -49.27 3.76 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.098 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 136' ' ' ILE . 11.9 p -69.45 -27.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 80.9 mtp -104.48 69.41 0.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.086 0.469 . . . . 0.0 111.21 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.6 p -138.82 -51.07 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.913 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.97 -121.12 11.4 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.717 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.37 14.24 6.92 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.944 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -76.2 132.01 39.68 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.156 -177.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -98.55 124.7 43.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.921 0.391 . . . . 0.0 111.351 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 91' ' ' GLN . 9.8 mm-40 -108.42 17.85 21.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.67 0.748 . . . . 0.0 109.917 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 10.3 tp10 -77.23 -177.73 4.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.929 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' HG3' ' A' ' 150' ' ' MET . 87.8 mt -52.24 -18.29 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.606 0.639 . . . . 0.0 111.602 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -23.51 7.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 8.1 pt-20 -56.51 -47.72 78.73 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.894 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 95' ' ' GLU . . . -63.82 -34.16 77.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.358 . . . . 0.0 110.604 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.2 -46.68 79.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.194 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.4 ptt85 -80.9 -11.26 59.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.542 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 62.3 mt -81.21 -46.49 14.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.686 0.279 . . . . 0.0 110.434 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.441 ' CZ ' HG12 ' A' ' 116' ' ' ILE . 22.0 m-85 -69.13 -49.59 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 12.4 t70 -119.29 95.56 4.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -77.3 -27.08 52.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.539 -173.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -90.96 45.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.69 -146.27 18.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.102 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -85.73 94.08 9.02 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 101' ' ' ASP . . . -80.66 103.16 2.17 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.478 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.57 ' HB3' ' OG1' ' A' ' 143' ' ' THR . 79.6 m-85 -73.36 74.37 1.36 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 170.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.0 pt -69.45 141.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.208 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 m -60.49 133.31 55.97 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.701 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.664 HG21 ' CB ' ' A' ' 137' ' ' ASP . 20.4 p -65.05 -18.81 65.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -56.99 -42.92 81.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.277 0.561 . . . . 0.0 109.685 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.66 -37.86 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.225 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.0 ttt -64.12 -37.3 86.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.027 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.458 ' HG2' HG13 ' A' ' 133' ' ' ILE . 96.2 mtt180 -60.83 -27.16 67.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.67 0.271 . . . . 0.0 111.158 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.73 -48.0 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.943 0.401 . . . . 0.0 109.99 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 ' CZ ' ' A' ' 100' ' ' TYR . 48.8 mt -53.38 -52.28 33.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.684 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.895 ' HB3' ' HA3' ' A' ' 156' ' ' GLY . 9.2 mp -54.15 -53.28 55.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.093 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . . . -61.59 -20.21 63.07 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.58 -17.85 61.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 154' ' ' THR . 3.2 tm? -94.42 -65.64 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -167.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 157' ' ' ASP . 1.9 t70 -87.82 -169.72 2.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.423 0.63 . . . . 0.0 112.65 -161.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.46 67.37 0.4 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.517 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 121' ' ' ASP . 13.8 t -176.57 -9.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.814 ' HG ' ' HB3' ' A' ' 157' ' ' ASP . 3.3 pp -130.77 161.59 31.38 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.882 -0.512 . . . . 0.0 110.306 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.5 m -109.8 174.8 5.7 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.642 -171.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' HD13 ' A' ' 129' ' ' LEU . 44.2 m -60.46 -28.66 68.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.683 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.26 -24.38 67.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.587 0.232 . . . . 0.0 111.594 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB2' HD13 ' A' ' 124' ' ' LEU . 6.9 m-20 -68.34 -46.55 69.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.324 0.583 . . . . 0.0 109.44 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.677 HD11 ' H ' ' A' ' 157' ' ' ASP . 5.1 mp -62.08 -36.89 83.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.218 174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.81 -38.24 78.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.789 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.36 -38.68 63.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.436 ' HE1' ' O ' ' A' ' 155' ' ' GLY . 71.9 mtm -75.52 -55.08 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.157 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 15.9 mm -78.9 64.51 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.61 0.719 . . . . 0.0 109.892 -177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -151.34 -45.56 0.11 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.393 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -106.88 -7.92 16.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.577 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.544 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.1 OUTLIER -84.9 -27.42 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.717 0.77 . . . . 0.0 110.12 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.664 ' CB ' HG21 ' A' ' 110' ' ' THR . 17.9 p-10 -112.16 17.76 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.931 -170.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.57 41.32 0.62 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.461 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.06 -13.73 15.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.184 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.7 55.44 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.614 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.0 m 55.14 64.86 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.225 0.536 . . . . 0.0 110.951 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 137' ' ' ASP . . . 74.34 67.96 1.66 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.467 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 107' ' ' TYR . 1.6 t -142.32 130.05 21.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.094 0.473 . . . . 0.0 109.949 173.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.31 128.67 72.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.299 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -108.15 -165.34 1.03 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.964 0.412 . . . . 0.0 110.903 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 10.2 p90 -62.59 166.54 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.235 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 0.3 OUTLIER 72.52 -51.33 0.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.337 0.655 . . . . 0.0 111.311 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -66.73 -36.48 82.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -74.59 75.89 2.0 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.528 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.656 ' HG3' HD12 ' A' ' 93' ' ' LEU . 20.2 ttt -172.41 -52.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.915 171.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -68.27 -35.73 83.3 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.538 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.879 HG12 HD21 ' A' ' 117' ' ' LEU . 18.4 t -72.84 -40.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.135 0.493 . . . . 0.0 109.836 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.468 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 26.9 ttt -63.5 152.16 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.504 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.743 HG22 ' HG ' ' A' ' 120' ' ' LEU . 14.3 p 70.23 -19.64 0.21 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.129 0.972 . . . . 0.0 111.441 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 153' ' ' MET . . . -87.93 9.68 73.44 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.895 ' HA3' ' HB3' ' A' ' 117' ' ' LEU . . . -119.73 154.85 16.31 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.814 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 12.7 t0 -172.51 151.12 2.37 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.141 -170.622 . . . . . . . . 0 0 . 1 stop_ save_